Genes for modifying plant traits xi

ABSTRACT

The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs and orthologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods and is also disclosed.

FIELD OF THE INVENTION AND INTRODUCTION

[0001] This invention relates to the field of plant biology. More particularly, the present invention pertains to compositions and methods for phenotypically modifying a plant.

[0002] A plant's traits, such as its biochemical, developmental, or phenotypic characteristics, can be controlled through a number of cellular processes. One important way to manipulate that control is through transcription factors—proteins that influence the expression of a particular gene or sets of genes. Transgenic plants that comprise cells having altered levels of at least one selected transcription factor, for example, possess advantageous or desirable traits. Strategies for manipulating traits by altering a plant cell's transcription factor content can therefore result in plants and crops with commercially valuable properties. Applicants have identified polynulceotides encoding transcription factors, developed numerous transgenic plants using these polynucleotides, and have analyzed the plants for a variety of important traits. In so doing, applicants have identified important polynucleotide and polypeptide sequences for producing commercially valuable plants and crops as well as the methods for making them and using them. Other aspects and embodiments of the invention are described below and can be derived from the teachings of this disclosure as a whole.

BACKGROUND OF THE INVENTION

[0003] Transcription factors can modulate gene expression, either increasing or decreasing (inducing or repressing) the rate of transcription. This modulation results in differential levels of gene expression at various developmental stages, in different tissues and cell types, and in response to different exogenous (e.g., environmental) and endogenous stimuli throughout the life cycle of the organism.

[0004] Because transcription factors are key controlling elements of biological pathways, altering the expression levels of one or more transcription factors can change entire biological pathways in an organism. For example, manipulation of the levels of selected transcription factors may result in increased expression of economically useful proteins or metabolic chemicals in plants or to improve other agriculturally relevant characteristics. Conversely, blocked or reduced expression of a transcription factor may reduce biosynthesis of unwanted compounds or remove an undesirable trait. Therefore, manipulating transcription factor levels in a plant offers tremendous potential in agricultural biotechnology for modifying a plant's traits.

[0005] The present invention provides novel transcription factors useful for modifying a plant's phenotype in desirable ways.

SUMMARY OF THE INVENTION

[0006] In a first aspect, the invention relates to a recombinant polynucleotide comprising a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a polypeptide sequence selected from those of the Sequence Listing, SEQ ID NOs:2 and 4, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence encoding a polypeptide comprising a variant of a polypeptide of (a) having one or more, or between 1 and about 5, or between 1 and about 10, or between 1 and about 30, conservative amino acid substitutions; (c) a nucleotide sequence comprising a sequence selected from those of SEQ ID NOs:1 and 3, or a complementary nucleotide sequence thereof; (d) a nucleotide sequence comprising silent substitutions in a nucleotide sequence of (c); (e) a nucleotide sequence which hybridizes under stringent conditions over substantially the entire length of a nucleotide sequence of one or more of: (a), (b), (c), or (d); (f) a nucleotide sequence comprising at least 10 or 15, or at least about 20, or at least about 30 consecutive nucleotides of a sequence of any of (a)-(e), or at least 10 or 15, or at least about 20, or at least about 30 consecutive nucleotides outside of a region encoding a conserved domain of any of (a)-(e); (g) a nucleotide sequence comprising a subsequence or fragment of any of (a)-(f), which subsequence or fragment encodes a polypeptide having a biological activity that modifies a plant's characteristic, functions as a transcription factor, or alters the level of transcription of a gene or transgene in a cell; (h) a nucleotide sequence having at least 31% sequence identity to a nucleotide sequence of any of (a)-(g); (i) a nucleotide sequence having at least 60%, or at least 70%, or at least 80%, or at least 90 or at least 95% sequence identity to a nucleotide sequence of any of (a)-(g) or a 10 or 15 nucleotide, or at least about 20, or at least about 30 nucleotide region of a sequence of (a)-(g) that is outside of a region encoding a conserved domain; (j) a nucleotide sequence that encodes a polypeptide having at least 31% sequence identity to a polypeptide listed in the Sequence Listing or in Tables 6 and 7; (k) a nucleotide sequence which encodes a polypeptide having at least 60%, or at least 70%, or at least 80%, or at least 90%, or at least 95% sequence identity to a polypeptide listed in the Sequence Listing or in Tables 6 and 7; and (1) a nucleotide sequence that encodes a conserved domain of a polypeptide having at least 85%, or at least 90%, or at least 95%, or at least 98% sequence identity to a conserved domain of a polypeptide listed in the Sequence Listing or in Tables 6 and 7. The recombinant polynucleotide may further comprise a constitutive, inducible, or tissue-specific promoter operably linked to the nucleotide sequence. The invention also relates to compositions comprising at least two of the above-described polynucleotides.

[0007] In a second aspect, the invention comprises an isolated or recombinant polypeptide comprising a subsequence of at least about 10, or at least about 15, or at least about 20, or at least about 30 contiguous amino acids encoded by the recombinant or isolated polynucleotide described above, or comprising a subsequence of at least about 8, or at least about 12, or at least about 15, or at least about 20, or at least about 30 contiguous amino acids outside a conserved domain.

[0008] In a third aspect, the invention comprises an isolated or recombinant polynucleotide which encodes a polypeptide which is a paralog of the isolated polypeptide described in paragraph 6 above. In one aspect, the invention is an paralog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

[0009] In a fourth aspect, the invention comprises an isolated or recombinant polynucleotide which encodes a polypeptide which is an ortholog of the isolated polypeptide described in paragraph 6 above. In one aspect, the invention is an ortholog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

[0010] In a fifth aspect, the invention comprises an isolated or recombinant polynucleotide which encodes a polypeptide which is a paralog of the isolated polypeptide described in paragraph 6 above. In one aspect, the invention is an paralog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

[0011] In another aspect, the invention comprises an isolated polypeptide which is an ortholog of the isolated polypeptide described in paragraph 6 above. In one aspect, the invention is an ortholog which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

[0012] In yet another aspect, the invention comprises an isolated synthetic polypeptide which is a homolog of the isolated polypeptide described in paragraph 6 above. In one aspect, the invention is a synthetic polypeptide which, when expressed in Arabidopsis, modifies a trait of the Arabidopsis plant.

[0013] In another aspect, the invention is a transgenic plant comprising one or more of the above-described recombinant polynucleotides. In yet another aspect, the invention is a plant with altered expression levels of a polynucleotide described above or a plant with altered expression or activity levels of an above-described polypeptide. Further, the invention is a plant lacking a nucleotide sequence encoding a polypeptide described above or substantially lacking a polypeptide described above. The plant may be any plant, including, but not limited to, Arabidopsis, mustard, soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, rosaceous fruits, vegetable brassicas, and mint or other labiates. In yet another aspect, the inventions is an isolated plant material of a plant, including, but not limited to, plant tissue, fruit, seed, plant cell, embryo, protoplast, pollen, and the like. In yet another aspect, the invention is a transgenic plant tissue culture of regenerable cells, including, but not limited to, embryos, meristematic cells, microspores, protoplast, pollen, and the like.

[0014] In a further aspect the invention provides a method of using the polynucleotide composition to breed progeny from a parent plant including crossing plants, producing seeds from transgenic plants, and methods of breeding using transgenic plants.

[0015] In a further aspect, the invention provides a progeny plant derived from a parental plant wherein said progeny plant exhibits at least three fold greater messenger RNA levels than said parental plant, wherein the messenger RNA encodes a DNA-binding protein which is capable of binding to a DNA regulatory sequence and inducing expression of a plant trait gene, wherein the progeny plant is characterized by a change in the plant trait compared to said parental plant. In yet a further aspect, the progeny plant exhibits at least ten fold greater messenger RNA levels compared to said parental plant. In yet a further aspect, the progeny plant exhibits at least fifty fold greater messenger RNA levels compared to said parental plant.

[0016] In a further aspect, the invention relates to a cloning or expression vector comprising the isolated or recombinant polynucleotide described above or cells comprising the cloning or expression vector.

[0017] In yet a further aspect, the invention relates to a composition produced by incubating a polynucleotide of the invention with a nuclease, a restriction enzyme, a polymerase; a polymerase and a primer; a cloning vector, or with a cell.

[0018] Furthermore, the invention relates to a method for producing a plant having a modified trait. The method comprises altering the expression of an isolated or recombinant polynucleotide of the invention or altering the expression or activity of a polypeptide of the invention in a plant to produce a modified plant, and selecting the modified plant for a modified trait. In one aspect, the plant is a monocot plant. In another aspect, the plant is a dicot plant. In another aspect the recombinant polynucleotide is from a dicot plant and the plant is a monocot plant. In yet another aspect the recombinant polynucleotide is from a monocot plant and the plant is a dicot plant. In yet another aspect the recombinant polynucleotide is from a monocot plant and the plant is a monocot plant. In yet another aspect the recombinant polynucleotide is from a dicot plant and the plant is a dicot plant.

[0019] In another aspect, the invention relates to a method of identifying a factor that is modulated by or interacts with a polypeptide encoded by a polynucleotide of the invention. The method comprises expressing a polypeptide encoded by the polynucleotide in a plant; and identifying at least one factor that is modulated by or interacts with the polypeptide. In one embodiment the method for identifying modulating or interacting factors is by detecting binding by the polypeptide to a promoter sequence, or by detecting interactions between an additional protein and the polypeptide in a yeast two hybrid system, or by detecting expression of a factor by hybridization to a microarray, subtractive hybridization, or differential display.

[0020] In yet another aspect, the invention is a method of identifying a molecule that modulates activity or expression of a polynucleotide or polypeptide of interest. The method comprises placing the molecule in contact with a plant comprising the polynucleotide or polypeptide encoded by the polynucleotide of the invention and monitoring one or more of the expression level of the polynucleotide in the plant, the expression level of the polypeptide in the plant, and modulation of an activity of the polypeptide in the plant. In a farther aspect, the invention is a method of using a molecule that modulates activity or expression of a polynucleotide or polypeptide of interest. The polynucleotide may be selected from the group comprising SEQ ID NOs:1 and 3, a variant or ortholog thereof. In the alternative, the polypeptide may be selected from the group comprising SEQ ID NOs:2 and 4, a variant or ortholog thereof. The method comprises placing the molecule in contact with a plant comprising the polynucleotide or polypeptide encoded by the polynucleotide of the invention and monitoring one or more of the expression level of the polynucleotide in the plant, the expression level of the polypeptide in the plant, and modulation of an activity of the polypeptide in the plant.

[0021] In yet another aspect, the invention relates to an integrated system, computer or computer readable medium comprising one or more character strings corresponding to a polynucleotide of the invention, or to a polypeptide encoded by the polynucleotide. The integrated system, computer or computer readable medium may comprise a link between one or more sequence strings to a modified plant trait.

[0022] In yet another aspect, the invention is a method for identifying a sequence similar or homologous to one or more polynucleotides of the invention, or one or more polypeptides encoded by the polynucleotides. The method comprises providing a sequence database, and querying the sequence database with one or more target sequences corresponding to the one or more polynucleotides or to the one or more polypeptides to identify one or more sequence members of the database that display sequence similarity or homology to one or more of the one or more target sequences.

[0023] The method may further comprise of linking the one or more of the polynucleotides of the invention, or encoded polypeptides, to a modified plant phenotype.

[0024] Brief Description of the Sequence Listing and Tables

[0025] The Sequence Listing provides exemplary polynucleotide and polypeptide sequences of the invention. The traits associated with the use of the sequences are included in the “Examples” section of the invention disclosure.

[0026] Tables 1 through 5 are shown and described in the invention disclosure.

[0027] Table 6 lists a summary of orthologous and homologous sequences of the polynucleotide sequences and polypeptide sequences of the invention (SEQ ID NOs:1-4) identified using BLAST (TBLASTX program). The first column shows the polynucleotide sequence identifier (SEQ ID NO), the second column shows the transcription factor CDNA identifier (Gene ID), the third column shows the orthologous or homologous polynucleotide GenBank Accession Number (Test Sequence ID), the fourth column shows the orthologous or homologous polynucleotide sequence identifier (Test Sequence SEQ ID NO), the fifth column shows the calculated probability value that the sequence identity is due to chance (Smallest Sum Probability), and the sixth column shows the orthologous or homologous GenBank annotation (Test Sequence GenBank Annotation).

[0028] Table 7 lists orthologous and homologous sequences of the polynucleotide sequences and polypeptide sequences of the invention (SEQ ID NOs:1-4) identified using BLAST (TBLASTX program). The first column shows the polynucleotide sequence identifier (SEQ ID NO), the second column shows the transcription factor cDNA identifier (Gene ID), the third column shows the orthologous or homologous polynucleotide GenBank Accession Number (Test Sequence ID), the fourth column shows the orthologous or homologous polynucleotide sequence GenBank annotation (Test Sequence GenBank Annotation) identifier (Test Sequence SEQ ID NO), the fifth column shows the reading frame of the Test sequence which encodes the orthologous or homologous sequence (Reading Frame), the sixth column shows the calculated score value of the aligned sequences (High Score), the seventh column shows the calculated probability value that the sequence identity is due to chance (Smallest Sum Probability), and the eighth column shows the number of regions of the orthologous or homologous Test Sequences which aligned with the sequence encoded by the transcription factor cDNA sequence GenBank annotation (N).

DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

[0029] In an important aspect, the present invention relates to polynucleotides and polypeptides, e.g. for modifying phenotypes of plants. Throughout this disclosure, various information sources are referred to and/or are specifically incorporated. The information sources include scientific journal articles, patent documents, textbooks, and world wide web browser-inactive page addresses, for example. While the reference to these information sources clearly indicates that they can be used by one of skill in the art, applicants specifically incorporate each and every one of the information sources cited herein, in their entirety, whether or not a specific mention of “incorporation by reference” is noted. The contents and teachings of each and every one of the information sources can be relied on and used to make and use embodiments of the invention.

[0030] It must be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, a reference to “a plant” includes a plurality of such plants, and a reference to “a stress” is a reference to one or more stresses and equivalents thereof known to those skilled in the art, and so forth.

[0031] The polynucleotides of the invention encode plant transcription factors. As one of ordinary skill in the art recognizes, transcription factors can be identified by the presence of a region or domain of structural similarity or identity to a specific consensus sequence or the presence of a specific consensus DNA-binding site or DNA-binding site motif (see, for example, Riechmann et al., Science 290: 2105-2110 (2000)). The plant transcription factors may belong to one of the following transcription factor families: the AP2 (APETALA2) domain transcription factor family (Riechmann and Meyerowitz (1998) Biol. Chem. 379:633-646); the MYB transcription factor family (Martin and Paz-Ares, (1997) Trends Genet. 13:67-73); the MADS domain transcription factor family (Riechmann and Meyerowitz (1997) Biol. Chem. 378:1079-1101); the WRKY protein family (Ishiguro and Nakamura (1994) Mol. Gen. Genet. 244:563-571); the ankyrin-repeat protein family (Zhang et al. (1992) Plant Cell 4:1575-1588); the zinc finger protein (Z) family (Klug and Schwabe (1995) FASEB J. 9: 597-604); the homeobox (HB) protein family (Duboule (1994) Guidebook to the Homeobox Genes, Oxford University Press); the CAAT-element binding proteins (Forsburg and Guarente (1989) Genes Dev. 3:1166-1178); the squamosa promoter binding proteins (SPB) (Klein et al. (1996) Mol. Gen. Genet. 1996 250:7-16); the NAM protein family (Souer et al. (1996) Cell 85:159-170); the IAA/AUX proteins (Rouse et al. (1998) Science 279:1371-1373); the HLH/MYC protein family (Littlewood et al. (1994) Prot. Profile 1:639-709); the DNA-binding protein (DBP) family (Tucker et al. (1994) EMBO J. 13:2994-3002); the bZIP family of transcription factors (Foster et al. (1994) FASEB J. 8:192-200); the Box P-binding protein (the BPF-1) family (da Costa e Silva et al. (1993) Plant J. 4:125-135); the high mobility group (HMG) family (Bustin and Reeves (1996) Prog. Nucl. Acids Res. Mol. Biol. 54:35-100); the scarecrow (SCR) family (Di Laurenzio et al. (1996) Cell 86:423-433); the GF14 family (Wu et al. (1997) Plant Physiol. 114:1421-1431); the polycomb (PCOMB) family (Kennison (1995) Annu. Rev. Genet. 29:289-303); the teosinte branched (TEO) family (Luo et al. (1996) Nature 383:794-799; the ABI3 family (Giraudat et al. (1992) Plant Cell 4:1251-1261); the triple helix (TH) family (Dehesh et al. (1990) Science 250:1397-1399); the EIL family (Chao et al. (1997) Cell 89:1133-44); the AT-HOOK family (Reeves and Nissen (1990) Journal of Biological Chemistry 265:8573-8582); the SIFA family (Zhou et al. (1995) Nucleic Acids Res. 23:1165-1169); the bZIPT2 family (Lu and Ferl (1995) Plant Physiol. 109:723); the YABBY family (Bowman et al. (1999) Development 126:2387-96); the PAZ family (Bohmert et al. (1998) EMBO J. 17:170-80); miscellaneous (MISC) transcription factors including the DPBF family (Kim et al. (1997) Plant J. 11: 1237-1251) and the SPF1 family (Ishiguro and Nakamura (1994) Mol. Gen. Genet. 244:563-571); the golden (GLD) family (Hall et al. (1998) Plant Cell 10:925-936); the TUBBY family (Boggin et al, (1999) Science 286:2119-2125); the heat shock family (Wu C (1995) Annu Rev Cell Dev Biol 11:441-469); the ENBP family (Christiansen et al (1996) Plant Mol Biol 32:809-821); the RING-zinc family (Jensen et al. (1998) FEBS letters 436:283-287); the PDBP family (Janik et al Virology. (1989)168:320-329); the PCF family (Cubas P, et al. Plant J. (1999)18:215-22); the SRS (SHI-related) family (Fridborg et al Plant Cell (1999) 11:1019-1032); the CPP (cysteine-rich polycomb-like) family (Cvitanich et al Proc. Natl. Acad. Sci. U S A. (2000) 97:8163-8168); the ARF (auxin response factor) family (Ulmasov, et al. (1999) Proc. Natl. Acad. Sci. USA 96: 5844-5849); the SWI/SNF family (Collingwood et al J. Mol. End. 23:255-275); the ACBF family (Seguin et al Plant Mol Biol. (1997) 35:281-291); PCGL (CG-1 like) family (Plant Mol Biol. (1994) 25:921-924); the ARID family (Vazquez et al Development. (1999) 126: 733-42); the Jumonji family (Balciunas et al Trends Biochem Sci. (2000) 25: 274-276); the bZIP-NIN family (Schauser et al Nature. (1999) 402: 191-195); the E2F family Kaelin et al (1992) Cell 70: 351-364); and the GRF-like family (Knaap et al (2000) Plant Physiol. 122: 695-704. As indicated by any part of the list above and as known in the art, transcription factors have been sometimes categorized by class, family, and sub-family according to their structural content and consensus DNA-binding site motif, for example. Many of the classes and many of the families and sub-families are listed here. However, the inclusion of one sub-family and not another, or the inclusion of one family and not another, does not mean that the invention does not encompass polynucleotides or polypeptides of a certain family or sub-family. The list provided here is merely an example of the types of transcription factors and the knowledge available concerning the consensus sequences and consensus DNA-binding site motifs that help define them as known to those of skill in the art (each of the references noted above are specifically incorporated herein by reference). A transcription factor may include, but is not limited to, any polypeptide that can activate or repress transcription of a single gene or a number of genes. This polypeptide group includes, but is not limited to, DNA-binding proteins, DNA-binding protein binding proteins, protein kinases, protein phosphatases, GTP-binding proteins, and receptors, and the like.

[0032] In addition to methods for modifying a plant phenotype by employing one or more polynucleotides and polypeptides of the invention described herein, the polynucleotides and polypeptides of the invention have a variety of additional uses. These uses include their use in the recombinant production (i.e, expression) of proteins; as regulators of plant gene expression, as diagnostic probes for the presence of complementary or partially complementary nucleic acids (including for detection of natural coding nucleic acids); as substrates for further reactions, e.g., mutation reactions, PCR reactions, or the like; as substrates for cloning e.g., including digestion or ligation reactions; and for identifying exogenous or endogenous modulators of the transcription factors.

[0033] A “polynucleotide” is a nucleic acid sequence comprising a plurality of polymerized nucleotides, e.g., at least about 15 consecutive polymerized nucleotide, optionally at least about 30 consecutive nucleotides, at least about 50 consecutive nucleotides. In many instances, a polynucleotide comprises a nucleotide sequence encoding a polypeptide (or protein) or a domain or fragment thereof. Additionally, the polynucleotide may comprise a promoter, an intron, an enhancer region, a polyadenylation site, a translation initiation site, 5′ or 3′ untranslated regions, a reporter gene, a selectable marker, or the like. The polynucleotide can be single stranded or double stranded DNA or RNA. The polynucleotide optionally comprises modified bases or a modified backbone. The polynucleotide can be, e.g., genomic DNA or RNA, a transcript (such as an MRNA), a cDNA, a PCR product, a cloned DNA, a synthetic DNA or RNA, or the like. The polynucleotide can comprise a sequence in either sense or antisense orientations.

[0034] A “recombinant polynucleotide” is a polynucleotide that is not in its native state, e.g., the polynucleotide comprises a nucleotide sequence not found in nature, or the polynucleotide is in a context other than that in which it is naturally found, e.g., separated from nucleotide sequences with which it typically is in proximity in nature, or adjacent (or contiguous with) nucleotide sequences with which it typically is not in proximity. For example, the sequence at issue can be cloned into a vector, or otherwise recombined with one or more additional nucleic acid.

[0035] A “synthetic polynucleotide” is a polynucleotide not fund in nature and encodes a polypeptide not found in nature. The encoded polypeptide comprises at least four consecutive amino acid residues of a polypeptide found in nature.

[0036] An “isolated polynucleotide” is a polynucleotide whether naturally occurring or recombinant, that is present outside the cell in which it is typically found in nature, whether purified or not. Optionally, an isolated polynucleotide is subject to one or more enrichment or purification procedures, e.g., cell lysis, extraction, centrifugation, precipitation, or the like.

[0037] A “polypeptide” is an amino acid sequence comprising a plurality of consecutive polymerized amino acid residues e.g., at least about 15 consecutive polymerized amino acid residues, optionally at least about 30 consecutive polymerized amino acid residues, at least about 50 consecutive polymerized amino acid residues. In many instances, a polypeptide comprises a polymerized amino acid residue sequence which is a transcription factor or a domain or portion or fragment thereof. Additionally, the polypeptide may comprise a localization domain, 2) an activation domain, 3) a repression domain, 4) an oligomerization domain or 5) a DNA-binding domain, or the like. The polypeptide optionally comprises modified amino acid residues, naturally occurring amino acid residues not encoded by a codon, non-naturally occurring amino acid residues.

[0038] A “recombinant polypeptide” is a polypeptide produced by translation of a recombinant polynucleotide. A “synthetic polypeptide” is a polypeptide created by consecutive polymerization of isolated amino acid residues using methods well known in the art. An “isolated polypeptide,” whether a naturally occurring or a recombinant polypeptide, is more enriched in (or out of) a cell than the polypeptide in its natural state in a wild type cell, e.g., more than about 5% enriched, more than about 10% enriched, or more than about 20%, or more than about 50%, or more, enriched, i.e., alternatively denoted: 105%, 110%, 120%, 150% or more, enriched relative to wild type standardized at 100%. Such an enrichment is not the result of a natural response of a wild type plant. Alternatively, or additionally, the isolated polypeptide is separated from other cellular components with which it is typically associated, e.g., by any of the various protein purification methods herein.

[0039] A “synthetic polypeptide” is a polypeptide not fund in nature and has activity of a polypeptide found in nature. The polypeptide comprises at least four consecutive amino acid residues of a polypeptide found in nature.

[0040] “Altered” nucleic acid sequences encoding polypeptide include those sequences with deletions, insertions, or substitutions of different nucleotides, resulting in a polynucleotide encoding a polypeptide with at least one functional characteristic of the polypeptide. Included within this definition are polymorphisms which may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding polypeptide, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding polypeptide. The encoded polypeptide protein may also be “altered”, and may contain deletions, insertions, or substitutions of amino acid residues which produce a silent change and result in a functionally equivalent polypeptide. Deliberate amino acid substitutions may be made on the basis of similarity in residue side chain chemistry, including, but not limited to, polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues, as long as the biological activity of polypeptide is retained. For example, negatively charged amino acids may include aspartic acid and glutamic acid, positively charged amino acids may include lysine and arginine, and amino acids with uncharged polar head groups having similar hydrophilicity values may include leucine, isoleucine, and valine; glycine and alanine; asparagine and glutamine; serine and threonine; and phenylalanine and tyrosine. Alignments between different polypeptide sequences may be used to calculate “percentage sequence similarity”.

[0041] The term “plant” includes whole plants, shoot vegetative organs/structures (e.g., leaves, stems and tubers), roots, flowers and floral organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (e.g., vascular tissue, ground tissue, and the like) and cells (e.g., guard cells, egg cells, and the like), and progeny of same. The class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, horsetails, psilophytes, lycophytes, bryophytes, and multicellular algae. (See for example, Daly et al. 2001 Plant Physiology 127:1328-1333; and also Tudge, C., The Variety of Life, Oxford University Press, New York, 2000, pp. 547-606.)

[0042] A “transgenic plant” refers to a plant that contains genetic material not found in a wild type plant of the same species, variety or cultivar. The genetic material may include a transgene, an insertional mutagenesis event (such as by transposon or T-DNA insertional mutagenesis), an activation tagging sequence, a mutated sequence, a homologous recombination event or a sequence modified by chimeraplasty. Typically, the foreign genetic material has been introduced into the plant by human manipulation, but any method can be used as one of skill in the art recognizes.

[0043] A transgenic plant may contain an expression vector or cassette. The expression cassette typically comprises a polypeptide-encoding sequence operably linked (i.e., under regulatory control of) to appropriate inducible or constitutive regulatory sequences that allow for the expression of polypeptide. The expression cassette can be introduced into a plant by transformation or by breeding after transformation of a parent plant. A plant refers to a whole plant as well as to a plant part, such as seed, fruit, leaf, or root, plant tissue, plant cells or any other plant material, e.g., a plant explant, as well as to progeny thereof, and to in vitro systems that mimic biochemical or cellular components or processes in a cell.

[0044] “Ectopic expression or altered expression” in reference to a polynucleotide indicates that the pattern of expression in, e.g., a transgenic plant or plant tissue, is different from the expression pattern in a wild type plant or a reference plant of the same species. The pattern of expression may also be compared with a reference expression pattern in a wild type plant of the same species. For example, the polynucleotide or polypeptide is expressed in a cell or tissue type other than a cell or tissue type in which the sequence is expressed in the wild type plant, or by expression at a time other than at the time the sequence is expressed in the wild type plant, or by a response to different inducible agents, such as hormones or environmental signals, or at different expression levels (either higher or lower) compared with those found in a wild type plant. The term also refers to altered expression patterns that are produced by lowering the levels of expression to below the detection level or completely abolishing expression. The resulting expression pattern can be transient or stable, constitutive or inducible. In reference to a polypeptide, the term “ectopic expression or altered expression” further may relate to altered activity levels resulting from the interactions of the polypeptides with exogenous or endogenous modulators or from interactions with factors or as a result of the chemical modification of the polypeptides.

[0045] A “fragment” or “domain,” with respect to a polypeptide, refers to a subsequence of the polypeptide. In some cases, the fragment or domain, is a subsequence of the polypeptide which performs at least one biological finction of the intact polypeptide in substantially the same manner, or to a similar extent, as does the intact polypeptide. For example, a polypeptide fragment can comprise a recognizable structural motif or finctional domain such as a DNA-binding site or domain that binds to a DNA promoter region, an activation domain, or a domain for protein-protein interactions. Fragments can vary in size from as few as 6 amino acids to the full length of the intact polypeptide, but are preferably at least about 30 amino acids in length and more preferably at least about 60 amino acids in length. In reference to a polynucleotide sequence, “a fragment” refers to any subsequence of a polynucleotide, typically, of at least about 15 consecutive nucleotides, preferably at least about 30 nucleotides, more preferably at least about 50 nucleotides, of any of the sequences provided herein. [00451 A “conserved domain”, with respect to a polypeptide, refers to a domain within a transcription factor family which exhibits a higher degree of sequence homology, such as at least 65% sequence identity including conservative substitutions, and preferably at least 80% sequence identity, and more preferably at least 85%, or at least about 86%, or at least about 87%, or at least about 88%, or at least about 90%, or at least about 95%, or at least about 98% amino acid residue sequence identity of a polypeptide of consecutive amino acid residues. A fragment or domain can be referred to as outside a consensus sequence or outside a consensus DNA-binding site that is known to exist or that exists for a particular transcription factor class, family, or sub-family. In this case, the fragment or domain will not include the exact amino acids of a consensus sequence or consensus DNA-binding site of a transcription factor class, family or sub-family, or the exact amino acids of a particular transcription factor consensus sequence or consensus DNA-binding site. Furthermore, a particular fragment, region, or domain of a polypeptide, or a polynucleotide encoding a polypeptide, can be “outside a conserved domain” if all the amino acids of the fragment, region, or domain fall outside of a defined conserved domain(s) for a polypeptide or protein. The conserved domains for each of polypeptides of SEQ ID NOs:2 and 4 are listed in Table 4 as described in Example VII. A comparison of the regions of the polypeptides in SEQ ID NOs:2 and 4 allows one of skill in the art to identify conserved domain(s) for any of the polypeptides listed or referred to in this disclosure, including those in Tables 6 and 7.

[0046] A “trait” refers to a physiological, morphological, biochemical, or physical characteristic of a plant or particular plant material or cell. In some instances, this characteristic is visible to the human eye, such as seed or plant size, or can be measured by biochemical techniques, such as detecting the protein, starch, or oil content of seed or leaves, or by the observation of the expression level of a gene or genes, e.g., by employing Northern analysis, RT-PCR, microarray gene expression assays, or reporter gene expression systems, or by agricultural observations such as stress tolerance, yield, or pathogen tolerance. Any technique can be used to measure the amount of, comparative level of, or difference in any selected chemical compound or macromolecule in the transgenic plants, however.

[0047] “Trait modification” refers to a detectable difference in a characteristic in a plant ectopically expressing a polynucleotide or polypeptide of the present invention relative to a plant not doing so, such as a wild type plant. In some cases, the trait modification can be evaluated quantitatively. For example, the trait modification can entail at least about a 2% increase or decrease in an observed trait (difference), at least a 5% difference, at least about a 10% difference, at least about a 20% difference, at least about a 30%, at least about a 50%, at least about a 70%, or at least about a 100%, or an even greater difference compared with a wild type plant. It is known that there can be a natural variation in the modified trait. Therefore, the trait modification observed entails a change of the normal distribution of the trait in the plants compared with the distribution observed in wild type plant.

[0048] Trait modifications of particular interest include those to seed (such as embryo or endosperm), fruit, root, flower, leaf, stem, shoot, seedling or the like, including: enhanced tolerance to environmental conditions including freezing, chilling, heat, drought, water saturation, radiation and ozone; improved tolerance to microbial, fungal or viral diseases; improved tolerance to pest infestations, including nematodes, mollicutes, parasitic higher plants or the like; decreased herbicide sensitivity; improved tolerance of heavy metals or enhanced ability to take up heavy metals; improved growth under poor photoconditions (e.g., low light and/or short day length), or changes in expression levels of genes of interest. Other phenotype that can be modified relate to the production of plant metabolites, such as variations in the production of taxol, tocopherol, tocotrienol, sterols, phytosterols, vitamins, wax monomers, anti-oxidants, amino acids, lignins, cellulose, tannins, prenyllipids (such as chlorophylls and carotenoids), glucosinolates, and terpenoids, enhanced or compositionally altered protein or oil production (especially in seeds), or modified sugar (insoluble or soluble) and/or starch composition. Physical plant characteristics that can be modified include cell development (such as the number of trichomes), fruit and seed size and number, yields of plant parts such as stems, leaves and roots, the stability of the seeds during storage, characteristics of the seed pod (e.g., susceptibility to shattering), root hair length and quantity, internode distances, or the quality of seed coat. Plant growth characteristics that can be modified include growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, biomass or transpiration characteristics, as well as plant architecture characteristics such as apical dominance, branching patterns, number of organs, organ identity, organ shape or size.

[0049] Examples of plant trait modifications and how to measure and determine those plant traits or characteristics are provided in the invention disclosure and the “Examples” section, Table 5. The disclosures are intended to illustrate but not limit which plant trait or characteristic may be modified by the invention.

[0050] Polypeptides and Polynucleotides of the Invention

[0051] The present invention provides, among other things, transcription factors (TFs), and transcription factor homologue polypeptides, and isolated or recombinant polynucleotides encoding the polypeptides, or novel variant polypeptides or polynucleotides encoding novel variants of transcription factors derived from the specific sequences provided here. These polypeptides and polynucleotides may be employed to modify a plant's characteristic.

[0052] Exemplary polynucleotides encoding the polypeptides of the invention were identified in the Arabidopsis thaliana GenBank database using publicly available sequence analysis programs and parameters. Sequences initially identified were then further characterized to identify sequences comprising specified sequence strings corresponding to sequence motifs present in families of known transcription factors. In addition, farther exemplary polynucleotides encoding the polypeptides of the invention were identified in the plant GenBank database using publicly available sequence analysis programs and parameters. Sequences initially identified were then further characterized to identify sequences comprising specified sequence strings corresponding to sequence motifs present in families of known transcription factors. Polynucleotide sequences meeting such criteria were confirmed as transcription factors.

[0053] Additional polynucleotides of the invention were identified by screening Arabidopsis thaliana and/or other plant cDNA libraries with probes corresponding to known transcription factors under low stringency hybridization conditions. Additional sequences, including fall length coding sequences were subsequently recovered by the rapid amplification of cDNA ends (RACE) procedure, using a conunercially available kit according to the manufacturer's instructions. Where necessary, multiple rounds of RACE are performed to isolate 5′ and 3′ ends. The fall length cDNA was then recovered by a routine end-to-end polymerase chain reaction (PCR) using primers specific to the isolated 5′ and 3′ ends. Exemplary sequences are provided in the Sequence Listing.

[0054] The polynucleotides of the invention can be or were ectopically expressed in overexpressor or knockout plants and the changes in the characteristic(s) or trait(s) of the plants observed. Therefore, the polynucleotides and polypeptides can be employed to improve the characteristics of plants.

[0055] Producing Polypeptides

[0056] The polynucleotides of the invention include sequences that encode transcription factors and transcription factor homologue polypeptides and sequences complementary thereto, as well as unique fragments of coding sequence, or sequence complementary thereto. Such polynucleotides can be, e.g., DNA or RNA, e.g., mRNA, cRNA, synthetic RNA, genomic DNA, cDNA synthetic DNA, oligonucleotides, etc. The polynucleotides are either double-stranded or single-stranded, and include either, or both sense (i.e., coding) sequences and antisense (i.e., non-coding, complementary) sequences. The polynucleotides include the coding sequence of a transcription factor, or transcription factor homologue polypeptide, in isolation, in combination with additional coding sequences (e.g., a purification tag, a localization signal, as a fusion-protein, as a pre-protein, or the like), in combination with non-coding sequences (e.g., introns or inteins, regulatory elements such as promoters, enhancers, terminators, and the like), and/or in a vector or host environment in which the polynucleotide encoding a transcription factor or transcription factor homologue polypeptide is an endogenous or exogenous gene.

[0057] A variety of methods exist for producing the polynucleotides of the invention. Procedures for identifying and isolating DNA clones are well known to those of skill in the art, and are described in, e.g., Berger and Kimmel, Guide to Molecular Cloning Techniques, Methods in Enzymology volume 152 Academic Press, Inc., San Diego, Calif. (“Berger”); Sambrook et al., Molecular Cloning—A Laboratory Manual (2nd Ed.), Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1989 (“Sambrook”) and Current Protocols in Molecular Biology, F. M. Ausubel et al., eds., Current Protocols, a joint venture between Greene Publishing Associates, Inc. and John Wiley & Sons, Inc., (supplemented through 2000) (“Ausubel”).

[0058] Alternatively, polynucleotides of the invention, can be produced by a variety of in vitro amplification methods adapted to the present invention by appropriate selection of specific or degenerate primers. Examples of protocols sufficient to direct persons of skill through in vitro amplification methods, including the polymerase chain reaction (PCR) the ligase chain reaction (LCR), Qbeta-replicase amplification and other RNA polymerase mediated techniques (e.g., NASBA), e.g., for the production of the homologous nucleic acids of the invention are found in Berger, Sambrook, and Ausubel (all supra), as well as Mullis et al., (1987) PCR Protocols A Guide to Methods and Applications (Innis et al. eds) Academic Press Inc. San Diego, Calif. (1990) (Innis). Improved methods for cloning in vitro amplified nucleic acids are described in Wallace et al., U.S. Pat. No. 5,426,039. Improved methods for amplifying large nucleic acids by PCR are summarized in Cheng et al. (1994) Nature 369: 684-685 and the references cited therein, in which PCR amplicons of up to 40 kb are generated. One of skill will appreciate that essentially any RNA can be converted into a double stranded DNA suitable for restriction digestion, PCR expansion and sequencing using reverse transcriptase and a polymerase. See, e.g., Ausubel, Sambrook and Berger, all supra.

[0059] Alternatively, polynucleotides and oligonucleotides of the invention can be assembled from fragments produced by solid-phase synthesis methods. Typically, fragments of up to approximately 100 bases are individually synthesized and then enzymatically or chemically ligated to produce a desired sequence, e.g., a polynucletotide encoding all or part of a transcription factor. For example, chemical synthesis using the phosphoramidite method is described, e.g., by Beaucage et al. (1981) Tetrahedron Letters 22:1859-69; and Matthes et al. (1984) EMBO J. 3:801-5. According to such methods, oligonucleotides are synthesized, purified, annealed to their complementary strand, ligated and then optionally cloned into suitable vectors. And if so desired, the polynucleotides and polypeptides of the invention can be custom ordered from any of a number of commercial suppliers.

[0060] Homologous Sequences

[0061] Sequences homologous, i.e., that share significant sequence identity or similarity, to those provided in the Sequence Listing, derived from Arabidopsis thaliana or from other plants of choice are also an aspect of the invention. Homologous sequences can be derived from any plant including monocots and dicots and in particular agriculturally important plant species, including but not limited to, crops such as soybean, wheat, corn, potato, cotton, rice, oilseed rape (including canola), sunflower, alfalfa, sugarcane and turf; or fruits and vegetables, such as banana, blackberry, blueberry, strawberry, and raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, rosaceous fruits (such as apple, peach, pear, cherry and plum) and vegetable brassicas (such as broccoli, cabbage, cauliflower, brussel sprouts and kohlrabi). Other crops, fruits and vegetables whose phenotype can be changed include barley, rye, millet, sorghum, currant, avocado, citrus fruits such as oranges, lemons, grapefruit and tangerines, artichoke, cherries, nuts such as the walnut and peanut, endive, leek, roots, such as arrowroot, beet, cassava, turnip, radish, yam, and sweet potato, and beans. The homologous sequences may also be derived from woody species, such pine, poplar and eucalyptus, or mint or other labiates.

[0062] Transcription factors that are homologous to the listed sequences will typically share at least about 30% amino acid sequence identity, or at least about 30% amino acid sequence identity outside of a known consensus sequence or consensus DNA-binding site. More closely related transcription factors can share at least about 50%, about 60%, about 65%, about 70%, about 75% or about 80% or about 90% or about 95% or about 98% or more sequence identity with the listed sequences, or with the listed sequences but excluding or outside a known consensus sequence or consensus DNA-binding site, or with the listed sequences excluding one or all conserved domain. Factors that are most closely related to the listed sequences share, e.g., at least about 85%, about 90% or about 95% or more % sequence identity to the listed sequences, or to the listed sequences but excluding or outside a known consensus sequence or consensus DNA-binding site or outside one or all conserved domain. At the nucleotide level, the sequences will typically share at least about 40% nucleotide sequence identity, preferably at least about 50%, about 60%, about 70% or about 80% sequence identity, and more preferably about 85%, about 90%, about 95% or about 97% or more sequence identity to one or more of the listed sequences, or to a listed sequence but excluding or outside a known consensus sequence or consensus DNA-binding site, or outside one or all conserved domain. The degeneracy of the genetic code enables major variations in the nucleotide sequence of a polynucleotide while maintaining the amino acid sequence of the encoded protein. Conserved domains within a transcription factor family may exhibit a higher degree of sequence homology, such as at least 65% sequence identity including conservative substitutions, and preferably at least 80% sequence identity, and more preferably at least 85%, or at least about 86%, or at least about 87%, or at least about 88%, or at least about 90%, or at least about 95%, or at least about 98% sequence identity. Transcription factors that are homologous to the listed sequences should share at least 30%, or at least about 60%, or at least about 75%, or at least about 80%, or at least about 90%, or at least about 95% amino acid sequence identity over the entire length of the polypeptide or the homolog. In addition, transcription factors that are homologous to the listed sequences should share at least 30%, or at least about 60%, or at least about 75%, or at least about 80%, or at least about 90%, or at least about 95% amino acid sequence similarity over the entire length of the polypeptide or the homolog.

[0063] Identifying Orthologs And Paralogs

[0064] Several different methods are known by those of skill in the art for identifying and defining these functionally homologous sequences. Three general methods for defining paralogs and orthologs are described; a paralog or ortholog may be identified by only one or more of the methods described below.

[0065] Orthologs and paralogs are evolutionarily related genes that have similar sequence and similar functions. Paralogs are related genes within a single species and are most likely a result of gene duplication, whereas orthologs are related genes in different species derived from a common ancestral molecule prior to speciation.

[0066] Within a single plant species, gene duplication may causes two copies of a particular gene, giving rise to two or more genes with similar sequence and similar function known as paralogs. A paralog is therefore a similar gene with a similar function within the same species. Paralogs typically cluster together or in the same lade (a group of similar genes) when a gene family phylogeny is analyzed using programs such as CLUSTAL (Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680; Higgins et al. (1996) Methods Enzymol. 266 383-402). Groups of similar genes can also be identified using by pair-wise BLAST analysis (Feng and Doolittle (1987) J. Mol. Evol. 25:351-360). For example, a lade of very similar MADS domain transcription factors from Arabidopsis all share a common function in flowering time (Ratcliffe et al. (2001) Plant Physiol. 126:122-132), and a group of very similar AP2 domain transcription factors from Arabidopsis are involved in tolerance of plants to freezing (Gilmour et al. (1998) Plant J. 16:433-442). Analysis of groups of similar genes with similar function that fall within one lade can yield sub-sequences that are particular to the lade. These sub-sequences, known as consensus sequences, can not only be used to define the sequences within each lade, but define the functions of these genes, since genes within each lade typically share the same function. (See also, for example, Mount, D. W. (2001) Bioinformatics: Sequence and Genome Analysis Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. page 543.)

[0067] Speciation, the production of new species from a parental species, can also give rise to two or more genes with similar sequence and similar function. These genes, termed orthologs, often have an identical function within their host plants and are often interchangeable between species without losing function. Because plants have common ancestors, many genes in any plant species will have a corresponding orthologous gene in another plant species. Once a phylogenic tree for a gene family of one species has been constructed using a program such as CLUSTAL (Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680; Higgins et al. (1996) Methods Enzymol. 266:383-402), potential orthologous sequences can placed into the phylogenetic tree and its relationship to genes from the species of interest can be determined. Once the ortholog pair has been identified, the function of the test ortholog can be determined by determining the function of the reference ortholog.

[0068] Orthologs can also be identified by pair-wise BLAST analysis by aligning a set of reference sequences against a set of test sequences. Test sequences with the closest match to a particular reference sequence, as determined by the P-value of the BLAST analysis, can be taken and individually aligned against the reference set of sequences. The individual test sequence will either best match the particular reference sequence, in which case it is likely to be an ortholog, or not, in which case it may not be an ortholog.

[0069] A further way of identifying an ortholog is by identifying a consensus sequence within the candidate ortholog. Using pair-wise BLAST analysis, or programs such as CLUSTAL alignment program, sets of similar genes, or clades, can be identified. The particular sub-sequences which defining within a particular clade have in common to differentiate themselves can be derived from an alignment of those sequences. Orthologs would have the consensus sequence, or a sequence similar to the consensus sequence. Orthologs might also have a consensus sequence outside a conserved domain, which could be particular to that family of orthologous sequences.

[0070] Corresponding orthologs may bridge the monocot/dicot division of the plant kingdom and orthologous pairs of genes can be identified in rice and Arabidopsis, corn and Arabidopsis and Antirhinnum and corn. For example Peng et al showed that a mutant of the Arabidonsis gene termed Gibberellin Insensitive (GAI; mutant termed gai) encoded a transcription factor and which conferred a reduction in gibberellin responsiveness in the native plant (Peng et al. 1997 Genes and Development 11:3194-3205). In addition, Peng et al. subsequently showed that the Arabidopsis GAI protein has 62 % amino acid residue identity with the wheat Rht-D 1 a protein and 62% amino acid residue identity with the maize d8. Peng et al. showed that transgenic rice plants containing a mutant GAI allele give reduced response to gibberellin and are dwarfed, mimicking the dwarfed wheat variety from which the mutant Rht-Dla gene was isolated. Peng et al. taught that Arabidopsis GAI protein is an ortholog of the wheat Rht-Dla and maize d8 proteins. (Peng et al. 1999 Nature 400:256-261.)

[0071] In addition Fu et al. (2001 Plant Cell 13:1791-1802), Nandi et al. (2000 Curr. Biol. 10:215-218), Coupland (1995 Nature 377:482-483), and Weigel and Nilsson (1995 Nature 377:482-500) show that an Arabidopsis transcription factor expressed in an exogenous plant species elicits the same or very similar phenotypic response. Furthermore, Kater et al. (1998 Plant Cell 10:171-182), Mandel et al. (1992 Cell 71-133-143), and Suzuki et al. (2001 Plant J. 28:409-418) showed that a transcription factor expressed in another plant species elicits the same or very similar phenotypic response of the endogenous sequence, as often predicted in earlier studies of Arabidopsis transcription factors in Arabidopsis.

[0072] Identifying Polynucleotides Or Nucleic Acids By Hybridization

[0073] Polynucleotides homologous to the sequences illustrated in the Sequence Listing can be identified, e.g., by hybridization to each other under stringent or under highly stringent conditions. Single stranded polynucleotides hybridize when they associate based on a variety of well characterized physical-chemical forces, such as hydrogen bonding, solvent exclusion, base stacking and the like. The stringency of a hybridization reflects the degree of sequence identity of the nucleic acids involved, such that the higher the stringency, the more similar are the two polynucleotide strands. Stringency is influenced by a variety of factors, including temperature, salt concentration and composition, organic and non-organic additives, solvents, etc. present in both the hybridization and wash solutions and incubations (and number), as described in more detail in the references cited above.

[0074] An example of stringent hybridization conditions for hybridization of complementary nucleic acids which have more than 100 complementary residues on a filter in a Southern or northern blot is about 5° C. to 20° C. lower than the thermal melting point (T_(m)) for the specific sequence at a defined ionic strength and pH. The T_(m) is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Nucleic acid molecules that hybridize under stringent conditions will typically hybridize to a probe based on either the entire cDNA or selected portions, e.g., to a unique subsequence, of the cDNA under wash conditions of 0.2× SSC to 2.0× SSC, 0.1% SDS at 50-65° C. For example, high stringency is about 0.2× SSC, 0.1% SDS at 65° C. Ultra-high stringency will be the same conditions except the wash temperature is raised about 3 or about 5° C., and ultra-ultra-high stringency will be the same conditions except the wash temperature is raised about 6 or about 9° C. For identification of less closely related homologues washes can be performed at a lower temperature, e.g., 500 C. In general, stringency is increased by raising the wash temperature and/or decreasing the concentration of SSC, as known in the art.

[0075] As another example, stringent conditions can be selected such that an oligonucleotide that is perfectly complementary to the coding oligonucleotide hybridizes to the coding oligonucleotide with at least about a 5-10×higher signal to noise ratio than the ratio for hybridization of the perfectly complementary oligonucleotide to a nucleic acid encoding a transcription factor known as of the filing date of the application. Conditions can be selected such that a higher signal to noise ratio is observed in the particular assay which is used, e.g., about 15×, 25×, 35×, 50× or more. Accordingly, the subject nucleic acid hybridizes to the unique coding oligonucleotide with at least a 2× higher signal to noise ratio as compared to hybridization of the coding oligonucleotide to a nucleic acid encoding known polypeptide. Again, higher signal to noise ratios can be selected, e.g., about 5×, 10×, 25×, 35×, 50× or more. The particular signal will depend on the label used in the relevant assay, e.g., a fluorescent label, a colorimetric label, a radioactive label, or the like.

[0076] Alternatively, transcription factor homolog polypeptides can be obtained by screening an expression library using antibodies specific for one or more transcription factors. With the provision herein of the disclosed transcription factor, and transcription factor homologue nucleic acid sequences, the encoded polypeptide(s) can be expressed and purified in a heterologous expression system (e.g., E. coli) and used to raise antibodies (monoclonal or polyclonal) specific for the polypeptide(s) in question. Antibodies can also be raised against synthetic peptides derived from transcription factor, or transcription factor homologue, amino acid sequences. Methods of raising antibodies are well known in the art and are described in Harlow and Lane (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, New York. Such antibodies can then be used to screen an expression library produced from the plant from which it is desired to clone additional transcription factor homologues, using the methods described above. The selected cDNAs can be confirmed by sequencing and enzymatic activity.

[0077] Sequence Variations

[0078] It will readily be appreciated by those of skill in the art, that any of a variety of polynucleotide sequences are capable of encoding the transcription factors and transcription factor homologue polypeptides of the invention. Due to the degeneracy of the genetic code, many different polynucleotides can encode identical and/or substantially similar polypeptides in addition to those sequences illustrated in the Sequence Listing.

[0079] For example, Table 1 illustrates, e.g., that the codons AGC, AGT, TCA, TCC, TCG, and TCT all encode the same amino acid: serine. Accordingly, at each position in the sequence where there is a codon encoding serine, any of the above trinucleotide sequences can be used without altering the encoded polypeptide. TABLE 1 Amino acid Possible Codons Alanine Ala A GCA GCC GCG GCU Cysteine Cys C TGC TGT Aspartic acid Asp D GAC GAT Glutamic acid Glu E GAA GAG Phenylalanine Phe F TTC TTT Glycine Gly G GGA GGC GGG GGT Histidine His H CAC CAT Isoleucine Ile I ATA ATC ATT Lysine Lys K AAA AAG Leucine Leu L TTA TTG CTA CTC CTG CTT Methionine Met M ATG Asparagine Asn N AAC AAT Proline Pro P CCA CCC CCG CCT Glutamine Gln Q CAA CAG Arginine Arg R AGA AGG CGA CGC CGG CGT Serine Ser S AGC AGT TCA TCC TCG TCT Threonine Thr T ACA ACC ACG ACT Valine Val V GTA GTC GTG GTT Tryptophan Trp W TGG Tyrosine Tyr Y TAC TAT

[0080] Sequence alterations that do not change the amino acid sequence encoded by the polynucleotide are termed “silent” variations. With the exception of the codons ATG and TGG, encoding methionine and tryptophan, respectively, any of the possible codons for the same amino acid can be substituted by a variety of techniques, e.g., site-directed mutagenesis, available in the art. Accordingly, any and all such variations of a sequence selected from the above table are a feature of the invention.

[0081] In addition to silent variations, other conservative variations that alter one, or a few amino acids in the encoded polypeptide, can be made without altering the function of the polypeptide, these conservative variants are, likewise, a feature of the invention.

[0082] For example, substitutions, deletions and insertions introduced into the sequences provided in the Sequence Listing are also envisioned by the invention. Such sequence modifications can be engineered into a sequence by site-directed mutagenesis (Wu (ed.) Meth. Enzymol. (1993) vol. 217, Academic Press) or the other methods noted below. Amino acid substitutions are typically of single residues; insertions usually will be on the order of about from 1 to 10 amino acid residues; and deletions will range about from 1 to 30 residues. In preferred embodiments, deletions or insertions are made in adjacent pairs, e.g., a deletion of two residues or insertion of two residues. Substitutions, deletions, insertions or any combination thereof can be combined to arrive at a sequence. The mutations that are made in the polynucleotide encoding the transcription factor should not place the sequence out of reading frame and should not create complementary regions that could produce secondary mRNA structure. Preferably, the polypeptide encoded by the DNA performs the desired function.

[0083] Conservative substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 2 when it is desired to maintain the activity of the protein. Table 2 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as conservative substitutions. TABLE 2 Conservative Residue Substitutions Ala Ser Arg Lys Asn Gln; His Asp Glu Gln Asn Cys Ser Glu Asp Gly Pro His Asn; Gln Ile Leu, Val Leu Ile; Val Lys Arg; Gln Met Leu; Ile Phe Met; Leu; Tyr Ser Thr; Gly Thr Ser; Val Trp Tyr Tyr Trp; Phe Val Ile; Leu

[0084] Similar substitutions are those in which at least one residue in the amino acid sequence has been removed and a different residue inserted in its place. Such substitutions generally are made in accordance with the Table 3 when it is desired to maintain the activity of the protein. Table 3 shows amino acids which can be substituted for an amino acid in a protein and which are typically regarded as structural and functional substitutions. For example, a residue in column 1 of Table 3 may be substituted with residue in column 2; in addition, a residue in column 2 of Table 3 may be substituted with the residue of column 1. TABLE 3 Residue Similar Substitutions Ala Ser; Thr; Gly; Val; Leu; Ile Arg Lys; His; Gly Asn Gln; His; Gly; Ser; Thr Asp Glu, Ser; Thr Gln Asn; Ala Cys Ser; Gly Glu Asp Gly Pro; Arg His Asn; Gln; Tyr; Phe; Lys; Arg Ile Ala; Leu; Val; Gly; Met Leu Ala; Ile; Val; Gly; Met Lys Arg; His; Gln; Gly; Pro Met Leu; Ile; Phe Phe Met; Leu; Tyr; Trp; His; Val; Ala Ser Thr; Gly; Asp; Ala; Val; Ile; His Thr Ser; Val; Ala; Gly Trp Tyr; Phe; His Tyr Trp; Phe; His Val Ala; Ile; Leu; Gly; Thr; Ser; Glu

[0085] Substitutions that are less conservative than those in Table 2 or Table 3 can be selected by picking residues that differ more significantly in their effect on maintaining (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a sheet or helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain. The substitutions which in general are expected to produce the greatest changes in protein properties will be those in which (a) a hydrophilic residue, e.g., seryl or threonyl, is substituted for (or by) a hydrophobic residue, e.g., leucyl, isoleucyl, phenylalanyl, valyl or alanyl; (b) a cysteine or proline is substituted for (or by) any other residue; (c) a residue having an electropositive side chain, e.g., lysyl, arginyl, or histidyl, is substituted for (or by) an electronegative residue, e.g., glutamyl or aspartyl; or (d) a residue having a bulky side chain, e.g., phenylalanine, is substituted for (or by) one not having a side chain, e.g., glycine.

[0086]

[0087] Further Modifying Sequences of the Invention—Mutation/Forced Evolution

[0088] In addition to generating silent or conservative substitutions as noted, above, the present invention optionally includes methods of modifying the sequences of the Sequence Listing. In the methods, nucleic acid or protein modification methods are used to alter the given sequences to produce new sequences and/or to chemically or enzymatically modify given sequences to change the properties of the nucleic acids or proteins. These sequences may be synthetic polynuceotides and synthetic polypetides.

[0089] Thus, in one embodiment, given nucleic acid sequences are modified, e.g., according to standard mutagenesis or artificial evolution methods to produce modified sequences. For example, Ausubel, supra, provides additional details on mutagenesis methods. Artificial forced evolution methods are described, e.g., by Stemmer (1994) Nature 370:389-391, and Stemmer (1994) Proc. Natl. Acad. Sci. USA 91:10747-10751, and U.S. Pat. Nos. 5,811,238, 5,837,500, and 6,242,568. Many other mutation and evolution methods are also available and expected to be within the skill of the practitioner. A synthetic polypeptide encoded by a synthetic polynucleotide may have as little as 20% amino acid residue sequence identity to the polypeptide encoded by the claimed polynucleotides and still modify a plant's trait or characteristic.

[0090] Similarly, chemical or enzymatic alteration of expressed nucleic acids and polypeptides can be performed by standard methods. For example, sequence can be modified by addition of lipids, sugars, peptides, organic or inorganic compounds, by the inclusion of modified nucleotides or amino acids, or the like. For example, protein modification techniques are illustrated in Ausubel, supra. Further details on chemical and enzymatic modifications can be found herein. These modification methods can be used to modify any given sequence, or to modify any sequence produced by the various mutation and artificial evolution modification methods noted herein.

[0091] Accordingly, the invention provides for modification of any given nucleic acid by mutation, evolution, chemical or enzymatic modification, or other available methods, as well as for the products produced by practicing such methods, e.g., using the sequences herein as a starting substrate for the various modification approaches.

[0092] For example, optimized coding sequence containing codons preferred by a particular prokaryotic or eukaryotic host can be used e.g., to increase the rate of translation or to produce recombinant RNA transcripts having desirable properties, such as a longer half-life, as compared with transcripts produced using a non-optimized sequence. Translation stop codons can also be modified to reflect host preference. For example, preferred stop codons for S. cerevisiae and mammals are TAA and TGA, respectively. The preferred stop codon for monocotyledonous plants is TGA, whereas insects and E. coli prefer to use TAA as the stop codon.

[0093] The polynucleotide sequences of the present invention can also be engineered in order to alter a coding sequence for a variety of reasons, including but not limited to, alterations which modify the sequence to facilitate cloning, processing and/or expression of the gene product. For example, alterations are optionally introduced using techniques which are well known in the art, e.g., site-directed mutagenesis, to insert new restriction sites, to alter glycosylation patterns, to change codon preference, to introduce splice sites, etc.

[0094] Furthermore, a fragment or domain derived from any of the polypeptides of the invention can be combined with domains derived from other transcription factors or synthetic domains to modify the biological activity of a transcription factor. For instance, a DNA-binding domain derived from a transcription factor of the invention can be combined with the activation domain of another transcription factor or with a synthetic activation domain. A transcription activation domain assists in initiating transcription from a DNA-binding site. Examples include the transcription activation region of VP16 or GAL4 (Moore et al. (1998) Proc. Natl. Acad. Sci. USA 95: 376-381; and Aoyama et al. (1995) Plant Cell 7:1773-1785), peptides derived from bacterial sequences (Ma and Ptashne (1987) Cell 51; 113-119) and synthetic peptides (Giniger and Ptashne, (1987) Nature 330:670-672).

[0095] Expression and Modification of Polypeptides

[0096] Typically, polynucleotide sequences of the invention are incorporated into recombinant DNA (or RNA) molecules that direct expression of polypeptides of the invention in appropriate host cells, transgenic plants, in vitro translation systems, or the like. Due to the inherent degeneracy of the genetic code, nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence can be substituted for any listed sequence to provide for cloning and expressing the relevant homologue.

[0097] Vectors, Promoters, and Expression Systems

[0098] The present invention includes recombinant constructs comprising one or more of the nucleic acid sequences herein. The constructs typically comprise a vector, such as a plasmid, a cosmid, a phage, a virus (e.g., a plant virus), a bacterial artificial chromosome (BAC), a yeast artificial chromosome (YAC), or the like, into which a nucleic acid sequence of the invention has been inserted, in a forward or reverse orientation. In a preferred aspect of this embodiment, the construct further comprises regulatory sequences, including, for example, a promoter, operably linked to the sequence. Large numbers of suitable vectors and promoters are known to those of skill in the art, and are commercially available.

[0099] General texts which describe molecular biological techniques useful herein, including the use and production of vectors, promoters and many other relevant topics, include Berger, Sambrook and Ausubel, supra. Any of the identified sequences can be incorporated into a cassette or vector, e.g., for expression in plants. A number of expression vectors suitable for stable transformation of plant cells or for the establishment of transgenic plants have been described including those described in Weissbach and Weissbach, (1989) Methods for Plant Molecular Biology, Academic Press, and Gelvin et al., (1990) Plant Molecular Biology Manual, Kluwer Academic Publishers. Specific examples include those derived from a Ti plasmid of Agrobacterium tumefaciens, as well as those disclosed by Herrera-Estrella et al. (1983) Nature 303: 209, Bevan (1984) Nucl Acid Res. 12: 8711-8721, Klee (1985) Bio/Technology 3: 637-642, for dicotyledonous plants.

[0100] Alternatively, non-Ti vectors can be used to transfer the DNA into monocotyledonous plants and cells by using free DNA delivery techniques. Such methods can involve, for example, the use of liposomes, electroporation, microprojectile bombardment, silicon carbide whiskers, and viruses. By using these methods transgenic plants such as wheat, rice (Christou (1991) Bio/Technology 9: 957-962) and corn (Gordon-Kamm (1990) Plant Cell 2: 603-618) can be produced. An immature embryo can also be a good target tissue for monocots for direct DNA delivery techniques by using the particle gun (Weeks et al. (1993) Plant Physiol 102: 1077-1084; Vasil (1993) Bio/Technology 10: 667-674; Wan and Lemeaux (1994) Plant Physiol 104: 37-48, and for Agrobacterium-mediated DNA transfer (Ishida et al. (1996) Nature Biotech 14: 745-750).

[0101] Typically, plant transformation vectors include one or more cloned plant coding sequence (genomic or cDNA) under the transcriptional control of 5′ and 3′ regulatory sequences and a dominant selectable marker. Such plant transformation vectors typically also contain a promoter (e.g., a regulatory region controlling inducible or constitutive, environmentally-or developmentally-regulated, or cell- or tissue-specific expression), a transcription initiation start site, an RNA processing signal (such as intron splice sites), a transcription termination site, and/or a polyadenylation signal.

[0102] Examples of constitutive plant promoters which can be useful for expressing the TF sequence include: the cauliflower mosaic virus (CaMV) 35S promoter, which confers constitutive, high-level expression in most plant tissues (see, e.g., Odel et al. (1985) Nature 313:810); the nopaline synthase promoter (An et al. (1988) Plant Physiol 88:547); and the octopine synthase promoter (Fromm et al. (1989) Plant Cell 1: 977).

[0103] A variety of plant gene promoters that regulate gene expression in response to environmental, hormonal, chemical, developmental signals, and in a tissue-active manner can be used for expression of a TF sequence in plants. Choice of a promoter is based largely on the phenotype of interest and is determined by such factors as tissue (e.g., seed, fruit, root, pollen, vascular tissue, flower, carpel, etc.), inducibility (e.g., in response to wounding, heat, cold, drought, light, pathogens, etc.), timing, developmental stage, and the like. Numerous known promoters have been characterized and can favorable be employed to promote expression of a polynucleotide of the invention in a transgenic plant or cell of interest. For example, tissue specific promoters include: seed-specific promoters (such as the napin, phaseolin or DC3 promoter described in U.S. Pat. No. 5,773,697), fruit-specific promoters that are active during fruit ripening (such as the dru 1 promoter (U.S. Pat. No. 5,783,393), or the 2A11 promoter (U.S. Pat. No. 4,943,674) and the tomato polygalacturonase promoter (Bird et al. (1988) Plant Mol Biol 11:651), root-specific promoters, such as those disclosed in U.S. Pat. Nos. 5,618,988, 5,837,848 and 5,905,186, pollen-active promoters such as PTA29, PTA26 and PTA13 (U.S. Pat. No. 5,792,929), promoters active in vascular tissue (Ringli and Keller (1998) Plant Mol Biol 37:977-988), flower-specific (Kaiser et al, (1995) Plant Mol Biol 28:231-243), pollen (Baerson et al. (1994) Plant Mol Biol 26:1947-1959), carpels (Ohl et al. (1990) Plant Cell 2:837-848), pollen and ovules (Baerson et al. (1993) Plant Mol Biol 22:255-267), auxin-inducible promoters (such as that described in van der Kop et al. (1999) Plant Mol Biol 39:979-990 or Baumann et al. (1999) Plant Cell 11:323-334), cytokinin-inducible promoter (Guevara-Garcia (1998) Plant Mol Biol 38:743-753), promoters responsive to gibberellin (Shi et al. (1998) Plant Mol Biol 38:1053-1060, Willmott et al. (1998) 38:817-825) and the like. Additional promoters are those that elicit expression in response to heat (Ainley et al. (1993) Plant Mol Biol 22: 13-23), light (e.g., the pea rbcS-3A promoter, Kuhlemeier et al. (1989) Plant Cell 1:471, and the maize rbcS promoter, Schaffner and Sheen (1991) Plant Cell 3: 997); wounding (e.g., wunI, Siebertz et al. (1989) Plant Cell 1: 961); pathogens (such as the PR-1 promoter described in Buchel et al. (1999) Plant Mol. Biol. 40:387-396, and the PDF1.2 promoter described in Manners et al. (1998) Plant Mol. Biol. 38:1071-80), and chemicals such as methyl jasmonate or salicylic acid (Gatz et al. (1997) Annu Rev Plant Physiol Plant Mol Biol 48: 89-108). In addition, the timing of the expression can be controlled by using promoters such as those acting at senescence (Gan and Amasino (1995) Science 270: 1986-1988); or late seed development (Odell et al. (1994) Plant Physiol 106:447-458).

[0104] Plant expression vectors can also include RNA processing signals that can be positioned within, upstream or downstream of the coding sequence. In addition, the expression vectors can include additional regulatory sequences from the 3′-untranslated region of plant genes, e.g., a 3′ terminator region to increase mRNA stability of the mRNA, such as the PI-II terminator region of potato or the octopine or nopaline synthase 3′ terminator regions.

[0105] Additional Expression Elements

[0106] Specific initiation signals can aid in efficient translation of coding sequences. These signals can include, e.g., the ATG initiation codon and adjacent sequences. In cases where a coding sequence, its initiation codon and upstream sequences are inserted into the appropriate expression vector, no additional translational control signals may be needed. However, in cases where only coding sequence (e.g., a mature protein coding sequence), or a portion thereof, is inserted, exogenous transcriptional control signals including the ATG initiation codon can be separately provided. The initiation codon is provided in the correct reading frame to facilitate transcription. Exogenous transcriptional elements and initiation codons can be of various origins, both natural and synthetic. The efficiency of expression can be enhanced by the inclusion of enhancers appropriate to the cell system in use.

[0107] Expression Hosts

[0108] The present invention also relates to host cells which are transduced with vectors of the invention, and the production of polypeptides of the invention (including fragments thereof) by recombinant techniques. Host cells are genetically engineered (i.e, nucleic acids are introduced, e.g., transduced, transformed or transfected) with the vectors of this invention, which may be, for example, a cloning vector or an expression vector comprising the relevant nucleic acids herein. The vector is optionally a plasmid, a viral particle, a phage, a naked nucleic acid, etc. The engineered host cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants, or amplifying the relevant gene. The culture conditions, such as temperature, pH and the like, are those previously used with the host cell selected for expression, and will be apparent to those skilled in the art and in the references cited herein, including, Sambrook and Ausubel.

[0109] The host cell can be a eukaryotic cell, such as a yeast cell, or a plant cell, or the host cell can be a prokaryotic cell, such as a bacterial cell. Plant protoplasts are also suitable for some applications. For example, the DNA fragments are introduced into plant tissues, cultured plant cells or plant protoplasts by standard methods including electroporation (Fromm et al., (1985) Proc. Natl. Acad. Sci. USA 82, 5824, infection by viral vectors such as cauliflower mosaic virus (CaMV) (Hohn et al., (1982) Molecular Biology of Plant Tumors, (Academic Press, New York) pp. 549-560; U.S. Pat. No. 4,407,956), high velocity ballistic penetration by small particles with the nucleic acid either within the matrix of small beads or particles, or on the surface (Klein et al., (1987) Nature 327, 70-73), use of pollen as vector (WO 85/01856), or use of Agrobacterium tumefaciens or A. rhizogenes carrying a T-DNA plasmid in which DNA fragments are cloned. The T-DNA plasmid is transmitted to plant cells upon infection by Agrobacterium tumefaciens, and a portion is stably integrated into the plant genome (Horsch et al. (1984) Science 233:496-498; Fraley et al. (1983) Proc. Natl. Acad. Sci. USA 80, 4803).

[0110] The cell can include a nucleic acid of the invention which encodes a polypeptide, wherein the cells expresses a polypeptide of the invention. The cell can also include vector sequences, or the like. Furthermnore, cells and transgenic plants which include any polypeptide or nucleic acid above or throughout this specification, e.g., produced by transduction of a vector of the invention, are an additional feature of the invention.

[0111] For long-term, high-yield production of recombinant proteins, stable expression can be used. Host cells transformed with a nucleotide sequence encoding a polypeptide of the invention are optionally cultured under conditions suitable for the expression and recovery of the encoded protein from cell culture. The protein or fragment thereof produced by a recombinant cell may be secreted, membrane-bound, or contained intracellularly, depending on the sequence and/or the vector used. As will be understood by those of skill in the art, expression vectors containing polynucleotides encoding mature proteins of the invention can be designed with signal sequences which direct secretion of the mature polypeptides through a prokaryotic or eukaryotic cell membrane.

[0112] Modified Amino Acids

[0113] Polypeptides of the invention may contain one or more modified amino acids. The presence of modified amino acids may be advantageous in, for example, increasing polypeptide half-life, reducing polypeptide antigenicity or toxicity, increasing polypeptide storage stability, or the like. Amino acid(s) are modified, for example, co-translationally or post-translationally during recombinant production or modified by synthetic or chemical means.

[0114] Non-limiting examples of a modified amino acid include incorporation or other use of acetylated amino acids, glycosylated amino acids, sulfated amino acids, prenylated (e.g., famesylated, geranylgeranylated) amino acids, PEG modified (e.g., “PEGylated”) amino acids, biotinylated amino acids, carboxylated amino acids, phosphorylated amino acids, etc. References adequate to guide one of skill in the modification of amino acids are replete throughout the literature.

[0115] The modified amino acids may prevent or increase affinity of the polypeptide for another molecule, including, but not limited to, polynucleotide, proteins, carbohydrates, lipids and lipid derivatives, and other organic or synthetic compounds.

[0116] Identification of Additional Factors

[0117] A transcription factor provided by the present invention can also be used to identify additional endogenous or exogenous molecules that can affect a phentoype or trait of interest. On the one hand, such molecules include organic (small or large molecules) and/or inorganic compounds that affect expression of (i.e., regulate) a particular transcription factor. Alternatively, such molecules include endogenous molecules that are acted upon either at a transcriptional level by a transcription factor of the invention to modify a phenotype as desired. For example, the transcription factors can be employed to identify one or more downstream gene with which is subject to a regulatory effect of the transcription factor. In one approach, a transcription factor or transcription factor homologue of the invention is expressed in a host cell, e.g, a transgenic plant cell, tissue or explant, and expression products, either RNA or protein, of likely or random targets are monitored, e.g., by hybridization to a microarray of nucleic acid probes corresponding to genes expressed in a tissue or cell type of interest, by two-dimensional gel electrophoresis of protein products, or by any other method known in the art for assessing expression of gene products at the level of RNA or protein. Alternatively, a transcription factor of the invention can be used to identify promoter sequences (i.e., binding sites) involved in the regulation of a downstream target. After identifying a promoter sequence, interactions between the transcription factor and the promoter sequence can be modified by changing specific nucleotides in the promoter sequence or specific amino acids in the transcription factor that interact with the promoter sequence to alter a plant trait. Typically, transcription factor DNA-binding sites are identified by gel shift assays. After identifying the promoter regions, the promoter region sequences can be employed in double-stranded DNA arrays to identify molecules that affect the interactions of the transcription factors with their promoters (Bulyk et al. (1999) Nature Biotechnology 17:573-577). A test promoter region element of a transcription factor gene may also be screened using a phage-display analysis and a phage library which comprises polynucleotides encoding any transcription factor to identify a transcription factor so encoded which binds to the test promoter region element. Such phage-display methods are well known in the art.

[0118] The identified transcription factors are also useful to identify proteins that modify the activity of the transcription factor. Such modification can occur by covalent modification, such as by phosphorylation, or by protein-protein (homo or-heteropolymer) interactions. Any method suitable for detecting protein-protein interactions can be employed. Among the methods that can be employed are co-immunoprecipitation, cross-linking and co-purification through gradients or chromatographic columns, and the two-hybrid yeast system.

[0119] The two-hybrid system detects protein interactions in vivo and is described in Chien, et al., (1991), Proc. Natl. Acad. Sci. USA 88, 9578-9582 and is commercially available from Clontech (Palo Alto, Calif.). In such a system, plasmids are constructed that encode two hybrid proteins: one consists of the DNA-binding domain of a transcription activator protein fused to the TF polypeptide and the other consists of the transcription activator protein's activation domain fused to an unknown protein that is encoded by a cDNA that has been recombined into the plasmid as part of a cDNA library. The DNA-binding domain fusion plasmid and the cDNA library are transformed into a strain of the yeast Saccharomyces cerevisiae that contains a reporter gene (e.g., lacZ) whose regulatory region contains the transcription activator's binding site. Either hybrid protein alone cannot activate transcription of the reporter gene. Interaction of the two hybrid proteins reconstitutes the functional activator protein and results in expression of the reporter gene, which is detected by an assay for the reporter gene product. Then, the library plasmids responsible for reporter gene expression are isolated and sequenced to identify the proteins encoded by the library plasmids. After identifying proteins that interact with the transcription factors, assays for compounds that interfere with the TF protein-protein interactions can be preformed.

[0120] Identification of Modulators

[0121] In addition to the intracellular molecules described above, extracellular molecules that alter activity or expression of a transcription factor, either directly or indirectly, can be identified. For example, the methods can entail first placing a candidate molecule in contact with a plant or plant cell. The molecule can be introduced by topical administration, such as spraying or soaking of a plant, and then the molecule's effect on the expression or activity of the TF polypeptide or the expression of the polynucleotide monitored. Changes in the expression of the TF polypeptide can be monitored by use of polyclonal or monoclonal antibodies, gel electrophoresis or the like. Changes in the expression of the corresponding polynucleotide sequence can be detected by use of microarrays, Northerns, quantitative PCR, or any other technique for monitoring changes in mRNA expression. These techniques are exemplified in Ausubel et al. (eds) Current Protocols in Molecular Biology, John Wiley & Sons (1998, and supplements through 2001). Such changes in the expression levels can be correlated with modified plant traits and thus identified molecules can be useful for soaking or spraying on fruit, vegetable and grain crops to modify traits in plants.

[0122] Essentially any available composition can be tested for modulatory activity of expression or activity of any nucleic acid or polypeptide herein. Thus, available libraries of compounds such as chemicals, polypeptides, nucleic acids and the like can be tested for modulatory activity. Often, potential modulator compounds can be dissolved in aqueous or organic (e.g., DMSO-based) solutions for easy delivery to the cell or plant of interest in which the activity of the modulator is to be tested. Optionally, the assays are designed to screen large modulator composition libraries by automating the assay steps and providing compounds from any convenient source to assays, which are typically run in parallel (e.g., in microtitre formats on microtitre plates in robotic assays).

[0123] In one embodiment, high throughput screening methods involve providing a combinatorial library containing a large number of potential compounds (potential modulator compounds). Such “combinatorial chemical libraries” are then screened in one or more assays, as described herein, to identify those library members (particular chemical species or subclasses) that display a desired characteristic activity. The compounds thus identified can serve as target compounds.

[0124] A combinatorial chemical library can be, e.g., a collection of diverse chemical compounds generated by chemical synthesis or biological synthesis. For example, a combinatorial chemical library such as a polypeptide library is formed by combining a set of chemical building blocks (e.g., in one example, amino acids) in every possible way for a given compound length (i.e., the number of amino acids in a polypeptide compound of a set length). Exemplary libraries include peptide libraries, nucleic acid libraries, antibody libraries (see, e.g., Vaughn et al. (1996) Nature Biotechnology, 14(3):309-314 and PCT/US96/10287), carbohydrate libraries (see, e.g., Liang et al. Science (1996) 274:1520-1522 and U.S. Pat. No. 5,593,853), peptide nucleic acid libraries (see, e.g., U.S. Pat. No. 5,539,083), and small organic molecule libraries (see, e.g., benzodiazepines, Baum C&EN January 18, page 33 (1993); isoprenoids, U.S. Pat. No. 5,569,588; thiazolidinones and metathiazanones, U.S. Pat. No. 5,549,974; pyrrolidines, U.S. Pat. Nos. 5,525,735 and 5,519,134; morpholino compounds, U.S. Pat. No. 5,506,337) and the like.

[0125] Preparation and screening of combinatorial or other libraries is well known to those of skill in the art. Such combinatorial chemical libraries include, but are not limited to, peptide libraries (see, e.g., U.S. Pat. No. 5,010,175, Furka, Int. J. Pept. Prot. Res. 37:487-493 (1991) and Houghton et al. Nature 354:84-88 (1991)). Other chemistries for generating chemical diversity libraries can also be used.

[0126] In addition, as noted, compound screening equipment for high-throughput screening is generally available, e.g., using any of a number of well known robotic systems that have also been developed for solution phase chemistries useful in assay systems. These systems include automated workstations including an automated synthesis apparatus and robotic systems utilizing robotic arms. Any of the above devices are suitable for use with the present invention, e.g., for high-throughput screening of potential modulators. The nature and implementation of modifications to these devices (if any) so that they can operate as discussed herein will be apparent to persons skilled in the relevant art.

[0127] Indeed, entire high throughput screening systems are commercially available. These systems typically automate entire procedures including all sample and reagent pipetting, liquid dispensing, timed incubations, and final readings of the microplate in detector(s) appropriate for the assay. These configurable systems provide high throughput and rapid start up as well as a high degree of flexibility and customization. Similarly, microfluidic implementations of screening are also commercially available.

[0128] The manufacturers of such systems provide detailed protocols the various high throughput. Thus, for example, Zymark Corp. provides technical bulletins describing screening systems for detecting the modulation of gene transcription, ligand binding, and the like. The integrated systems herein, in addition to providing for sequence alignment and, optionally, synthesis of relevant nucleic acids, can include such screening apparatus to identify modulators that have an effect on one or more polynucleotides or polypeptides according to the present invention.

[0129] In some assays it is desirable to have positive controls to ensure that the components of the assays are working properly. At least two types of positive controls are appropriate. That is, known transcriptional activators or inhibitors can be incubated with cells/plants/etc. in one sample of the assay, and the resulting increase/decrease in transcription can be detected by measuring the resulting increase in RNA/protein expression, etc., according to the methods herein. It will be appreciated that modulators can also be combined with transcriptional activators or inhibitors to find modulators which inhibit transcriptional activation or transcriptional repression. Either expression of the nucleic acids and proteins herein or any additional nucleic acids or proteins activated by the nucleic acids or proteins herein, or both, can be monitored.

[0130] In an embodiment, the invention provides a method for identifying compositions that modulate the activity or expression of a polynucleotide or polypeptide of the invention. For example, a test compound, whether a small or large molecule, is placed in contact with a cell, plant (or plant tissue or explant), or composition comprising the polynucleotide or polypeptide of interest and a resulting effect on the cell, plant, (or tissue or explant) or composition is evaluated by monitoring, either directly or indirectly, one or more of: expression level of the polynucleotide or polypeptide, activity (or modulation of the activity) of the polynucleotide or polypeptide. In some cases, an alteration in a plant phenotype can be detected following contact of a plant (or plant cell, or tissue or explant) with the putative modulator, e.g., by modulation of expression or activity of a polynucleotide or polypeptide of the invention. Modulation of expression or activity of a polynucleotide or polypeptide of the invention may also be caused by molecular elements in a signal transduction second messenger pathway and such modulation can affect similar elements in the same or another signal transduction second messenger pathway.

[0131] Subsequences

[0132] Also contemplated are uses of polynucleotides, also referred to herein as oligonucleotides, typically having at least 12 bases, preferably at least 15, more preferably at least 20, 30, or 50 bases, which hybridize under at least highly stringent (or ultra-high stringent or ultra-ultra- high stringent conditions) conditions to a polynucleotide sequence described above. The polynucleotides may be used as probes, primers, sense and antisense agents, and the like, according to methods as noted supra.

[0133] Subsequences of the polynucleotides of the invention, including polynucleotide fragments and oligonucleotides are useful as nucleic acid probes and primers. An oligonucleotide suitable for use as a probe or primer is at least about 15 nucleotides in length, more often at least about 18 nucleotides, often at least about 21 nucleotides, frequently at least about 30 nucleotides, or about 40 nucleotides, or more in length. A nucleic acid probe is useful in hybridization protocols, e.g., to identify additional polypeptide homologues of the invention, including protocols for microarray experiments. Primers can be annealed to a complementary target DNA strand by nucleic acid hybridization to form a hybrid between the primer and the target DNA strand, and then extended along the target DNA strand by a DNA polymerase enzyme. Primer pairs can be used for amplification of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR) or other nucleic-acid amplification methods. See Sambrook and Ausubel, supra.

[0134] In addition, the invention includes an isolated or recombinant polypeptide including a subsequence of at least about 15 contiguous amino acids encoded by the recombinant or isolated polynucleotides of the invention. For example, such polypeptides, or domains or fragments thereof, can be used as immunogens, e.g., to produce antibodies specific for the polypeptide sequence, or as probes for detecting a sequence of interest. A subsequence can range in size from about 15 amino acids in length up to and including the full length of the polypeptide.

[0135] Production of Transgenic Plants

[0136] Modification of Traits

[0137] The polynucleotides of the invention are favorably employed to produce transgenic plants with various traits, or characteristics, that have been modified in a desirable manner, e.g., to improve the seed characteristics of a plant. For example, alteration of expression levels or patterns (e.g., spatial or temporal expression patterns) of one or more of the transcription factors (or transcription factor homologues) of the invention, as compared with the levels of the same protein found in a wild type plant, can be used to modify a plant's traits. An illustrative example of trait modification, improved characteristics, by altering expression levels of a particular transcription factor is described fuirther in the Examples and the Sequence Listing.

[0138] Antisense and Cosuppression Approaches

[0139] In addition to expression of the nucleic acids of the invention as gene replacement or plant phenotype modification nucleic acids, the nucleic acids are also useful for sense and anti-sense suppression of expression, e.g., to down-regulate expression of a nucleic acid of the invention, e.g., as a further mechanism for modulating plant phenotype. That is, the nucleic acids of the invention, or subsequences or anti-sense sequences thereof, can be used to block expression of naturally occurring homologous nucleic acids. A variety of sense and anti-sense technologies are known in the art, e.g., as set forth in Lichtenstein and Nellen (1997) Antisense Technology: A Practical Approach IRL Press at Oxford University, Oxford, England. In general, sense or anti-sense sequences are introduced into a cell, where they are optionally amplified, e.g., by transcription. Such sequences include both simple oligonucleotide sequences and catalytic sequences such as ribozymes.

[0140] For example, a reduction or elimination of expression (i.e., a “knock-out”) of a transcription factor or transcription factor homologue polypeptide in a transgenic plant, e.g., to modify a plant trait, can be obtained by introducing an antisense construct corresponding to the polypeptide of interest as a cDNA. For antisense suppression, the transcription factor or homologue cDNA is arranged in reverse orientation (with respect to the coding sequence) relative to the promoter sequence in the expression vector. The introduced sequence need not be the full length cDNA or gene, and need not be identical to the cDNA or gene found in the plant type to be transformed. Typically, the antisense sequence need only be capable of hybridizing to the target gene or RNA of interest. Thus, where the introduced sequence is of shorter length, a higher degree of homology to the endogenous transcription factor sequence will be needed for effective antisense suppression. While antisense sequences of various lengths can be utilized, preferably, the introduced antisense sequence in the vector will be at least 30 nucleotides in length, and improved antisense suppression will typically be observed as the length of the antisense sequence increases. Preferably, the length of the antisense sequence in the vector will be greater than 100 nucleotides. Transcription of an antisense construct as described results in the production of RNA molecules that are the reverse complement of mRNA molecules transcribed from the endogenous transcription factor gene in the plant cell.

[0141] Suppression of endogenous transcription factor gene expression can also be achieved using a ribozyme. Ribozymes are RNA molecules that possess highly specific endoribonuclease activity. The production and use of ribozymes are disclosed in U.S. Pat. No. 4,987,071 and U.S. Pat. No. 5,543,508. Synthetic ribozyme sequences including antisense RNAs can be used to confer RNA cleaving activity on the antisense RNA, such that endogenous MRNA molecules that hybridize to the antisense RNA are cleaved, which in turn leads to an enhanced antisense inhibition of endogenous gene expression.

[0142] Vectors in which RNA encoded by a transcription factor or transcription factor homologue cDNA is over-expressed can also be used to obtain co-suppression of a corresponding endogenous gene, e.g., in the manner described in U.S. Pat. No. 5,231,020 to Jorgensen. Such co-suppression (also termed sense suppression) does not require that the entire transcription factor cDNA be introduced into the plant cells, nor does it require that the introduced sequence be exactly identical to the endogenous transcription factor gene of interest. However, as with antisense suppression, the suppressive efficiency will be enhanced as specificity of hybridization is increased, e.g., as the introduced sequence is lengthened, and/or as the sequence similarity between the introduced sequence and the endogenous transcription factor gene is increased.

[0143] Vectors expressing an untranslatable form of the transcription factor mRNA, e.g., sequences comprising one or more stop codon, or nonsense mutation) can also be used to suppress expression of an endogenous transcription factor, thereby reducing or eliminating it's activity and modifying one or more traits. Methods for producing such constructs are described in U.S. Pat. No. 5,583,021. Preferably, such constructs are made by introducing a premature stop codon into the transcription factor gene. Alternatively, a plant trait can be modified by gene silencing using double-strand RNA (Sharp (1999) Genes and Development 13: 139-141).

[0144] Another method for abolishing the expression of a gene is by insertion mutagenesis using the T-DNA of Agrobacterium tumefaciens. After generating the insertion mutants, the mutants can be screened to identify those containing the insertion in a transcription factor or transcription factor homologue gene. Plants containing a single transgene insertion event at the desired gene can be crossed to generate homozygous plants for the mutation (Koncz et al. (1992) Methods in Arabidopsis Research. World Scientific).

[0145] Alternatively, a plant phenotype can be altered by eliminating an endogenous gene, such as a transcription factor or transcription factor homologue, e.g., by homologous recombination (Kempin et al. (1997) Nature 389:802).

[0146] A plant trait can also be modified by using the Cre-lox system (for example, as described in U.S. Pat. No. 5,658,772). A plant genome can be modified to include first and second lox sites that are then contacted with a Cre recombinase. If the lox sites are in the same orientation, the intervening DNA sequence between the two sites is excised. If the lox sites are in the opposite orientation, the intervening sequence is inverted.

[0147] The polynucleotides and polypeptides of this invention can also be expressed in a plant in the absence of an expression cassette by manipulating the activity or expression level of the endogenous gene by other means. For example, by ectopically expressing a gene by T-DNA activation tagging (Ichikawa et al. (1997) Nature 390 698-701; Kakimoto et al. (1996) Science 274: 982-985). This method entails transforming a plant with a gene tag containing multiple transcriptional enhancers and once the tag has inserted into the genome, expression of a flanking gene coding sequence becomes deregulated. In another example, the transcriptional machinery in a plant can be modified so as to increase transcription levels of a polynucleotide of the invention (See, e.g., PCT Publications WO 96/06166 and WO 98/53057 which describe the modification of the DNA-binding specificity of zinc finger proteins by changing particular amino acids in the DNA-binding motif).

[0148] The transgenic plant can also include the machinery necessary for expressing or altering the activity of a polypeptide encoded by an endogenous gene, for example by altering the phosphorylation state of the polypeptide to maintain it in an activated state.

[0149] Transgenic plants (or plant cells, or plant explants, or plant tissues) incorporating the polynucleotides of the invention and/or expressing the polypeptides of the invention can be produced by a variety of well established techniques as described above. Following construction of a vector, most typically an expression cassette, including a polynucleotide, e.g., encoding a transcription factor or transcription factor homologue, of the invention, standard techniques can be used to introduce the polynucleotide into a plant, a plant cell, a plant explant or a plant tissue of interest. Optionally, the plant cell, explant or tissue can be regenerated to produce a transgenic plant.

[0150] The plant can be any higher plant, including gymnosperms, monocotyledonous and dicotyledenous plants. Suitable protocols are available for Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, broccoli, etc.), Curcurbitaceae (melons and cucumber), Gramineae (wheat, corn, rice, barley, millet, etc.), Solanaceae (potato, tomato, tobacco, peppers, etc.), and various other crops. See protocols described in Ammirato et al. (1984) Handbook of Plant Cell Culture—Crop Species, Macmillan Publ. Co. Shimamoto et al. (1989) Nature 338:274-276; Fronim et al. (1990) Bio/Technolog 8:833-839; and Vasil et al. (1990) Bio/Technology 8:429-434.

[0151] Transformation and regeneration of both monocotyledonous and dicotyledonous plant cells is now routine, and the selection of the most appropriate transformation technique will be determined by the practitioner. The choice of method will vary with the type of plant to be transformed; those skilled in the art will recognize the suitability of particular methods for given plant types. Suitable methods can include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG) mediated transformation; transformation using viruses; micro-injection of plant cells; micro-projectile bombardment of plant cells; vacuum infiltration; and Agrobacterium tumeficiens mediated transformation. Transformation means introducing a nucleotide sequence into a plant in a manner to cause stable or transient expression of the sequence.

[0152] Successful examples of the modification of plant characteristics by transformation with cloned sequences which serve to illustrate the current knowledge in this field of technology, and which are herein incorporated by reference, include: U.S. Pat. Nos. 5,571,706; 5,677,175; 5,510,471; 5,750,386; 5,597,945; 5,589,615; 5,750,871; 5,268,526; 5,780,708; 5,538,880; 5,773,269; 5,736,369 and 5,610,042.

[0153] Following transformation, plants are preferably selected using a dominant selectable marker incorporated into the transformation vector. Typically, such a marker will confer antibiotic or herbicide resistance on the transformed plants, and selection of transformants can be accomplished by exposing the plants to appropriate concentrations of the antibiotic or herbicide.

[0154] After transformed plants are selected and grown to maturity, those plants showing a modified trait are identified. The modified trait can be any of those traits described above. Additionally, to confirm that the modified trait is due to changes in expression levels or activity of the polypeptide or polynucleotide of the invention can be determined by analyzing mRNA expression using Northern blots, RT-PCR or microarrays, or protein expression using immunoblots or Western blots or gel shift assays.

[0155] Integrated Systems—Sequence Identity

[0156] Additionally, the present invention may be an integrated system, computer or computer readable medium that comprises an instruction set for determining the identity of one or more sequences in a database. In addition, the instruction set can be used to generate or identify sequences that meet any specified criteria. Furthermore, the instruction set may be used to associate or link certain functional benefits, such improved characteristics, with one or more identified sequence.

[0157] For example, the instruction set can include, e.g., a sequence comparison or other alignment program, e.g., an available program such as, for example, the Wisconsin Package Version 10.0, such as BLAST, FASTA, PILEUP, FINDPATTERNS or the like (GCG, Madision, Wis.). Public sequence databases such as GenBank, EMBL, Swiss-Prot and PIR or private sequence databases such as PhytoSeq (Incyte Pharmaceuticals, Palo Alto, Calif.) can be searched.

[0158] Alignment of sequences for comparison can be conducted by the local homology algorithm of Smith and Waterman (1981) Adv. AMol. Math. 2:482, by the homology alignment algorithm of Needleman and Wunsch (1970) J. Mol. Biol. 48:443, by the search for similarity method of Pearson and Lipman (1988) Proc. Natl. Acad. Sci. U.S.A. 85: 2444, by computerized implementations of these algorithms. After alignment, sequence comparisons between two (or more) polynucleotides or polypeptides are typically performed by comparing sequences of the two sequences over a comparison window to identify and compare local regions of sequence similarity. The comparison window can be a segment of at least about 20 contiguous positions, usually about 50 to about 200, more usually about 100 to about 150 contiguous positions. A description of the method is provided in Ausubel et al., supra.

[0159] A variety of methods for determining sequence relationships can be used, including manual alignment and computer assisted sequence alignment and analysis. This later approach is a preferred approach in the present invention, due to the increased throughput afforded by computer assisted methods. As noted above, a variety of computer programs for performing sequence alignment are available, or can be produced by one of skill.

[0160] One example algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al. J. Mol. Biol 215:403-410 (1990). Software for performing BLAST analyses is publicly available, e.g., through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al., supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always>0) and N (penalty score for mismatching residues; always<0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses as defaults a wordlength (W) of 11, an expectation (E) of 10, a cutoff of 100, M=5, N=−4, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff (1989) Proc. Natl. Acad. Sci. USA 89:10915). Unless otherwise indicated, “sequence identity” here refers to the % sequence identity generated from a tblastx using the NCBI version of the algorithm at the default settings using gapped alignments with the filter “off” (http://www.ncbi.nlm.nih.gov/). Additionally, BLASTX and TBLASTX programs may be used.

[0161] In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5787). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence (and, therefore, in this context, homologous) if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.1, or less than about 0.01, and or even less than about 0.001. An additional example of a useful sequence alignment algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments. The program can align, e.g., up to 300 sequences of a maximum length of 5,000 letters.

[0162] The integrated system, or computer typically includes a user input interface allowing a user to selectively view one or more sequence records corresponding to the one or more character strings, as well as an instruction set which aligns the one or more character strings with each other or with an additional character string to identify one or more region of sequence similarity. The system may include a link of one or more character strings with a particular phenotype or gene function. Typically, the system includes a user readable output element which displays an alignment produced by the alignment instruction set.

[0163] The methods of this invention can be implemented in a localized or distributed computing environment. In a distributed environment, the methods may implemented on a single computer comprising multiple processors or on a multiplicity of computers. The computers can be linked, e.g. through a common bus, but more preferably the computer(s) are nodes on a network. The network can be a generalized or a dedicated local or wide-area network and, in certain preferred embodiments, the computers may be components of an intra-net or an internet.

[0164] Thus, the invention provides methods for identifying a sequence similar or homologous to one or more polynucleotides as noted herein, or one or more target polypeptides encoded by the polynucleotides, or otherwise noted herein and may include linking or associating a given plant phenotype or gene function with a sequence. In the methods, a sequence database is provided (locally or across an inter or intra net) and a query is made against the sequence database using the relevant sequences herein and associated plant phenotypes or gene functions.

[0165] Any sequence herein can be entered into the database, before or after querying the database. This provides for both expansion of the database and, if done before the querying step, for insertion of control sequences into the database. The control sequences can be detected by the query to ensure the general integrity of both the database and the query. As noted, the query can be performed using a web browser based interface. For example, the database can be a centralized public database such as those noted herein, and the querying can be done from a remote terminal or computer across an internet or intranet.

EXAMPLES

[0166] The following examples are intended to illustrate but not limit the present invention.

Example I Full Length Gene Identification and Cloning

[0167] Putative transcription factor sequences (genomic or ESTs) related to known transcription factors were identified in the Arabidopsis thaliana GenBank database using the tblastn sequence analysis program using default parameters and a P-value cutoff threshold of −4 or −5 or lower, depending on the length of the query sequence. Putative transcription factor sequence hits were then screened to identify those containing particular sequence strings. If the sequence hits contained such sequence strings, the sequences were confirmed as transcription factors.

[0168] Alternatively, Arabidopsis thaliana cDNA libraries derived from different tissues or treatments, or genomic libraries were screened to identify novel members of a transcription family using a low stringency hybridization approach. Probes were synthesized using gene specific primers in a standard PCR reaction (annealing temperature 60° C.) and labeled with ³²P dCTP using the High Prime DNA Labeling Kit (Boehringer Mannheim). Purified radiolabelled probes were added to filters immersed in Church hybridization medium (0.5 M NaPO₄ pH 7.0, 7% SDS, 1% w/v bovine serum albumin) and hybridized overnight at 60° C. with shaking. Filters were washed two times for 45 to 60 minutes with 1×SCC, 1% SDS at 60° C.

[0169] To identify additional sequence 5′ or 3′ of a partial cDNA sequence in a cDNA library, 5′ and 3′ rapid amplification of cDNA ends (RACE) was performed using the Marathon™ cDNA amplification kit (Clontech, Palo Alto, Calif.). Generally, the method entailed first isolating poly(A) mRNA, performing first and second strand cDNA synthesis to generate double stranded cDNA, blunting cDNA ends, followed by ligation of the Marathon™ Adaptor to the cDNA to form a library of adaptor-ligated ds cDNA.

[0170] Gene-specific primers were designed to be used along with adaptor specific primers for both 5′ and 3′ RACE reactions. Nested primers, rather than single primers, were used to increase PCR specificity. Using 5′ and 3′ RACE reactions, 5′ and 3′ RACE fragments were obtained, sequenced and cloned. The process can be repeated until 5′ and 3′ ends of the full-length gene were identified. Then the full-length cDNA was generated by PCR using primers specific to 5′ and 3′ ends of the gene by end-to-end PCR.

Example II Construction of Expression Vectors

[0171] The sequence was amplified from a genomic or cDNA library using primers specific to sequences upstream and downstream of the coding region. The expression vector was pMEN20 or pMEN65, which are both derived from pMON316 (Sanders et al, (1987) Nucleic Acids Research 15:1543-58) and contain the CaMV 35S promoter to express transgenes. To clone the sequence into the vector, both pMEN20 and the amplified DNA fragment were digested separately with SalI and NotI restriction enzymes at 37° C. for 2 hours. The digestion products were subject to electrophoresis in a 0.8% agarose gel and visualized by ethidium bromide staining. The DNA fragments containing the sequence and the linearized plasmid were excised and purified by using a Qiaquick gel extraction kit (Qiagen, Calif.). The fragments of interest were ligated at a ratio of 3:1 (vector to insert). Ligation reactions using T4 DNA ligase (New England Biolabs, MA) were carried out at 16° C. for 16 hours. The ligated DNAs were transformed into competent cells of the E. coli strain DH5alpha by using the heat shock method. The transformations were plated on LB plates containing 50 mg/l kanamycin (Sigma, Mo.).

[0172] Individual colonies were grown overnight in five milliliters of LB broth containing 50 mg/l kanamycin at 37° C. Plasmid DNA was purified by using Qiaquick Mini Prep kits (Qiagen, Calif.).

Example III Transformation of Agrobacterium with the Expression Vector

[0173] After the plasmid vector containing the gene was constructed, the vector was used to transform Agrobacterium tumefaciens cells expressing the gene products. The stock of Agrobacterium tumefaciens cells for transformation were made as described by Nagel et al. (1990) FEMS Microbiol Letts. 67: 325-328. Agrobacterium strain ABI was grown in 250 ml LB medium (Sigma) overnight at 28° C. with shaking until an absorbance (A₆₀₀) of 0.5-1.0 was reached. Cells were harvested by centrifugation at 4,000×g for 15 min at 4° C. Cells were then resuspended in 250 μl chilled buffer (1 mM HEPES, pH adjusted to 7.0 with KOH). Cells were centrifuged again as described above and resuspended in 125 μl chilled buffer. Cells were then centrifuged and resuspended two more times in the same HEPES buffer as described above at a volume of 100 μl and 750 μl, respectively. Resuspended cells were then distributed into 40 μl aliquots, quickly frozen in liquid nitrogen, and stored at −80° C.

[0174] Agrobacterium cells were transformed with plasmids prepared as described above following the protocol described by Nagel et al. For each DNA construct to be transformed, 50-100 ng DNA (generally resuspended in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0) was mixed with 40 μl of Agrobacterium cells. The DNA/cell mixture was then transferred to a chilled cuvette with a 2 mm electrode gap and subject to a 2.5 kV charge dissipated at 25 μF and 200 μF using a Gene Pulser II apparatus (Bio-Rad). After electroporation, cells were immediately resuspended in 1.0 ml LB and allowed to recover without antibiotic selection for 2-4 hours at 28° C. in a shaking incubator. After recovery, cells were plated onto selective medium of LB broth containing 100 μg/ml spectinomycin (Sigma) and incubated for 24-48 hours at 28° C. Single colonies were then picked and inoculated in fresh medium. The presence of the plasmid construct was verified by PCR amplification and sequence analysis.

Example IV Transformation of Arabidopsis Plants With Agrobacterium tumefaciens With Expression Vector

[0175] After transformation of Agrobacterium tumefaciens with plasmid vectors containing the gene, single Agrobacterium colonies were identified, propagated, and used to transform Arabidopsis plants. Briefly, 500 ml cultures of LB medium containing 50 mg/l kanamycin were inoculated with the colonies and grown at 28° C. with shaking for 2 days until an absorbance (A₆₀₀) of>2.0 is reached. Cells were then harvested by centrifugation at 4,000×g for 10 min, and resuspended in infiltration medium (½×Murashige and Skoog salts (Sigma), 1×Gamborg's B-5 vitamins (Sigma), 5.0% (w/v) sucrose (Sigma), 0.044 μM benzylamino purine (Sigma), 200 μl/1 Silwet L-77 (Lehle Seeds) until an absorbance (A₆₀₀) of 0.8 was reached.

[0176] Prior to transformation, Arabidopsis thaliana seeds (ecotype Columbia) were sown at a density of ˜10 plants per 4″ pot onto Pro-Mix BX potting medium (Hummert International) covered with fiberglass mesh (18 mm×16 mm). Plants were grown under continuous illumination (50-75 μE/m²/sec) at 22-23° C. with 65-70% relative humidity. After about 4 weeks, primary inflorescence stems (bolts) are cut off to encourage growth of multiple secondary bolts. After flowering of the mature secondary bolts, plants were prepared for transformation by removal of all siliques and opened flowers.

[0177] The pots were then immersed upside down in the mixture of Agrobacterium infiltration medium as described above for 30 sec, and placed on their sides to allow draining into a 1′×2′ flat surface covered with plastic wrap. After 24 h, the plastic wrap was removed and pots are turned upright. The immersion procedure was repeated one week later, for a total of two immersions per pot. Seeds were then collected from each transformation pot and analyzed following the protocol described below.

Example V Identification of Arabidopsis Primary Transformants

[0178] Seeds collected from the transformation pots were sterilized essentially as follows. Seeds were dispersed into in a solution containing 0.1% (v/v) Triton X-100 (Sigma) and sterile H₂O and washed by shaking the suspension for 20 min. The wash solution was then drained and replaced with fresh wash solution to wash the seeds for 20 min with shaking. After removal of the second wash solution, a solution containing 0.1% (v/v) Triton X-100 and 70% ethanol (Equistar) was added to the seeds and the suspension was shaken for 5 min. After removal of the ethanol/detergent solution, a solution containing 0.1% (v/v) Triton X-100 and 30% (v/v) bleach (Clorox) was added to the seeds, and the suspension was shaken for 10 min. After removal of the bleach/detergent solution, seeds were then washed five times in sterile distilled H₂O. The seeds were stored in the last wash water at 4° C. for 2 days in the dark before being plated onto antibiotic selection medium (1×Murashige and Skoog salts (pH adjusted to 5.7 with 1M KOH), 1×Gamborg's B-5 vitamins, 0.9% phytagar (Life Technologies), and 50 mg/l kanamycin). Seeds were germinated under continuous illumination (50-75 μE/m²/sec) at 22-23° C. After 7-10 days of growth under these conditions, kanamycin resistant primary transformants (T₁ generation) were visible and obtained. These seedlings were transferred first to fresh selection plates where the seedlings continued to grow for 3-5 more days, and then to soil (Pro-Mix BX potting medium).

[0179] Primary transformants were crossed and progeny seeds (T₂) collected; kanamycin resistant seedlings were selected and analyzed. The expression levels of the recombinant polynucleotides in the transformants varies from about a 5% expression level increase to a least a 100% expression level increase. Similar observations are made with respect to polypeptide level expression.

Example VI Identification of Arabidopsis Plants with Transcription Factor Gene Knockouts

[0180] The screening of insertion mutagenized Arabidopsis collections for null mutants in a known target gene was essentially as described in Krysan et al (1999) Plant Cell 11:2283-2290. Briefly, gene-specific primers, nested by 5-250 base pairs to each other, were designed from the 5′ and 3′ regions of a known target gene. Similarly, nested sets of primers were also created specific to each of the T-DNA or transposon ends (the “right” and “left” borders). All possible combinations of gene specific and T-DNA/transposon primers were used to detect by PCR an insertion event within or close to the target gene. The amplified DNA fragments were then sequenced which allows the precise determination of the T-DNA/transposon insertion point relative to the target gene. Insertion events within the coding or intervening sequence of the genes were deconvoluted from a pool comprising a plurality of insertion events to a single unique mutant plant for functional characterization. The method is described in more detail in Yu and Adam, U.S. application Ser. No. 09/177,733 filed Oct. 23, 1998.

Example VII Identification of Modified Phenotypes in Overexpression or Gene Knockout Plants

[0181] Experiments were performed to identify those transformants or knockouts that exhibited modified biochemical characteristics. Among the biochemicals that were assayed were insoluble sugars, such as arabinose, fucose, galactose, mannose, rhamnose or xylose or the like; prenyl lipids, such as lutein, beta-carotene, xanthophyll-1, xanthophyll-2, chlorophylls A or B, or alpha-, delta- or gamma-tocopherol or the like; fatty acids, such as 16:0 (palmitic acid), 16:1 (palmitoleic acid), 18:0 (stearic acid), 18:1 (oleic acid), 18:2 (linoleic acid), 20:0, 18:3 (linolenic acid), 20:1 (eicosenoic acid), 20:2, 22: 1 (erucic acid) or the like; waxes, such as by altering the levels of C29, C31, or C33 alkanes; sterols, such as brassicasterol, campesterol, stigmasterol, sitosterol or stigmastanol or the like, glucosinolates, protein or oil levels.

[0182] Fatty acids were measured using two methods depending on whether the tissue was from leaves or seeds. For leaves, lipids were extracted and esterified with hot methanolic H2SO4 and partitioned into hexane from methanolic brine. For seed fatty acids, seeds were pulverized and extracted in methanol:heptane:toluene:2,2-dimethoxypropane:H2SO4 (39:34:20:5:2) for 90 minutes at 80° C. After cooling to room temperature the upper phase, containing the seed fatty acid esters, was subjected to GC analysis. Fatty acid esters from both seed and leaf tissues were analyzed with a Supelco SP-2330 column.

[0183] Glucosinolates were purified from seeds or leaves by first heating the tissue at 95° C. for 10 minutes. Preheated ethanol:water (50:50) is and after heating at 95° C. for a further 10 minutes, the extraction solvent is applied to a DEAE Sephadex column which had been previously equilibrated with 0.5 M pyridine acetate. Desulfoglucosinolates were eluted with 300 ul water and analyzed by reverse phase HPLC monitoring at 226 nm.

[0184] For wax alkanes, samples were extracted using an identical method as fatty acids and extracts were analyzed on a HP 5890 GC coupled with a 5973 MSD. Samples were chromatographed on a J&W DB35 mass spectrometer (J&W Scientific).

[0185] To measure prenyl lipids levels, seeds or leaves were pulverized with 1 to 2% pyrogallol as an antioxidant. For seeds, extracted samples were filtered and a portion removed for tocopherol and carotenoid/chlorophyll analysis by HPLC. The remaining material was saponified for sterol determination. For leaves, an aliquot was removed and diluted with methanol and chlorophyll A, chlorophyll B, and total carotenoids measured by spectrophotometry by determining absorbance at 665.2 nm, 652.5 nm, and 470 nm. An aliquot was removed for tocopherol and carotenoid/chlorophyll composition by HPLC using a Waters uBondapak C18 column (4.6 mm×150 mm). The remaining methanolic solution was saponified with 10% KOH at 80° C. for one hour. The samples were cooled and diluted with a mixture of methanol and water. A solution of 2% methylene chloride in hexane was mixed in and the samples were centrifuged. The aqueous methanol phase was again re-extracted 2% methylene chloride in hexane and, after centrifugation, the two upper phases were combined and evaporated. 2% methylene chloride in hexane was added to the tubes and the samples were then extracted with one ml of water. The upper phase was removed, dried, and resuspended in 400 ul of 2% methylene chloride in hexane and analyzed by gas chromatography using a 50 m DB-5 ms (0.25 mm ID, 0.25 um phase, J&W Scientific).

[0186] Insoluble sugar levels were measured by the method essentially described by Reiter et al., Plant Journal 12:335-345. This method analyzes the neutral sugar composition of cell wall polymers found in Arabidopsis leaves. Soluble sugars were separated from sugar polymers by extracting leaves with hot 70% ethanol. The remaining residue containing the insoluble polysaccharides was then acid hydrolyzed with allose added as an internal standard. Sugar monomers generated by the hydrolysis were then reduced to the corresponding alditols by treatment with NaBH4, then were acetylated to generate the volatile alditol acetates which were then analyzed by GC-FID. Identity of the peaks was determined by comparing the retention times of known sugars converted to the corresponding alditol acetates with the retention times of peaks from wild-type plant extracts. Alditol acetates were analyzed on a Supelco SP-2330 capillary column (30 m×250 um×0.2 um) using a temperature program beginning at 180° C. for 2 minutes followed by an increase to 220° C. in 4 minutes. After holding at 220° C. for 10 minutes, the oven temperature is increased to 240° C. in 2 minutes and held at this temperature for 10 minutes and brought back to room temperature.

[0187] To identify plants with alterations in total seed oil or protein content, 150 mg of seeds from T2 progeny plants were subjected to analysis by Near Infrared Reflectance (NIR) using a Foss NirSystems Model 6500 with a spinning cup transport system.

[0188] Experiments were performed to identify those transformants or knockouts that exhibited an improved pathogen tolerance. For such studies, the transformants were exposed to biotropic fungal pathogens, such as Erisyphe orontii, and necrotropic flimgal pathogens, such as Fusarium oxysporum. Fusarium oxysporum isolates cause vascular wilts and damping off of various annual vegetables, perennials and weeds (Mauch-Mani and Slusarenko (1994) Molecular Plant-Microbe Interactions 7: 378-383). For Fusarium oxysporum experiments, plants grown on petri dishes were sprayed with a fresh spore suspension of F. oxysporum. The spore suspension was prepared as follows: A plug of fungal hyphae from a plate culture was placed on a fresh potato dextrose agar plate and allowed to spread for one week. 5 ml sterile water was then added to the plate, swirled, and pipetted into 50 ml Armstrong Fusarium medium. Spores were grown overnight in Fusarium medium and then sprayed onto plants using a Preval paint sprayer. Plant tissue was harvested and frozen in liquid nitrogen 48 hours post infection.

[0189]Erysiphe orontii is a causal agent of powdery mildew. For Erysiphe orontii experiments, plants were grown approximately 4 weeks in a greenhouse under 12 hour light (20° C.,˜30% relative humidity (rh)). Individual leaves were infected with E. orontii spores from infected plants using a camel's hair brush, and the plants were transferred to a Percival growth chamber (20° C., 80% rh.). Plant tissue was harvested and frozen in liquid nitrogen 7 days post infection.

[0190]Botrytis cinerea is a necrotrophic pathogen. Botrytis cinerea was grown on potato dextrose agar in the light. A spore culture was made by spreading 10 ml of sterile water on the ftingus plate, swirling and transferring spores to 10 ml of sterile water. The spore inoculum (approx. 105 spores/ml) was used to spray 10 day-old seedlings grown under sterile conditions on MS (minus sucrose) media. Symptoms were evaluated every day up to approximately 1 week.

[0191] Infection with bacterial pathogens Pseudomonas syringae pv maculicola strain 4326 and pv maculicola strain 4326 was performed by hand inoculation at two doses. Two inoculation doses allows the differentiation between plants with enhanced susceptibility and plants with enhanced resistance to the pathogen. Plants were grown for 3 weeks in the greenhouse, then transferred to the growth chamber for the remainder of their growth. Psm ES4326 was hand inoculated with 1 ml syringe on 3 fully-expanded leaves per plant (4½ wk old), using at least 9 plants per overexpressing line at two inoculation doses, OD=0.005 and OD=0.0005. Disease scoring occured at day 3 post-inoculation with pictures of the plants and leaves taken in parallel.

[0192] In some instances, expression patterns of the pathogen-induced genes (such as defense genes) was monitored by microarray experiments. cDNAs were generated by PCR and resuspended at a final concentration of˜100 ng/ul in 3×SSC or 150 mM Na-phosphate (Eisen and Brown (1999) Meth. in Enzymol. 303:179-205). The cDNAs were spotted on microscope glass slides coated with polylysine. The prepared cDNAs were aliquoted into 384 well plates and spotted on the slides using an x-y-z gantry (OnmiGrid) purchased from GeneMachines (Menlo Park, Calif.) outfitted with quill type pins purchased from Telechem International (Sunnyvale, Calif.). After spotting, the arrays were cured for a minimum of one week at room temperature, rehydrated and blocked following the protocol recommended by Eisen and Brown (1999). ]Sample total RNA (10 ug) samples were labeled using fluorescent Cy3 and Cy5 dyes. Labeled samples were resuspended in 4×SSC/0.03% SDS/4 ug salmon sperm DNA/2 ug tRNA/50 mM Na-pyrophosphate, heated for 95° C. for 2.5 minutes, spun down and placed on the array. The array was then covered with a glass coverslip and placed in a sealed chamber. The chamber was then kept in a water bath at 62° C. overnight. The arrays were washed as described in Eisen and Brown (1999) and scanned on a General Scanning 3000 laser scanner. The resulting files are subsequently quantified using Imagene a software purchased from BioDiscovery (Los Angeles, Calif.).

[0193] Experiments were performed to identify those transformants or knockouts that exhibited an improved environmental stress tolerance. For such studies, the transformants were exposed to a variety of environmental stresses. Plants were exposed to chilling stress (6 hour exposure to 4-8° C.), heat stress (6 hour exposure to 32-37° C.), high salt stress (6 hour exposure to 200 mM NaCl), drought stress (168 hours after removing water from trays), osmotic stress (6 hour exposure to 3 M mannitol), or nutrient limitation (nitrogen, phosphate, and potassium) (Nitrogen: all components of MS medium remained constant except N was reduced to 20 mg/l of NH 4 NO3, or Phosphate: All components of MS medium except KH 2 PO 4, which was replaced by K2SO4, Potassium: All components of MS medium except removal of KNO3 and KH2PO4, which were replaced by NaH4PO4).

[0194] Experiments were performed to identify those transformants or knockouts that exhibited a modified structure and development characteristics. For such studies, the transformants were observed by eye to identify novel structural or developmental characteristics associated with the ectopic expression of the polynucleotides or polypeptides of the invention.

[0195] Experiments were performed to identify those transformants or knockouts that exhibited modified sugar-sensing. For such studies, seeds from transformants were germinated on media containing 5% glucose or 9.4% sucrose which normally partially restrict hypocotyl elongation. Plants with altered sugar sensing may have either longer or shorter hypocotyls than normal plants when grown on this media. Additionally, other plant traits may be varied such as root mass.

[0196] Flowering time was measured by the number of rosette leaves present when a visible inflorescence of approximately 3 cm is apparent Rosette and total leaf number on the progeny stem are tightly correlated with the timing of flowering (Koomneef et al (1991) Mol. Gen. Genet 229:57-66. The vernalization response was measured. For vernalization treatments, seeds were sown to MS agar plates, sealed with micropore tape, and placed in a 4° C. cold room with low light levels for 6-8 weeks. The plates were then transferred to the growth rooms alongside plates containing freshly sown non-vernalized controls. Rosette leaves were counted when a visible inflorescence of approximately 3 cm was apparent.

[0197] Modified phenotypes observed for particular overexpressor or knockout plants are provided in Table 4 and Table 5. For a particular overexpressor that shows a less beneficial characteristic, it may be more useful to select a plant with a decreased expression of the particular transcription factor. For a particular knockout that shows a less beneficial characteristic, it may be more useful to select a plant with an increased expression of the particular transcription factor.

[0198] The sequences of the Sequence Listing or those discloses here can be used to prepare transgenic plants and plants with altered traits. The specific transgenic plants listed below are produced from the sequences of the Sequence Listing, as noted. Table 4 and Table 5 provide exemplary polynucleotide and polypeptide sequences of the invention. Table 4 includes, from left to right for each sequence: the first column shows the polynucleotide SEQ ID NO; the second column shows the polypeptide SEQ ID NO encoded by the polynucleotide; the third column shows the Mendel Gene ID No., GID; the fourth column, CDS, shows the start and stop nucleotide positions of the encoded polypeptide, respectively, with respect to the polynucleotide co-ordinates; the fifth column shows the amino acid residue positions of the conserved domain in amino acid (AA) co-ordinates; and the sixth column shows if the polynucleotide was knocked out (KO) or overexpressed (OE) in a transgenic plant. Table 5 includes, from left to right for each sequence: the first column shows the nucleotide SEQ ID NO.; the second column shows the polypeptide SEQ ID NO encoded by the polynucleotide; the third column shows the Mendel Gene ID No., GID; the fourth column shows if the polynucleotide was knocked out (KO) or overexpressed (OE) in a transgenic plant; and the fifth column shows the trait resulting from the knock out or overexpression of the polynucleotide in the transgenic plant. TABLE 4 SEQ ID NO SEQ ID NO Conserved domain in AA Knockout or (polynucleotide) (polypeptide) GID CDS coordinates overexpressor 1 2 G481 103 . . . 528  20-109 OE 3 4 G1466  16 . . . 1278 154-420 OE

[0199] TABLE 5 SEQ ID SEQ ID NO (poly- NO nucle- (poly- Observed phenotype Overexpressor otide) peptide) GID or trait or knockout 1 2 G481 Germination assay: OE High sucrose, osmotic stress 3 4 G1466 Seed composition assay: OE High seed oil and protein content

[0200] G481: Better Germination on High Sucrose

[0201] Seed of plants overexpressing sequence G481 (SEQ ID NOs: 1 and 2) showed slightly better germination when grown on high sucrose medium (5% glucose or 9.4% sucrose). The plants showed longer radicle and more cotyledon expansion. In one line (line 8) analysis of leaf insoluble sugars showed a slight increase in decrease in Rhamnose levels (16.9% vs. approximately 11.4% in wild-type plants) and a decrease in Arabinose and Xylose levels (15.3% and 12.8% vs. approximately 19.0% and 21% in wild-type plants, respectively).

[0202] In wild-type plants, G481 was predominantly expressed in flower and silique, and to a lesser extent, in rosette, embryo, and germinating seed.

[0203] The potential utility of G481 includes a possible role in sugar sensing, a plant mechanism that has been shown to be involved in the following: 1) altering storage compound accumulation (oil and/or protein) in seeds which could impact yield and seed quality, and 2) altering photosynthetic rate which could also impact yield in vegetative tissues as well as seed. Sugars are key regulatory molecules that affect diverse processes in higher plants including germination, growth, flowering, senescence, sugar metabolism and photosynthesis. Sucrose is the major transport form of photosynthate and its flux through cells has been shown to affect gene expression and alter storage compound accumulation in seeds (source-sink relationships).

[0204] The enhanced germination phenotype of transgenic plants overexpressing G481 under a condition of osmotic stress (such as high concentrations of sucrose) suggests the gene could also be used to improve plant tolerance to water deficit related conditions such as drought stress, salt stress, and freezing stress. Thus G481 could be used to engineer plants with enhanced stress tolerance that could ultimately impact survivability and yield.

[0205] G1466: Increased Seed Oil; Decreased Protein Content

[0206] Seed of plants overexpressing sequences G1466 (SEQ ID NOs:3 and 4) was subjected to NIR analysis and an increase in seed oil content compared with seed from wild-type plants was identified (39% vs. approximately 35% in wild-type plants). In addition, a slight decrease in seed protein content compared with seed from wild-type plants was identified (20.8% vs. approximately 23% in wild-type plants).

[0207] In wild-type plants, G1466 was expressed in all tissues examined.

[0208] Therefore, G1466 could be used to modify high value seed quality traits such protein, oil and carbohydrates content and composition in any plant in which the expression of this gene is altered. Altering the amount of seed oil, protein or carbohydrate could effectively increase the yield and quality. Altering the composition of seeds would improve feed quality by altering availability of energy and phosphorus, and to improve the amino acid balance of grain meal or to improve oil quality for human food and industrial uses. Altering seed composition with G1466 could also improved grain quality for the wet milling industry as well as provide a means for the production of novel polymers and chemicals.

Example VIII Identification of Homologous Sequences

[0209] Homologous sequences from Arabidopsis and plant species other than Arabidopsis were identified using database sequence search tools, such as the Basic Local Alignment Search Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucl. Acid Res. 25: 3389-3402). The tblastx sequence analysis programs were employed using the BLOSUM-62 scoring matrix (Henikoff, S. and Henikoff, J. G. (1992) Proc. Natl. Acad. Sci. 89: 10915-10919).

[0210] Identified orthologs and homologs of Arabidopsis sequences are provided in Tables 6 and 7. The percent sequence identity among these sequences can be as low as 47%, or even lower sequence identity. Additionally, the entire NCBI GenBank database was filtered for sequences from all plants except Arabidopsis thaliana by selecting all entries in the NCBI GenBank database associated with NCBI taxonomic ID 33090 (Viridiplantae; all plants) and excluding entries associated with taxonomic ID 3701 (Arabidopsis thaliana). These sequences are compared to sequences representing genes of SEQ IDs NOs:2 and 4 using the Washington University TBLASTX algorithm (version 2.0a19MP) at the default settings using gapped alignments with the filter “off”. For each gene of SEQ IDs NOs:2 and 4 individual comparisons were ordered by probability score (P-value), where the score reflects the probability that a particular alignment occurred by chance. For example, a score of 3.6e-40 is 3.6×10 ⁻⁴⁰. In addition to P-values, comparisons were also scored by percentage identity. Percentage identity reflects the degree to which two segments of DNA or protein are identical over a particular length. The identified homologous polynucleotide and polypeptide sequences and homologues of the Arabidopsis polynucleotides and polypeptides may be orthologs of the Arabidopsis polynucleotides and polypeptides.

[0211] As shown in Table 6, polynucleotide and polypeptide sequences which were identified as orthologous and homologous of SEQ ID NOs: 1 and 2 were found in Gossypium arboreum, Glycine max, Zea mays, Gossypium hirsutum, Medicago truncatula, Lycopersicon esculentum, Solanum tuberosum, Triticum aestivum, Hordeum vulgare, Triticum monococcum, Oryza sativa, Vemonia galamensis, Argemone mexicana, and Triticum aestivum.

[0212] As shown in Table 6, polynucleotide and polypeptide sequences which were identified as orthologous and homologous of SEQ ID NOs:3 and 4 were found in Brassica oleracea, Lycopersicon esculentum, Lycopersicon pennellii, Lotus japonicus, Oryza sativa, Solanum tuberosum, Medicago truncatula, Glycine max, Euphorbia esula, Gossypium arboreum, Antirrhinum hispanicum, Oryza sativa (japonica cultivar-group), and Triticum aestivum. Additional orthologous and homologous polynucleotides and polypeptide sequences from other plant species are shown in Table 7.

[0213] All references, publications, patent documents, web pages, and other documents cited or mentioned herein are hereby incorporated by reference in their entirety for all purposes. Although the invention has been described with reference to specific embodiments and examples, it should be understood that one of ordinary skill can make various modifications without departing from the spirit of the invention. The scope of the invention is not limited to the specific embodiments and examples provided. TABLE 6 Smallest Test Sum SEQ ID NO Gene ID Sequence ID Probability Test Sequence Species Test Sequence GenBank Annotation 1 G481 BG440251 9.00E−42 [Gossypium arboreum] GA_Ea0006K20f Gossypium arboreum 7-10 d 1 G481 BM887558 3.90E−41 [Glycine max] sam40c09.y1 Gm-c1068 Glycine max cDNA clone SOY 1 G481 ZMNFYB 1.70E−40 [Zea mays] Z. mays mRNA for CAAT-box DNA binding protein subun 1 G481 AI728916 2.40E−40 [Gossypium hirsutum] BNLGHi12022 Six-day Cotton fiber Gossypi 1 G481 AW775623 3.80E−40 [Medicago truncatula] EST334688 DSIL Medicago truncatula cDNA 1 G481 AW738727 9.80E−40 [Lycopersicon esculentum] EST340154 tomato flower buds, anthe 1 G481 BG599785 1.70E−38 [Solanum tuberosum] EST504680 cSTS Solanum tuberosum cDNA clo 1 G481 BE413647 2.50E−38 [Triticum aestivum] SCU001.E10.R990714 ITEC SCU Wheat Endospe 1 G481 BF065056 5.80E−38 [Hordeum vulgare] HV_CEb0022M01f Hordeum vulgare seedling gre 1 G481 BG314203 1.00E−37 [Triticum monococcum] WHE2460_E10_I20ZS Triticum monococcum i 1 G481 gi22380 1.10E−45 [Zea mays] CAAT-box DNA binding protein subunit B (NF-YB). 1 G481 gi15408794 2.60E−30 [Oryza sativa] putative CCAAT-binding transcription factor 1 G481 gi16902054 1.00E−28 [Vernonia galamensis] CCAAT-box binding factor HAP3 B domai 1 G481 gi16902050 2.70E−28 [Glycine max] CCAAT-box binding factor HAP3 B domain. 1 G481 gi16902056 4.30E−28 [Argemone mexicana] CCAAT-box binding factor HAP3 B domain. 1 G481 gi16902058 1.50E−23 [Triticum aestivum] CCAAT-box binding factor HAP3 B domain. 3 G1466 BH596941 1.40E−65 [Brassica oleracea] BOHFG41TR BOHF Brassica oleracea genomic 3 G1466 BE462774 0.00014 [Lycopersicon esculentum] EST325108 tomato flower buds 0-3 mm 3 G1466 AW399721 0.00049 [Lycopersicon pennellii] EST310221 L. pennellii trichome, Cor 3 G1466 AV413010 0.00054 [Lotus japonicus] AV413010 Lotus japonicus young plants (two- 3 G1466 OSJN00182 0.0029 [Oryza sativa] chromosome 4 clone OSJNBa0086O06, *** SEQUENC 3 G1466 BG599234 0.0047 [Solanum tuberosum] EST504134 cSTS Solanum tuberosum cDNA clo 3 G1466 BG580068 0.0095 [Medicago truncatula] EST481790 GVN Medicago truncatula cDNA 3 G1466 BI316339 0.026 [Glycine max] saf02a08.y1 Gm-c1065 Glycine max cDNA clone GEN 3 G1466 BG409415 0.026 [Euphorbia esula] 00787 leafy spurge Lambda HybriZAP 2.1 two- 3 G1466 BF278686 0.11 [Gossypium arboreum] GA_Eb0035E21f Gossypium arboreum 7-10 d 3 G1466 gi8096405 2.30E−12 [Oryza sativa] Similar to Arabidopsis thaliana chromosome 1 3 G1466 gi13161526 3.40E−08 [Antirrhinum hispanicum] S locus F-box (SLF)-S2 protein. 3 G1466 gi18844804 0.083 [Oryza sativa (japonica cultivar-group)] contains ESTs D151 3 G1466 gi9858770 0.83 [Lycopersicon esculentum] BAC19.2. 3 G1466 gi6505722 1 [Triticum aestivum] ribosomal RNA apurinic site specificly

[0214] TABLE 7 SEQ ID Test Reading High Smallest Sum NO Gene ID Sequence ID Test Sequence GenBank Annotation Frame Score Probability N 1 G481 BG440251 BG440251 GA_Ea0006K20f Gossypium arboreum 7 . . . 3 263 9.00E−42 2 1 G481 BM887558 BM887558 sam40c09.y1 Gm-c1068 Glycine max cD . . . 3 268 3.90E−41 2 1 G481 BG362898 BG362898 sac13e07.y1 Gm-c1040 Glycine max cD . . . 3 263 4.90E−41 2 1 G481 AW395227 AW395227 sh45e04.y1 Gm-c1017 Glycine max cDN . . . 1 264 9.10E−41 2 1 G481 BM525962 BM525962 sak74b11.y1 Gm-c1036 Glycine max cD . . . 3 264 9.20E−41 2 1 G481 BI972318 BI972318 sag90a01.y1 Gm-c1084 Glycine max cD . . . 3 264 9.70E−41 2 1 G481 BG363233 BG363233 sac11h11.y1 Gm-c1040 Glycine max cD . . . 3 264 9.90E−41 2 1 G481 BE021941 BE021941 sm64d05.y1 Gm-c1028 Glycine max cDN . . . 1 264 1.00E−40 2 1 G481 BI316766 BI316766 saf73a12.y1 Gm-c1078 Glycine max cD . . . 3 264 1.10E−40 2 1 G481 BE803572 BE803572 sr60e11.y1 Gm-c1052 Glycine max cDN . . . 2 264 1.10E−40 2 1 G481 ZMNFYB X59714 Z. mays mRNA for CAAT-box DNA binding . . . 2 262 1.70E−40 2 1 G481 BF071234 BF071234 st06h05.y1 Gm-c1065 Glycine max cDN . . . 3 258 2.00E−40 2 1 G481 AI728916 AI728916 BNLGHi12022 Six-day Cotton fiber Go . . . 3 261 2.40E−40 2 1 G481 BF597252 BF597252 su96c06.y1 Gm-c1056 Glycine max cDN . . . 2 264 2.90E−40 2 1 G481 AW597630 AW597630 sj96g06.y1 Gm-c1023 Glycine max cDN . . . 2 259 3.40E−40 2 1 G481 AW775623 AW775623 EST334688 DSIL Medicago truncatula . . . 2 259 3.80E−40 2 1 G481 AW733618 AW733618 sk75h06.y1 Gm-c1016 Glycine max cDN . . . 3 257 6.00E−40 2 1 G481 AW738727 AW738727 EST340154 tomato flower buds, anthe . . . 1 249 9.80E−40 2 1 G481 BG642751 BG642751 EST510945 tomato shoot/meristem Lyc . . . 1 249 9.90E−40 2 1 G481 BE441135 BE441135 EST408405 tomato developing/immatur . . . 1 249 9.90E−40 2 1 G481 AW621652 AW621652 EST312450 tomato root during/after . . . 1 249 1.10E−39 2 1 G481 AI900024 AI900024 sb97g11.y1 Gm-c1012 Glycine max cDN . . . 1 264 3.20E−39 2 1 G481 BG445358 BG445358 GA_Ea0027N18f Gossypium arboreum 7 . . . 2 243 1.40E−38 2 1 G481 BG599785 BG599785 EST504680 cSTS Solanum tuberosum cD . . . 2 254 1.70E−38 2 1 G481 BG350430 BG350430 091D09 Mature tuber lambda ZAP Sola . . . 3 254 1.70E−38 2 1 G481 BE413647 BE413647 SCU001.E10.R990714 ITEC SCU Wheat E . . . 3 248 2.50E−38 2 1 G481 BE516510 BE516510 WHE611_D10_H19ZA Wheat ABA-treated . . . 2 248 3.00E−38 2 1 G481 BF065056 BF065056 HV_CEb0022M01f Hordeum vulgare seed . . . 3 247 5.80E−38 2 1 G481 BG314203 BG314203 WHE2460_E10_I20ZS Triticum monococc . . . 1 243 1.00E−37 2 1 G481 AI725612 AI725612 BNLGHi12445 Six-day Cotton fiber Go . . . 2 247 1.20E−37 2 1 G481 AL387357 AL387357 MtBC42A04F1 MtBC Medicago truncatul . . . 3 231 2.00E−37 2 1 G481 AW907348 AW907348 EST343471 potato stolon, Cornell Un . . . 2 246 2.40E−37 2 1 G481 BG274786 BG274786 WHE2234_C03_E06ZS Aegilops speltoid . . . 1 248 2.50E−37 2 1 G481 AW459387 AW459387 sh23f03.y1 Gm-c1016 Glycine max cDN . . . 2 233 3.40E−37 2 1 G481 BE804236 BE804236 sr77b04.y1 Gm-c1052 Glycine max cDN . . . 2 254 4.30E−37 2 1 G481 BE210041 BE210041 so38b01.y1 Gm-c1039 Glycine max cDN . . . 3 231 5.70E−37 2 1 G481 AW980494 AW980494 EST391647 GVN Medicago truncatula c . . . 1 229 6.30E−37 2 1 G481 BG263362 BG263362 WHE2341_B02_C03ZS Wheat pre-anthesi . . . 1 238 7.10E−37 2 1 G481 BH532457 BH532457 BOGLV08TR BOGL Brassica oleracea ge . . . 2 225 8.00E−37 2 1 G481 BG847452 BG847452 1024017D03.y1 C. reinhardtii CC-169 . . . 2 236 8.20E−37 2 1 G481 BG857007 BG857007 1024049D01.y1 C. reinhardtii CC-169 . . . 3 236 9.30E−37 2 1 G481 BG858372 BG858372 1024057C11.y1 C. reinhardtii CC-169 . . . 3 236 9.50E−37 2 1 G481 BG850689 BG850689 1024029A11.y2 C. reinhardtii CC-169 . . . 2 236 9.50E−37 2 1 G481 BI718232 BI718232 1031024F10.y1 C. reinhardtii CC-169 . . . 3 236 9.70E−37 2 1 G481 BI719728 BI719728 1031045D08.y1 C. reinhardtii CC-169 . . . 3 236 9.80E−37 2 1 G481 BI875221 BI875221 963122G10.y1 C. reinhardtii CC-1690 . . . 3 236 9.90E−37 2 1 G481 BE496857 BE496857 WHE0761_D09_H17ZS Wheat heat-stress . . . 1 238 1.00E−36 2 1 G481 BF651151 BF651151 NF101H10EC1F1090 Elicited cell cult . . . 3 227 1.10E−36 2 1 G481 BE441739 BE441739 925009A11.x1 C. reinhardtii CC-2290 . . . 2 236 1.30E−36 2 1 G481 BG846124 BG846124 1024012C11.y1 C. reinhardtii CC-169 . . . 1 234 1.50E−36 2 1 G481 AX288144 AX288144 Sequence 15 from Patent WO0177311. . . . 2 231 2.90E−36 2 1 G481 AW570530 AW570530 sj63c01.y1 Gm-c1033 Glycine max cDN . . . 2 263 2.90E−36 2 1 G481 AX180950 AX180950 Sequence 1 from Patent WO0145493. 8 . . . 2 231 3.30E−36 2 1 G481 BF585526 BF585526 FM1_23_E09.g1_A003 Floral-Induced M . . . 1 224 3.50E−36 2 1 G481 BI271802 BI271802 NF013D06FL1F1057 Developing flower . . . 1 226 5.40E−36 2 1 G481 BF270944 BF270944 GA_Eb0010B11f Gossypium arboreum 7 . . . 1 240 5.60E−36 2 1 G481 AI731275 AI731275 BNLGHi9078 Six-day Cotton fiber Gos . . . 2 221 1.30E−35 2 1 G481 BI967397 BI967397 GM830001B20E03 Gm-r1083 Glycine max . . . −3 226 1.40E−35 2 1 G481 BF585616 BF585616 FM1_23_E09.b1_A003 Floral-Induced M . . . 1 265 1.80E−35 2 1 G481 BF263449 BF263449 HV_CEa0006M10f Hordeum vulgare seed . . . 1 230 2.70E−35 2 1 G481 BF263455 BF263455 HV_CEa0006M16f Hordeum vulgare seed . . . 1 230 2.70E−35 2 1 G481 BF459554 BF459554 061A04 Mature tuber lambda ZAP Sola . . . 2 227 2.90E−35 2 1 G481 BF460267 BF460267 073E08 Mature tuber lambda ZAP Sola . . . 2 209 3.00E−35 3 1 G481 BG594268 BG594268 EST492946 cSTS Solanum tuberosum cD . . . 3 236 5.10E−35 2 1 G481 BI469382 BI469382 sai11b10.y1 Gm-c1053 Glycine max cD . . . 1 225 5.50E−35 2 1 G481 AI731250 AI731250 BNLGHi9010 Six-day Cotton fiber Gos . . . 3 236 6.40E−35 2 1 G481 BG850688 BG850688 1024029A11.y1 C. reinhardtii CC-169 . . . 2 236 7.50E−35 2 1 G481 AW132359 AW132359 se03b02.y1 Gm-c1013 Glycine max cDN . . . 1 264 8.10E−35 2 1 G481 BM269434 BM269434 MEST409-G11.univ ISUM5-RN Zea mays . . . −2 216 8.70E−35 2 1 G481 AW035570 AW035570 EST281308 tomato callus, TAMU Lycop . . . 3 249 9.30E−35 2 1 G481 BE418716 BE418716 SCL074.B01R990724 ITEC SCL Wheat Le . . . 1 227 1.20E−34 2 1 G481 AW648378 AW648378 EST326832 tomato germinating seedli . . . 1 223 1.20E−34 2 1 G481 AV424305 AV424305 AV424305 Lotus japonicus young plan . . . −3 219 1.50E−34 2 1 G481 BF715909 BF715909 saa11e08.y1 Gm-c1058 Glycine max cD . . . 3 222 2.20E−34 2 1 G481 BI423967 BI423967 sah64c11.y1 Gm-c1049 Glycine max cD . . . 1 215 2.30E−34 2 1 G481 BG890447 BG890447 EST516298 cSTD Solanum tuberosum cD . . . 2 220 3.00E−34 2 1 G481 AI495007 AI495007 sa89f03.y1 Gm-c1004 Glycine max cDN . . . 3 220 5.70E−34 2 1 G481 AW760103 AW760103 sl58b03.y1 Gm-c1027 Glycine max cDN . . . 3 225 7.40E−34 2 1 G481 BF517889 BF517889 NXSI_029_D01_F NXSI (Nsf Xylem Side . . . 3 222 1.70E−33 2 1 G481 BE060015 BE060015 sn39h06.y1 Gm-c1027 Glycine max cDN . . . 2 219 1.90E−33 2 1 G481 AW625817 AW625817 EST319724 tomato radicle, 5 d post- . . . 3 211 2.90E−33 2 1 G481 AW397727 AW397727 sg83f04.y1 Gm-c1026 Glycine max cDN . . . 3 210 3.10E−33 2 1 G481 BI207873 BI207873 EST525913 cTOS Lycopersicon esculen . . . 2 227 3.20E−33 2 1 G481 AV632945 AV632945 AV632945 Chlamydomonas reinhardtii . . . 3 236 3.40E−33 2 1 G481 AW931634 AW931634 EST357477 tomato fruit mature green . . . 1 223 4.90E−33 2 1 G481 BM888735 BM888735 952068E04.y1 952 —BMS tissue from . . . 2 214 5.10E−33 2 1 G481 AI486503 AI486503 EST244824 tomato ovary, TAMU Lycope . . . 3 223 5.40E−33 2 1 G481 BE641101 BE641101 Cri2_2_E11_SP6 Ceratopteris Spore L . . . 3 224 8.60E−33 2 1 G481 BI953657 BI953657 HVSMEm0013M03f Hordeum vulgare gree . . . 1 230 9.80E−33 2 1 G481 BM341536 BM341536 MEST336-C11.T3 ISUM5-RN Zea mays cD . . . −1 214 1.80E−32 2 1 G481 AX180957 AX180957 Sequence 8 from Patent WO0145493. 8 . . . 2 231 2.70E−32 2 1 G481 AW201996 AW201996 sf09g11.y1 Gm-c1027 Glycine max cDN . . . 1 207 2.90E−32 2 1 G481 BG135204 BG135204 EST468096 tomato crown gall Lycoper . . . 3 230 3.20E−32 2 1 G481 BI406257 BI406257 158C12 Mature tuber lambda ZAP Sola . . . 2 201 1.20E−31 2 1 G481 BM341107 BM341107 MEST330-D11.T3 ISUM5-RN Zea mays cD . . . −1 214 1.30E−31 2 1 G481 AI782351 AI782351 EST263230 tomato susceptible, Corne . . . 2 208 2.50E−31 2 1 G481 BM331836 BM331836 MEST171-B11.T3 ISUM5-RN Zea mays cD . . . −3 214 3.30E−31 2 1 G481 BM268414 BM268414 MEST395-C12.univ ISUM5-RN Zea mays . . . −2 214 3.40E−31 2 1 G481 BM337630 BM337630 MEST215-B12.T3 ISUM5-RN Zea mays cD . . . −2 214 3.40E−31 2 1 G481 BM349646 BM349646 MEST253-D11.T3 ISUM5-RN Zea mays cD . . . −2 214 3.40E−31 2 1 G481 BE356560 BE356560 DG1_126_D05.b1_A002 Dark Grown 1 (D . . . 3 265 3.70E−31 2 1 G481 AV632044 AV632044 AV632044 Chlamydomonas reinhardtii . . . 2 236 4.50E−31 2 1 G481 BE054369 BE054369 GA_Ea0002A05f Gossypium arboreum 7 . . . 1 263 5.80E−31 2 1 G481 AC108500 AC108500 Oryza sativa chromosome 5 clone OJ1 . . . −3 230 6.20E−31 2 1 G481 BI129814 BI129814 G095P88Y Populus cambium cDNA libra . . . 1 266 6.90E−31 2 1 G481 BG318871 BG318871 NXPV_020_H08_F NXPV (Nsf Xylem Plan . . . 1 216 7.60E−31 2 1 G481 AV420653 AV420653 AV420653 Lotus japonicus young plan . . . 1 256 1.70E−30 2 1 G481 AW348165 AW348165 GM210001A21D7 Gm-r1021 Glycine max . . . −3 196 4.60E−30 2 1 G481 AI442376 AI442376 sa26b07.y1 Gm-c1004 Glycine max cDN . . . 2 197 5.10E−30 2 1 G481 AI442765 AI442765 sa26b07.x1 Gm-c1004 Glycine max cDN . . . −1 192 1.70E−29 2 1 G481 BE604847 BE604847 WHE1713-1716_D19_D19ZS Wheat heat s . . . 3 241 1.90E−29 2 1 G481 AW043377 AW043377 ST32F09 Pine TriplEx shoot tip libr . . . 1 233 3.90E−29 2 1 G481 AP003271 AP003271 Oryza sativa genomic DNA, chromosom . . . −2 240 7.60E−29 2 1 G481 BG832836 BG832836 NXPV_081_C10_F NXPV (Nsf Xylem Plan . . . 1 222 9.10E−29 2 1 G481 AP004366 AP004366 Oryza sativa chromosome 1 clone P04 . . . −3 240 9.30E−29 2 1 G481 BE603222 BE603222 HVSMEh0102J16f Hordeum vulgare 5-45 . . . 2 204 3.50E−28 2 1 G481 AW754604 AW754604 PC04B12 Pine TriplEx pollen cone li . . . 2 197 3.70E−28 2 1 G481 AW756413 AW756413 sl21a12.y1 Gm-c1036 Glycine max cDN . . . 1 201 4.00E−28 2 1 G481 AW432980 AW432980 si03a01.y1 Gm-c1029 Glycine max cDN . . . 3 201 4.40E−28 2 1 G481 BG551755 BG551755 sad42f11.y1 Gm-c1075 Glycine max cD . . . 3 201 4.80E−28 2 1 G481 BF595304 BF595304 su76f03.y1 Gm-c1055 Glycine max cDN . . . 2 201 5.10E−28 2 1 G481 BM308208 BM308208 sak43a12.y1 Gm-c1036 Glycine max cD . . . 2 200 5.20E−28 2 1 G481 AC104284 AC104284 Oryza sativa chromosome 5 clone OJ1 . . . −3 224 5.70E−28 2 1 G481 BM528842 BM528842 sak69b03.y1 Gm-c1036 Glycine max cD . . . 2 200 5.70E−28 2 1 G481 BI268123 BI268123 NF116D11IN1F1094 Insect herbivory M . . . 3 224 9.10E−28 2 1 G481 AW981720 AW981720 PC15H07 Pine TriplEx pollen cone li . . . 3 204 9.10E−28 2 1 G481 AA660543 AA660543 00429 MtRHE Medicago truncatula cDN . . . 3 187 1.30E−27 2 1 G481 BE726750 BE726750 894093C12.y3 C. reinhardtii CC-1690 . . . 2 236 1.90E−27 2 1 G481 BI309186 BI309186 EST530596 GPOD Medicago truncatula . . . 2 224 4.00E−27 2 1 G481 AW931376 AW931376 EST357219 tomato fruit mature green . . . 2 244 7.10E−27 2 1 G481 BF636140 BF636140 NF060H09DT1F1079 Drought Medicago t . . . 3 224 1.70E−26 2 1 G481 BG526135 BG526135 57-6 Stevia field grown leaf cDNA S . . . −1 228 2.50E−26 2 1 G481 BI311277 BI311277 EST5313027 GESD Medicago truncatula . . . 2 192 2.60E−26 2 1 G481 BI721770 BI721770 1031057H04.y1 C. reinhardtii CC-169 . . . 2 212 2.90E−26 2 1 G481 AW200790 AW200790 se93e11.y1 Gm-c1027 Glycine max cDN . . . 2 225 3.50E−26 2 1 G481 AY058919 AY058919 Vernonia galamensis CCAAT-box bindi . . . 1 187 3.80E−26 2 1 G481 BM109471 BM109471 EST557007 potato roots Solanum tube . . . 3 220 4.20E−26 2 1 G481 AY058917 AY058917 Glycine max clone se2.11d12 CCAAT-b . . . 1 188 1.00E−25 2 1 G481 AY058920 AY058920 Argemone mexicana CCAAT-box binding . . . 1 189 1.30E−25 2 1 G481 AU088581 AU088581 AU088581 Rice callus Oryza sativa c . . . 2 178 1.40E−25 2 1 G481 AW720671 AW720671 LjNEST6a3rc Lotus japonicus nodule . . . 2 192 2.10E−25 2 1 G481 BI419749 BI419749 LjNEST14e12r Lotus japonicus nodule . . . 1 192 2.10E−25 2 1 G481 AW719547 AW719547 LjNEST6a3r Lotus japonicus nodule I . . . 2 192 2.20E−25 2 1 G481 BM134935 BM134935 WHE0460_A02_A03ZS Wheat Fusarium gr . . . 2 211 2.60E−25 2 1 G481 AI965590 AI965590 sc74b05.y1 Gm-c1018 Glycine max cDN . . . 2 208 4.00E−25 2 1 G481 BI875522 BI875522 963125B06.y1 C. reinhardtii CC-1690 . . . 3 212 5.70E−25 2 1 G481 BI531782 BI531782 1024116E03.y1 C. reinhardtii CC-169 . . . 3 212 5.90E−25 2 1 G481 AW688588 AW688588 NF009C11ST1F1000 Developing stem Me . . . 2 218 8.00E−25 2 1 G481 BG368375 BG368375 HVSMEi0018C01f Hordeum vulgare 20 D . . . 1 214 8.20E−25 2 1 G481 BF270164 BF270164 GA_Eb0007A21f Gossypium arboreum 7 . . . 2 206 1.70E−24 2 1 G481 BH472297 BH472297 BOGJF90TF BOGJ Brassica oleracea ge . . . 1 187 1.70E−24 2 1 G481 AY058918 AY058918 Glycine max clone ses2w.pk0015.a4 C . . . 1 178 1.10E−23 2 1 G481 BF291752 BF291752 WHE2205_F04_K07ZS Aegilops speltoid . . . 3 205 1.10E−23 2 1 G481 BF169598 BF169598 NXCI_125_B04_F NXCI (Nsf Xylem Comp . . . 2 210 8.30E−23 2 1 G481 BH470962 BH470962 BOGNF35TF BOGN Brassica oleracea ge . . . 3 185 1.00E−22 2 1 G481 BI952722 BI952722 HVSMEm0007l19f Hordeum vulgare gree . . . 1 230 2.20E−22 2 1 G481 AL506199 AL506199 AL506199 Hordeum vulgare Barke deve . . . 1 179 2.30E−22 2 1 G481 BH659234 BH659234 BOMDK68TR BO_2_3_KB Brassica olerac . . . 3 179 4.00E−22 2 1 G481 BE802539 BE802539 sr32f02.y1 Gm-c1050 Glycine max cDN . . . 2 221 1.40E−21 2 1 G481 BE196056 BE196056 HVSMEh0091D23f Hordeum vulgare 5-45 . . . 3 211 1.60E−21 2 1 G481 AL509098 AL509098 AL509098 Hordeum vulgare Barke deve . . . 3 179 2.70E−21 2 1 G481 AP003266 AP003266 Oryza sativa genomic DNA, chromosom . . . −3 194 3.00E−21 2 1 G481 AF410176 AF410176 Zea mays leafy cotyledon1 (Lec1) mR . . . 3 179 3.30E−21 2 1 G481 AX365282 AX365282 Sequence 18 from Patent WO0206499. . . . 3 179 3.30E−21 2 1 G481 AY058921 AY058921 Triticum aestivum CCAAT-box binding . . . 1 175 5.70E−21 2 1 G481 BG662094 BG662094 Ljirnpest38-110-g8 Ljirnp Lambda Hy . . . 1 266 8.90E−20 1 1 G481 BH645253 BH645253 BOMFL56TR BO_2_3_KB Brassica olerac . . . 3 166 2.70E−19 2 1 G481 AP004179 AP004179 Oryza sativa chromosome 2 clone OJ1 . . . 3 180 4.60E−19 2 1 G481 BM500534 BM500534 PAC000000000627 Pioneer AF-1 array . . . 2 179 8.20E−19 2 1 G481 BH701005 BH701005 BOMMD16TR BO_2_3_KB Brassica olerac . . . 2 248 5.60E−18 1 1 G481 BH678940 BH678940 BOMIF09TF BO_2_3_KB Brassica olerac . . . −1 244 1.10E−17 1 1 G481 AP004791 AP004791 Oryza sativa (japonica cultivar-gro . . . −1 183 9.20E−17 2 1 G481 BE121888 BE121888 894015G05.y1 C. reinhardtii CC-1690 . . . 1 236 1.30E−16 1 1 G481 AX288136 AX288136 Sequence 7 from Patent WO0177311. 1 . . . 3 231 3.90E−16 1 1 G481 AV411210 AV411210 AV411210 Lotus japonicus young plan . . . 2 228 1.10E−15 1 1 G481 AV425835 AV425835 AV425835 Lotus japonicus young plan . . . 2 228 1.10E−15 1 1 G481 BI206716 BI206716 EST524756 cTOS Lycopersicon esculen . . . 3 227 1.10E−15 1 1 G481 BF645376 BF645376 NF040B05EC1F1044 Elicited cell cult . . . 2 224 1.90E−15 1 1 G481 BM347760 BM347760 MEST281-G09.T3 lSUM5-RN Zea mays cD . . . −3 219 6.10E−15 1 1 G481 AW648379 AW648379 EST326833 tomato germinating seedli . . . 1 218 1.40E−14 1 1 G481 BI176409 BI176409 EST521199 P. infestans-challenged l . . . 2 142 1.90E−14 2 1 G481 BM109406 BM109406 EST556942 potato roots Solanum tube . . . 1 214 1.90E−14 1 1 G481 BM348480 BM348480 MEST291-E08.T3 lSUM5-RN Zea mays cD . . . −3 214 2.30E−14 1 1 G481 BI531808 BI531808 1024116G03.y1 C. reinhardtii CC-169 . . . 3 122 2.70E−14 2 1 G481 BM158109 BM158109 NXLV_029_E11_F NXLV (Nsf Xylem Late . . . 3 212 4.40E−14 1 1 G481 AI966550 AI966550 sc51h01.y1 Gm-c1015 Glycine max cDN . . . 2 212 5.90E−14 1 1 G481 BM341073 BM341073 MEST329-H08.T3 ISUM5-RN Zea mays cD . . . −2 210 6.00E−14 1 1 G481 BM335521 BM335521 MEST162-H08.T3 ISUM5-RN Zea mays cD . . . −2 210 6.60E−14 1 1 G481 AV422691 AV422691 AV422691 Lotus japonicus young plan . . . 2 138 2.20E−13 2 1 G481 BG039303 BG039303 NXSI_097_E11_F NXSI (Nsf Xylem Side . . . 3 205 2.70E−13 1 1 G481 BF068031 BF068031 st86h12.y1 Gm-c1054 Glycine max cDN . . . 1 205 3.50E−13 1 1 G481 BF777951 BF777951 NXSI_079_003_F NXSI (Nsf Xylem Side . . . 2 205 4.80E−13 1 1 G481 BI720257 BI720257 1031048F06.y1 C. reinhardtii CC-169 . . . 3 204 4.90E−13 1 1 G481 BM441686 BM441686 EBed07_SQ001_E05_R IGF Barley EBed0 . . . 2 115 1.70E−12 2 1 G481 AX365284 AX365284 Sequence 20 from Patent WO0206499. . . . 3 124 4.10E−12 2 1 G481 BH153040 BH153040 Gm_ISb001_083_P16R ISU Soybean BAC . . . −1 185 2.90E−11 1 1 G481 BG589029 BG589029 EST490838 MHRP-Medicago truncatula . . . 2 187 3.30E−11 1 1 G481 BG350792 BG350792 098C07 Mature tuber lambda ZAP Sola . . . 1 185 1.90E−10 1 1 G481 BM094268 BM094268 sah27d01.y1 Gm-c1036 Glycine max cD . . . 3 167 3.20E−09 1 1 G481 BM271333 BM271333 sak08b06.y1 Gm-c1075 Glycine max cD . . . 1 156 5.10E−08 1 1 G481 AW693654 AW693654 NF066H08ST1F1000 Developing stem Me . . . 3 161 6.30E−08 1 1 G481 C19290 C19290 C19290 Rice panicle at ripening stage . . . 1 153 1.40E−07 1 1 G481 AL388746 AL388746 MtBC50E04F1 MtBC Medicago truncatul . . . −2 145 8.90E−07 1 1 G481 BI068503 BI068503 C022P78U Populus strain T89 leaves . . . 1 142 2.70E−06 1 1 G481 BH591716 BH591716 BOGTY51TR BOGT Brassica oleracea ge . . . −2 139 3.50E−06 1 1 G481 BM333505 BM333505 MEST156-F03.T3 ISUM5-RN Zea mays cD . . . −2 138 4.40E−06 1 1 G481 BH645120 BH645120 BOHZM09TF BO_2_3_KB Brassica olerac . . . 3 149 5.50E−06 1 1 G481 BM112643 BM112643 EST560179 potato roots Solanum tube . . . 2 143 9.40E−06 1 1 G481 BE356637 BE356637 DG1_126_D05.g1_A002 Dark Grown 1 (D . . . 1 133 1.80E−05 1 1 G481 BH580896 BH580896 BOGLY95TR BOGL Brassica oleracea ge . . . −2 146 2.20E−05 1 1 G481 BE400220 BE400220 AWB001.E09F000328 ITEC AWB Wheat Me . . . 3 132 2.20E−05 1 1 G481 AW981721 AW981721 PC15H08 Pine TriplEx pollen cone li . . . 2 129 4.40E−05 1 1 G481 BI325183 BI325183 baa05b02.x1 Cassava EYC library1 Ma . . . −1 124 0.00029 1 1 G481 BE822946 BE822946 GM700019A20C12 Gm-r1070 Glycine max . . . −3 130 0.00055 1 1 G481 BI271659 BI271659 NF026A03FL1F1020 Developing flower . . . 1 121 0.00076 1 1 G481 AMTAM4 X59057 A. majus transposable element Tam4 DNA . . . 2 134 0.0019 1 1 G481 BG653330 BG653330 sad87a07.y1 Gm-c1055 Glycine max cD . . . 3 114 0.0023 1 1 G481 BG644353 BG644353 EST505972 KV3 Medicago truncatula c . . . 2 126 0.004 1 1 G481 BG650027 BG650027 sad90h01.y1 Gm-c1055 Glycine max cD . . . 1 110 0.0056 1 1 G481 AW734322 AW734322 sk81f11.y1 Gm-c1016 Glycine max cDN . . . 3 110 0.0057 1 1 G481 BG046421 BG046421 saa63e06.y1 Gm-c1060 Glycine max cD . . . 2 110 0.0059 1 1 G481 BG726061 BG726061 sae06d09.y1 Gm-c1055 Glycine max CD . . . 3 110 0.0062 1 1 G481 BF070629 BF070629 st23b12.y1 Gm-c1065 Glycine max cDN . . . 1 110 0.0062 1 1 G481 AI443631 AI443631 sa42e05.y1 Gm-c1004 Glycine max cDN . . . 2 110 0.0065 1 1 G481 BF009637 BF009637 ss81h09.y1 Gm-c1064 Glycine max cDN . . . 1 109 0.0076 1 1 G481 BF627138 BF627138 HVSMEb0004A20f Hordeum vulgare seed . . . 1 125 0.008 1 1 G481 AV420244 AV420244 AV420244 Lotus japonicus young plan . . . 3 109 0.0085 1 1 G481 BH637694 BH637694 1008018B12.2EL_x1 1008 —RescueMu G . . . −2 111 0.0097 1 1 G481 AI967494 AI967494 Ljirnpest03-196-b3 Ljirnp Lambda Hy . . . 2 109 0.01 1 1 G481 AV416827 AV416827 AV416827 Lotus japonicus young plan . . . 1 109 0.011 1 1 G481 BG131195 BG131195 EST464087 tomato crown gall Lycoper . . . 3 107 0.012 1 1 G481 BF052943 BF052943 EST438173 potato leaves and petiole . . . 1 107 0.012 1 1 G481 AV409183 AV409183 AV409183 Lotus japonicus young plan . . . 3 108 0.015 1 1 G481 AW776198 AW776198 EST335263 DSIL Medicago truncatula . . . 1 105 0.022 1 1 G481 AL368819 AL368819 MtBA27A03F1 MtBA Medicago truncatul . . . 3 105 0.026 1 1 G481 C99407 C99407 C99407 Rice panicle at ripening stage . . . −3 105 0.026 1 1 G481 BH448006 BH448006 BOGBH37TR BOGB Brassica oleracea ge . . . −1 113 0.049 1 1 G481 AW185273 AW185273 se89c10.y1 Gm-c1023 Glycine max cDN . . . 3 110 0.061 1 1 G481 AW423569 AW423569 sh68f08.y1 Gm-c1015 Glycine max cDN . . . 3 110 0.065 1 1 G481 BG507868 BG507868 sac82d02.y1 Gm-c1072 Glycine max cD . . . 3 110 0.083 1 1 G481 C19737 C19737 C19737 Rice panicle at ripening stage . . . 3 100 0.089 1 1 G481 AW719575 AW719575 LjNEST6a11r Lotus japonicus nodule . . . 1 109 0.095 1 1 G481 AW706867 AW706867 sk07d05.y1 Gm-c1023 Glycine max cDN . . . 3 110 0.099 1 1 G481 AI460665 AI460665 sa71g05.y1 Gm-c1004 Glycine max cDN . . . 2 110 0.11 1 1 G481 AW759521 AW759521 sl44d11.y1 Gm-c1027 Glycine max cDN . . . 2 110 0.11 1 1 G481 BF595796 BF595796 sv04f12.y1 Gm-c1056 Glycine max cDN . . . 2 110 0.11 1 1 G481 BM178052 BM178052 saj68e01.y1 Gm-c1072 Glycine max cD . . . 3 109 0.16 1 1 G481 BI424397 BI424397 saf34c08.y4 Gm-c1077 Glycine max cD . . . 1 110 0.16 1 1 G481 BG044257 BG044257 saa25h07.y1 Gm-c1059 Glycine max cD . . . 2 110 0.17 1 1 G481 AW234956 AW234956 sf21b08.y1 Gm-c1028 Glycine max cDN . . . 1 110 0.17 1 1 G481 AW759820 AW759820 sl54e01.y1 Gm-c1027 Glycine max cDN . . . 3 110 0.18 1 1 G481 AI959799 AI959799 sc94d03.y1 Gm-c1019 Glycine max cDN . . . 1 110 0.18 1 1 G481 AW201988 AW201988 sf09f10.y1 Gm-c1027 Glycine max cDN . . . 3 109 0.2 1 1 G481 AW164642 AW164642 se74f06.y1 Gm-c1023 Glycine max cDN . . . 3 110 0.2 1 1 G481 AT002114 AT002114 AT002114 Flower bud cDNA Brassica r . . . 2 98 0.23 1 1 G481 BF113032 BF113032 EST440542 tomato breaker fruit Lyco . . . 1 107 0.25 1 1 G481 BE659989 BE659989 1010 GmaxSC Glycine max cDNA, mRNA . . . 2 110 0.26 1 1 G481 OSA300218 AJ300218 Oryza sativa nf-yb1 gene and nf-YB1 . . . 2 111 0.27 1 1 G481 BG597547 BG597547 EST496225 cSTS Solanum tuberosum cD . . . 1 107 0.32 1 1 G481 BF644204 BF644204 NF060B12EC1F1101 Elicited cell cult . . . 2 105 0.33 1 1 G481 AF464906 AF464906 Glycine max repressor protein (Dr1) . . . 1 110 0.34 1 1 G481 BE436801 BE436801 EST407919 tomato breaker fruit, TlG . . . 2 107 0.36 1 1 G481 BE659987 BE659987 7-F12 GmaxSC Glycine max cDNA, mRNA . . . 1 109 0.36 1 1 G481 BG451060 BG451060 NF098C04DT1F1024 Drought Medicago t . . . 3 105 0.42 1 1 G481 BM436739 BM436739 WA009B06_53061 An expressed sequen . . . 3 107 0.45 1 1 G481 BF273545 BF273545 GA_Eb0018J12f Gossypium arboreum 7 . . . 1 104 0.5 1 1 G481 BM411335 BM411335 EST585662 tomato breaker fruit Lyco . . . 3 107 0.5 1 1 G481 AW830697 AW830697 sm06h11.y1 Gm-c1027 Glycine max cDN . . . 2 91 0.54 1 1 G481 BE202566 BE202566 EST392975 KV1 Medicago truncatula c . . . 2 105 0.55 1 1 G481 BG240158 BG240158 OV1_18_F02.b1_A002 Ovary 1 (OV1) So . . . 3 101 0.56 1 1 G481 BM817060 BM817060 HC01C02_T3.ab1 HC Hordeum vulgare c . . . 1 103 0.58 1 1 G481 BE998485 BE998485 EST430208 GVSN Medicago truncatula . . . 3 105 0.58 1 1 G481 BE022456 BE022456 sm74b08.y1 Gm-c1015 Glycine max cDN . . . 2 103 0.6 1 1 G481 BF647976 BF647976 NF013H04EC1F1042 Elicited cell cult . . . 1 105 0.63 1 1 G481 BG102166 BG102166 RHIZ2_21_F06.b1_A003 Rhizome2 (RHIZ . . . 3 101 0.63 1 1 G481 AU084707 AU084707 AU084707 Cryptomeria japonica inner . . . 1 101 0.68 1 1 G481 BG648823 BG648823 EST510442 HOGA Medicago truncatula . . . 1 105 0.7 1 1 G481 BG648909 BG648909 EST510528 HOGA Medicago truncatula . . . 2 105 0.72 1 1 G481 BM380524 BM380524 MEST521-B07.univ ISUM6 Zea mays cDN . . . −3 103 0.75 1 1 G481 BG593107 BG593107 EST491785 cSTS Solanum tuberosum cD . . . 3 103 0.81 1 1 G481 BG052069 BG052069 RHIZ2_5_F11.b1_A003 Rhizome2 (RHIZ2 . . . 3 101 0.9 1 1 G481 BE497740 BE497740 WHE0956_G06_M12ZS Wheat pre-anthesi . . . 2 100 0.92 1 1 G481 BG873649 BG873649 MEST8-E10.T7-1 ISUM3-TL Zea mays cD . . . 3 101 0.94 1 1 G481 AW432997 AW432997 si03b08.y1 Gm-c1029 Glycine max cDN . . . 2 88 0.96 1 1 G481 AW064635 AW064635 ST33H06 Pine TriplEx shoot tip libr . . . 2 100 0.96 1 1 G481 AX365283 AX365283 Sequence 19 from Patent WO0206499. . . . 1 101 0.97 1 1 G481 BG648613 BG648613 EST510232 HOGA Medicago truncatula . . . 3 99 0.993 1 1 G481 BE640725 BE640725 Cri2_1_E07_SP6 Ceratopteris Spore L . . . 2 100 0.995 1 1 G481 AF464902 AF464902 Oryza sativa repressor protein (Dr1 . . . 2 101 0.996 1 1 G481 AF464903 AF464903 Triticum aestivum repressor protein . . . 2 100 0.999 1 1 G481 BE449790 BE449790 EST361228 tomato root, plants pre-a . . . 3 97 0.9991 1 1 G481 BI206380 BI206380 EST524420 cTOS Lycopersicon esculen . . . 1 97 0.9996 1 1 G481 GI-22380 CAAT-box DNA binding protein subunit B (N . . . 1 262 1.10E−45 3 1 G481 GI-115840 CBFA_MAIZE CCAAT-BINDING 1 262 1.10E−45 3 TRANSCRIPTION FAC . . . 1 G481 GI-7443522 S22820 transcription factor NF-Y, CCAAT-bi . . . 1 262 1.10E−45 3 1 G481 GI-15408794 putative CCAAT-binding transcription facto . . . 1 194 2.60E−30 2 1 G481 GI-16902054 CCAAT-box binding factor HAP3 B domain [Ve . . . 1 187 1.00E−28 2 1 G481 GI-16902050 CCAAT-box binding factor HAP3 B domain [Gl . . . 1 188 2.70E−28 2 1 G481 GI-16902056 CCAAT-box binding factor HAP3 B domain [Ar . . . 1 189 4.30E−28 2 1 G481 GI-15321716 AF410176_1 leafy cotyledon1 [Zea mays] 1 179 1.20E−26 3 1 G481 GI-16902052 CCAAT-box binding factor HAP3 B domain [Gl . . . 1 178 2.90E−26 2 1 G481 GI-15408793 hypothetical protein˜similar to CCAAT-bind . . . 1 180 2.70E−24 2 1 G481 GI-16902058 CCAAT-box binding factor HAP3 B domain [Tr . . . 1 175 1.50E−23 2 1 G481 GI-18481628 AF464906_1 repressor protein [Glycine max ] 1 110 2.10E−09 2 1 G481 GI-13928060 NF-YB1 protein [Oryza sativa ] 1 111 0.00069 1 1 G481 GI-18481620 AF464902_1 repressor protein [Oryza sativa] 1 101 0.037 1 1 G481 GI-18481622 AF464903_1 repressor protein [Triticum aes . . . 1 100 0.052 1 3 G1466 BH596941 BH596941 BOHFG41TR BOHF Brassica oleracea ge . . . 1 557 1.40E−65 2 3 G1466 BH497171 BH497171 BOHKV94TF BOHK Brassica oleracea ge . . . −1 531 7.70E−49 1 3 G1466 BH515525 BH515525 BOGZE84TR BOGZ Brassica oleracea ge . . . −1 518 1.60E−47 1 3 G1466 BH685857 BH685857 BOHWL93TF BO_2_3_KB Brassica olerac . . . 1 409 6.90E−36 1 3 G1466 BH556937 BH556937 BOHCT42TF BOHC Brassica oleracea ge . . . 3 374 3.20E−32 1 3 G1466 BH716964 BH716964 BOMNM26TR BO_2_3_KB Brassica olerac . . . −2 371 6.40E−32 1 3 G1466 BH556945 BH556945 BOHCT42TR BOHC Brassica oleracea ge . . . −3 205 3.40E−24 2 3 G1466 BH586673 BH586673 BOHPK25TF BOHP Brassica oleracea ge . . . −1 293 1.80E−23 1 3 G1466 BH479514 BH479514 BOHEU46TF BOHE Brassica oleracea ge . . . −3 293 2.50E−23 1 3 G1466 BH442040 BH442040 BOHJW94TR BOHJ Brassica oleracea ge . . . 2 284 2.00E−22 1 3 G1466 BH468201 BH468201 BOHAW05TF BOHA Brassica oleracea ge . . . 3 263 6.80E−20 1 3 G1466 BH554599 BH554599 BOHES28TF BOHE Brassica oleracea ge . . . −2 126 4.40E−17 3 3 G1466 BH443975 BH443975 BOGYY14TR BOGY Brassica oleracea ge . . . −1 220 7.20E−15 1 3 G1466 BH478506 BH478506 BOGJO28TR BOGJ Brassica oleracea ge . . . 2 184 3.10E−11 1 3 G1466 BH248066 BH248066 BOGAU25TR BOGA Brassica oleracea ge . . . 2 164 7.00E−08 1 3 G1466 BH455609 BH455609 BOHPV23TF BOHP Brassica oleracea ge . . . −1 160 6.60E−07 1 3 G1466 BH453095 BH453095 BOGVR55TF BOGV Brassica oleracea ge . . . 2 141 8.30E−05 1 3 G1466 BH536461 BH536461 BOHMJ41TR BOHM Brassica oleracea ge . . . 2 139 8.90E−05 1 3 G1466 BE462774 BE462774 EST325108 tomato flower buds 0-3 mm . . . 1 129 0.00014 1 3 G1466 AW399721 AW399721 EST310221 L. pennellii trichome, Co . . . 3 124 0.00049 1 3 G1466 AV413010 AV413010 AV413010 Lotus japonicus young plan . . . 3 119 0.00054 1 3 G1466 AW032605 AW032605 EST276164 tomato callus, TAMU Lycop . . . 3 114 0.0021 1 3 G1466 BI927221 BI927221 EST547110 tomato flower, 3-8 mm b . . . 2 121 0.0023 1 3 G1466 OSJN00182 AL662981 Oryza sativa chromosome 4 clone OSJ . . . 3 132 0.0029 1 3 G1466 BG662160 BG662160 Ljirnpest39-183-g3 Ljirnp Lambda Hy . . . 2 111 0.0037 1 3 G1466 BG599234 BG599234 EST504134 cSTS Solanum tuberosum cD . . . 3 125 0.0047 1 3 G1466 BG133465 BG133465 EST466357 tomato crown gall Lycoper . . . 3 110 0.0059 1 3 G1466 BG596415 BG596415 EST495093 cSTS Solanum tuberosum cD . . . 3 109 0.0061 1 3 G1466 BI922297 BI922297 EST542201 tomato callus Lycopersico . . . 3 114 0.0065 1 3 G1466 BG097828 BG097828 EST462347 potato leaves and petiole . . . 1 122 0.0081 1 3 G1466 BI178485 BI178485 EST519430 cSTE Solanum tuberosum cD . . . 1 120 0.0095 1 3 G1466 BG580068 BG580068 EST481790 GVN Medicago truncatula c . . . 3 114 0.0095 1 3 G1466 AW932502 AW932502 EST358345 tomato fruit mature green . . . 3 118 0.011 1 3 G1466 BH700517 BH700517 BOMEG26TR BO_2_3_KB Brassica olerac . . . 1 106 0.013 1 3 G1466 AV414925 AV414925 AV414925 Lotus japonicus young plan . . . 1 106 0.014 1 3 G1466 BG887252 BG887252 EST513103 cSTD Solanum tuberosum cD . . . 3 121 0.015 1 3 G1466 BH649717 BH649717 BOHTZ83TF BO_2_3_KB Brassica olerac . . . −2 121 0.016 1 3 G1466 AW691672 AW691672 NF047G10ST1F1000 Developing stem Me . . . 3 105 0.02 1 3 G1466 BI316339 BI316339 saf02a08.y1 Gm-c1065 Glycine max cD . . . 1 115 0.026 1 3 G1466 BG409415 BG409415 00787 leafy spurge Lambda HybriZAP . . . 2 115 0.026 1 3 G1466 AP003837 AP003837 Oryza sativa chromosome 7 clone OJ1 . . . −2 123 0.027 1 3 G1466 AW928976 AW928976 EST337860 tomato flower buds 8 mm t . . . 2 115 0.03 1 3 G1466 OSJN00167 AL662965 Oryza sativa chromosome 4 clone OSJ . . . −2 122 0.034 1 3 G1466 BH660321 BH660321 BOMGE76TR BO_2_3_KB Brassica olerac . . . −3 116 0.036 1 3 G1466 AW395660 AW395660 sg73f12.y1 Gm-c1007 Glycine max cDN . . . 3 102 0.037 1 3 G1466 BE459691 BE459691 EST414983 tomato developing/immatur . . . 2 102 0.038 1 3 G1466 BH558685 BH558685 BOGEH17TR BOGE Brassica oleracea ge . . . 1 116 0.05 1 3 G1466 BH486360 BH486360 BOHLY92TF BOHL Brassica oleracea ge . . . 3 116 0.056 1 3 G1466 AW218077 AW218077 EST296792 tomato flower buds, anthe . . . 1 114 0.078 1 3 G1466 AW650052 AW650052 EST328506 tomato germinating seedli . . . 1 112 0.08 1 3 G1466 BH698615 BH698615 BOHUQ33TR BO_2_3_KB Brassica olerac . . . 3 113 0.081 1 3 G1466 BG596140 BG596140 EST494818 cSTS Solanum tuberosum cD . . . 1 114 0.093 1 3 G1466 BE205043 BE205043 EST397719 KV0 Medicago truncatula c . . . 2 112 0.097 1 3 G1466 BE919377 BE919377 EST423230 potato leaves and petiole . . . 3 111 0.097 1 3 G1466 BH437084 BH437084 BOHKZ27TF BOHK Brassica oleracea ge . . . −3 99 0.1 1 3 G1466 BF278686 BF278686 GA_Eb0035E21f Gossypium arboreum 7 . . . 3 111 0.11 1 3 G1466 BI933949 BI933949 EST553838 tomato flower, anthesis L . . . 3 113 0.12 1 3 G1466 BF096307 BF096307 EST360356 tomato nutrient deficient . . . 2 109 0.13 1 3 G1466 BH737844 BH737844 BOMAX76TF BO_2_3_KB Brassica olerac . . . −1 109 0.14 1 3 G1466 BI929823 BI929823 EST549712 tomato flower, 3-8 mm b . . . 3 104 0.17 1 3 G1466 BH513097 BH513097 BOGEX21TR BOGE Brassica oleracea ge . . . −1 112 0.17 1 3 G1466 BE203214 BE203214 EST403236 KV1 Medicago truncatula c . . . 1 110 0.18 1 3 G1466 BE202448 BE202448 EST392897 KV1 Medicago truncatula c . . . 2 104 0.19 1 3 G1466 BF644564 BF644564 NF016D06EC1F1057 Elicited cell cult . . . 1 110 0.19 1 3 G1466 BI420528 BI420528 LjNEST58c10r Lotus japonicus nodule . . . 3 96 0.2 1 3 G1466 BF010496 BE010496 NXCI_084_G01_F NXCI (Nsf Xylem Comp . . . 2 95 0.2 1 3 G1466 BI308763 BI308763 EST530173 GPOD Medicago truncatula . . . 3 107 0.21 1 3 G1466 BH469525 BH469525 BOGSA70TF BOGS Brassica oleracea ge . . . 2 111 0.22 1 3 G1466 BE442810 BE442810 WHE1106_C02_E04ZS Wheat etiolated s . . . 1 110 0.23 1 3 G1466 BH569775 BH569775 BOGMV91TF BOGM Brassica oleracea ge . . . −3 109 0.23 1 3 G1466 BH723965 BH723965 BOMHF56TF BO_2_3_KB Brassica olerac . . . −2 110 0.25 1 3 G1466 BH475440 BH475440 BOHNA92TF BOHN Brassica oleracea ge . . . −2 109 0.26 1 3 G1466 BH730453 BH730453 BOHVD24TR BO_2_3_KB Brassica olerac . . . 1 110 0.27 1 3 G1466 AC082644 AC082644 Oryza sativa chromosome 3 BAC OSJNB . . . −2 113 0.28 1 3 G1466 AZ124264 AZ124264 T223049b Medicago truncatula BAC li . . . −3 93 0.31 1 3 G1466 BI922762 BI922762 EST542666 tomato callus Lycopersico . . . 3 104 0.34 1 3 G1466 AI443156 AI443156 sa50f01.y1 Gm-c1004 Glycine max cDN . . . 3 105 0.34 1 3 G1466 BE249557 BE249557 NF022C06LF1F1049 Developing leaf Me . . . 1 94 0.34 1 3 G1466 AL379504 AL379504 MtBB45G03F1 MtBB Medicago truncatul . . . 1 102 0.35 1 3 G1466 BF646352 BF646352 NF068G05EC1F1039 Elicited cell cult . . . 1 106 0.47 1 3 G1466 BH498652 BH498652 BOGZR84TR BOGZ Brassica oleracea ge . . . −2 107 0.48 1 3 G1466 BM442042 BM442042 EBan01_SQ002_A06_R IGF Barley EBan0 . . . 2 96 0.49 1 3 G1466 BG447666 BG447666 NF019E03ST1F1000 Developing stem Me . . . 1 106 0.49 1 3 G1466 AV427033 AV427033 AV427033 Lotus japonicus young plan . . . 1 98 0.5 1 3 G1466 AW216996 AW216996 EST295710 tomato callus, TAMU Lycop . . . 2 92 0.53 1 3 G1466 AW648500 AW648500 EST326954 tomato germinating seedli . . . 3 102 0.55 1 3 G1466 AW649521 AW649521 EST327975 tomato germinating seedli . . . 1 102 0.59 1 3 G1466 BF187212 BF187212 EST443499 potato stolon, Cornell Un . . . 3 102 0.62 1 3 G1466 BE202443 BE202443 EST392892 KV1 Medicago truncatula c . . . 3 104 0.65 1 3 G1466 BE344294 BE344294 EST409456 potato stolon, Cornell Un . . . 3 102 0.66 1 3 G1466 C72509 C72509 C72509 Rice panicle at flowering stag . . . 2 89 0.67 1 3 G1466 BH743977 BH743977 gt29g06.b1 BoBuds01 Brassica olerac . . . 2 101 0.68 1 3 G1466 AI967453 AI967453 Ljirnpest02-129-d2 Ljirnp Lambda Hy . . . 1 99 0.7 1 3 G1466 BI419994 BI419994 LjNEST42f9r Lotus japonicus nodule . . . 2 102 0.7 1 3 G1466 BG646874 BG646874 EST508493 HOGA Medicago truncatula . . . 2 104 0.7 1 3 G1466 AW694435 AW694435 NF076B06ST1F1048 Developing stem Me . . . 1 102 0.75 1 3 G1466 AP004055 AP004055 Oryza sativa chromosome 2 clone OJ1 . . . 1 107 0.77 1 3 G1466 AP004144 AP004144 Oryza sativa chromosome 2 clone OJ1 . . . −3 107 0.77 1 3 G1466 OSJN00115 AL606997 Oryza sativa chromosome 4 clone OSJ . . . −1 107 0.77 1 3 G1466 AP002071 AP002071 Oryza sativa genomic DNA, chromosom . . . −1 107 0.77 1 3 G1466 BE095245 BE095245 00306 leafy spurge Lambda HybriZAP . . . 1 88 0.79 1 3 G1466 BM526605 BM526605 sal43e01.y1 Gm-c1059 Glycine max cD . . . 2 100 0.8 1 3 G1466 BI933721 BI933721 EST553610 tomato flower, anthesis L . . . 3 102 0.86 1 3 G1466 BI272408 BI272408 NF020H09FL1F1079 Developing flower . . . 3 102 0.87 1 3 G1466 BI933639 BI933639 EST553528 tomato flower, anthesis L . . . 3 102 0.89 1 3 G1466 BM108916 BM108916 EST556452 potato roots Solanum tube . . . 1 102 0.89 1 3 G1466 BH581102 BH581102 BOHKD50TF BOHK Brassica oleracea ge . . . 3 95 0.9 1 3 G1466 BH692394 BH692394 BOMKE64TF BO_2_3_KB Brassica olerac . . . 3 99 0.92 1 3 G1466 BG131783 BG131783 EST464675 tomato crown gall Lycoper . . . 3 97 0.93 1 3 G1466 AI896339 AI896339 EST265782 tomato callus, TAMU Lycop . . . 2 94 0.93 1 3 G1466 BG404995 BG404995 sac46g02.y1 Gm-c1062 Glycine max cD . . . 1 97 0.95 1 3 G1466 AP004042 AP004042 Oryza sativa chromosome 8 clone OJ1 . . . 1 104 0.95 1 3 G1466 AP004708 AP004708 Oryza sativa chromosome 8 clone P07 . . . −3 104 0.95 1 3 G1466 AP004274 AP004274 Oryza sativa chromosome 7 clone P04 . . . −1 104 0.95 1 3 G1466 BE919578 BE919578 EST423347 potato leaves and petiole . . . 1 100 0.95 1 3 G1466 BF634570 BF634570 NF061B09DT1F1076 Drought Medicago t . . . 3 100 0.96 1 3 G1466 BI420155 BI420155 LjNEST53f7r Lotus japonicus nodule . . . 3 96 0.97 1 3 G1466 AQ917137 AQ917137 T233170b Medicago truncatula BAC li . . . −1 99 0.97 1 3 G1466 AW720029 AW720029 LjNEST15c9r Lotus japonicus nodule . . . 2 96 0.98 1 3 G1466 AW568479 AW568479 si59c09.y1 Gm-r1030 Glycine max cDN . . . 3 97 0.98 1 3 G1466 BI420626 BI420626 LjNEST59e5r Lotus japonicus nodule . . . 3 96 0.99 1 3 G1466 BE433506 BE433506 EST400035 tomato breaker fruit, TIG . . . 2 97 0.99 1 3 G1466 BI785473 BI785473 sai41d06.y1 Gm-c1065 Glycine max cD . . . 3 97 0.991 1 3 G1466 BH737087 BH737087 BOMGM48TR BO_2_3_KB Brassica olerac . . . 3 98 0.991 1 3 G1466 BM324672 BM324672 PIC1_34_B01.b1_A002 Pathogen-infect . . . 3 98 0.992 1 3 G1466 BH425892 BH425892 BOGDN33TF BOGD Brassica oleracea ge . . . −3 98 0.994 1 3 G1466 BH645340 BH645340 BOHWO42TF BO_2_3_KB Brassica olerac . . . −3 97 0.995 1 3 G1466 AW687534 AW687534 NF010F07RT1F1062 Developing root Me . . . 3 96 0.997 1 3 G1466 BF176934 BF176934 EM1_4_E11.b1_A002 Embryo 1 (EM1) So . . . 3 96 0.997 1 3 G1466 BI419241 BI419241 LjNEST44a5r Lotus japonicus nodule . . . 3 96 0.998 1 3 G1466 AL380183 AL380183 MtBB50H09F1 MtBB Medicago truncatul . . . 1 94 0.998 1 3 G1466 AC079128 AC079128 Oryza sativa chromosome 10 clone OS . . . 3 101 0.998 1 3 G1466 BF070938 BF070938 st85e05.y1 Gm-c1054 Glycine max cDN . . . 3 95 0.999 1 3 G1466 AW928966 AW928966 EST337850 tomato flower buds 8 mm t . . . 3 86 0.9995 1 3 G1466 BH429646 BH429646 BOGSF37TF BOGS Brassica oleracea ge . . . −3 97 0.9997 1 3 G1466 BH560749 BH560749 BOGPC01TR BOGP Brassica oleracea ge . . . −1 97 0.9997 1 3 G1466 AP004150 AP004150 Oryza sativa chromosome 2 clone OJ1 . . . −1 100 0.9998 1 3 G1466 AP004077 AP004077 Oryza sativa chromosome 2 clone OJ1 . . . 1 100 0.9998 1 3 G1466 BG130763 BG130763 EST463655 tomato crown gall Lycoper . . . 3 96 0.9998 1 3 G1466 BH484808 BH484808 BOGQC69TR BOGQ Brassica oleracea ge . . . 1 97 0.9998 1 3 G1466 BF651138 BF651138 NF101G05EC1F1038 Elicited cell cult . . . 1 96 0.9999 1 3 G1466 BF650226 BF650226 NF090F10EC1F1089 Elicited cell cult . . . 3 96 0.9999 1 3 G1466 BF647598 BF647598 NF012A06EC1F1039 Elicited cell cult . . . 3 96 0.9999 1 3 G1466 BG447988 BG447988 NF103H10EC1F1090 Elicited cell cult . . . 3 96 0.9999 1 3 G1466 BH480188 BH480188 BOGZW54TR BOGZ Brassica oleracea ge . . . 3 97 0.99991 1 3 G1466 BF519054 BF519054 EST456514 DSIL Medicago truncatula . . . 3 96 0.99994 1 3 G1466 GI-8096405 Similar to Arabdopsis thaliana chromosome . . . −3 137 2.30E−12 2 3 G1466 GI-8096413 hypothetical protein [Oryza sativa] −3 135 2.20E−11 2 3 G1466 GI-8096416 hypothetical protein [Oryza sativa] −3 111 9.40E−09 3 3 G1466 GI-13161526 S locus F-box (SLF)-S2 protein [Antirrhinu . . . −3 92 3.40E−08 3 3 G1466 GI-13161540 SLF-S2 protein [Antirrhinum hispanicum] −3 92 3.40E−08 3 3 G1466 GI-13161528 S locus F-box (SLF)-S2-like protein [Antir . . . −1 87 1.20E−07 3 3 G1466 GI-8096415 hypothetical protein [Oryza sativa] −1 102 3.60E−07 2 3 G1466 GI-18854994 AC087599_5 unknown protein [Oryza sativa] −1 90 1.10E−05 3 3 G1466 GI-14028986 AC079128_10 Unknown protein [Oryza sativa] −1 101 4.60E−05 2 3 G1466 GI-18854992 AC087599_3 putative transposase [Oryza sat . . . −3 93 0.0014 3 3 G1466 GI-12039340 AC082644_9 hypothetical protein [Oryza sat . . . −1 113 0.0029 1 3 G1466 GI-14018043 AC079936_2 Hypothetical protein [Oryza sat . . . −1 87 0.012 2 3 G1466 GI-15451623 AC091734_4 Hypothetical protein [Oryza sat . . . −1 87 0.012 2 3 G1466 GI-15528755 hypothetical protein [Oryza sativa] −1 96 0.012 2 3 G1466 GI-8096406 hypothetical protein [Oryza sativa] −3 98 0.013 2 3 G1466 GI-8096410 hypothetical protein [Oryza sativa] −1 103 0.022 1 3 G1466 GI-18844804 contains ESTs D15126(C0122),C97919(C0122)˜. . . −1 99 0.083 1 3 G1466 GI-18449949 AC099733_6 Unknown protein [Oryza sativa] −1 81 0.099 2 3 G1466 GI-18464016 AC090873_9 Hypothetical protein [Oryza sat . . . −3 69 0.23 2 3 G1466 GI-19224986 AC077693_1 putative transposase protein, 5 . . . −3 93 0.24 2 3 G1466 GI-12039332 AC082644_1 hypothetical protein [Oryza sat . . . −1 91 0.5 1 3 G1466 GI-18461280 similar to Oryza sativa chromosome 1, P045 . . . −3 72 0.61 2 3 G1466 GI-9858770 AF273333_2 BAC19.2 [Lycopersicon esculentum] −1 70 0.83 2 3 G1466 GI-12039337 AC082644_6 hypothetical protein [Oryza sat . . . −1 87 0.85 1 3 G1466 GI-18642684 AC074283_6 Hypothetical protein [Oryza sat . . . −1 79 0.9 2 3 G1466 GI-18642688 AC074283_7 Unknown protein [Oryza sativa] −1 75 0.97 1 3 G1466 GI-18087878 AC087182_15 hypothetical protein [Oryza sa . . . −1 87 0.98 1 3 G1466 GI-18873858 AC079874_27 hypothetical protein [Oryza sa . . . −3 81 0.994 1 3 G1466 GI-6505722 ribosomal RNA apurinic site specific lyase −1 81 0.99993 1 3 G1466 GI-6513849 ribosomal RNA apurinic site specific lyase −1 81 0.99993 1

[0215]

1 4 1 832 DNA Arabidopsis thaliana CDS (103)...(528) G481 1 gagcgtttcg tagaaaaatt cgatttctct aaagccctaa aactaaaacg actatcccca 60 attccaagtt ctagggtttc catcttcccc aatctagtat aa atg gcg gat acg 114 Met Ala Asp Thr 1 cct tcg agc cca gct gga gat ggc gga gaa agc ggc ggt tcc gtt agg 162 Pro Ser Ser Pro Ala Gly Asp Gly Gly Glu Ser Gly Gly Ser Val Arg 5 10 15 20 gag cag gat cga tac ctt cct ata gct aat atc agc agg atc atg aag 210 Glu Gln Asp Arg Tyr Leu Pro Ile Ala Asn Ile Ser Arg Ile Met Lys 25 30 35 aaa gcg ttg cct cct aat ggt aag att gga aaa gat gct aag gat aca 258 Lys Ala Leu Pro Pro Asn Gly Lys Ile Gly Lys Asp Ala Lys Asp Thr 40 45 50 gtt cag gaa tgc gtc tct gag ttc atc agc ttc atc act agc gag gcc 306 Val Gln Glu Cys Val Ser Glu Phe Ile Ser Phe Ile Thr Ser Glu Ala 55 60 65 agt gat aag tgt caa aaa gag aaa agg aaa act gtg aat ggt gat gat 354 Ser Asp Lys Cys Gln Lys Glu Lys Arg Lys Thr Val Asn Gly Asp Asp 70 75 80 ttg ttg tgg gca atg gca aca tta gga ttt gag gat tac ctg gaa cct 402 Leu Leu Trp Ala Met Ala Thr Leu Gly Phe Glu Asp Tyr Leu Glu Pro 85 90 95 100 cta aag ata tac cta gcg agg tac agg gag ttg gag ggt gat aat aag 450 Leu Lys Ile Tyr Leu Ala Arg Tyr Arg Glu Leu Glu Gly Asp Asn Lys 105 110 115 gga tca gga aag agt gga gat gga tca aat aga gat gct ggt ggc ggt 498 Gly Ser Gly Lys Ser Gly Asp Gly Ser Asn Arg Asp Ala Gly Gly Gly 120 125 130 gtt tct ggt gaa gaa atg ccg agc tgg taa aagaagttgc aagtagtgat 548 Val Ser Gly Glu Glu Met Pro Ser Trp * 135 140 taagaacaat cgccaaatga tcaagggaaa ttagagatca gtgagttgtt tatagttgag 608 ctgatcgaca actatttcgg gtttactctc aatttcggtt atgttagttt gaacgtttgg 668 tttattgttt ccggtttagt tggttgtatt taaagatttc tctgttagat gttgagaaca 728 cttgaatgaa ggaaaaattt gtccacatcc tgttgttatt ttcgattcac tttcggaatt 788 tcatagctaa tttattctca tttaatacca aatccttaaa ttaa 832 2 141 PRT Arabidopsis thaliana 2 Met Ala Asp Thr Pro Ser Ser Pro Ala Gly Asp Gly Gly Glu Ser Gly 1 5 10 15 Gly Ser Val Arg Glu Gln Asp Arg Tyr Leu Pro Ile Ala Asn Ile Ser 20 25 30 Arg Ile Met Lys Lys Ala Leu Pro Pro Asn Gly Lys Ile Gly Lys Asp 35 40 45 Ala Lys Asp Thr Val Gln Glu Cys Val Ser Glu Phe Ile Ser Phe Ile 50 55 60 Thr Ser Glu Ala Ser Asp Lys Cys Gln Lys Glu Lys Arg Lys Thr Val 65 70 75 80 Asn Gly Asp Asp Leu Leu Trp Ala Met Ala Thr Leu Gly Phe Glu Asp 85 90 95 Tyr Leu Glu Pro Leu Lys Ile Tyr Leu Ala Arg Tyr Arg Glu Leu Glu 100 105 110 Gly Asp Asn Lys Gly Ser Gly Lys Ser Gly Asp Gly Ser Asn Arg Asp 115 120 125 Ala Gly Gly Gly Val Ser Gly Glu Glu Met Pro Ser Trp 130 135 140 3 1342 DNA Arabidopsis thaliana CDS (16)...(1278) G1466 3 caacaagctt caaaa atg ggg gaa gaa gaa gag aac cct aat tcg atc gac 51 Met Gly Glu Glu Glu Glu Asn Pro Asn Ser Ile Asp 1 5 10 att ctt ccc gag cta ctt gaa gaa gtt ctc ctt aga ttg ccc acg aaa 99 Ile Leu Pro Glu Leu Leu Glu Glu Val Leu Leu Arg Leu Pro Thr Lys 15 20 25 tcg atc ctc aaa tgc aga atc gtc tca aaa caa tgg agg tca ctc ctg 147 Ser Ile Leu Lys Cys Arg Ile Val Ser Lys Gln Trp Arg Ser Leu Leu 30 35 40 gaa tcg agt agg ttc gcg gag agg cat atg agt ctt caa aac agc cgc 195 Glu Ser Ser Arg Phe Ala Glu Arg His Met Ser Leu Gln Asn Ser Arg 45 50 55 60 cgg aga atc tta gct gct tac aac tgc gac tgc ggc gga cgg agg aag 243 Arg Arg Ile Leu Ala Ala Tyr Asn Cys Asp Cys Gly Gly Arg Arg Lys 65 70 75 ctc cta ccc gag tca cgg ttt gaa ggg gac gaa gag att gtc tat ctg 291 Leu Leu Pro Glu Ser Arg Phe Glu Gly Asp Glu Glu Ile Val Tyr Leu 80 85 90 cac tgc gac gcc tca cga ccc tcg atg act tgc caa ggt gtg atc tgc 339 His Cys Asp Ala Ser Arg Pro Ser Met Thr Cys Gln Gly Val Ile Cys 95 100 105 ttc ccc gag caa gat tgg atc atc gtt ttg aac cca tcg act agc caa 387 Phe Pro Glu Gln Asp Trp Ile Ile Val Leu Asn Pro Ser Thr Ser Gln 110 115 120 ctt cgg cga ttc cct tcc ggc ttg aac cat aac tgc aga ttt aga att 435 Leu Arg Arg Phe Pro Ser Gly Leu Asn His Asn Cys Arg Phe Arg Ile 125 130 135 140 gga tta tgg aag act ttc tct ccg gga aac tgg gta atg ggg ttt ggt 483 Gly Leu Trp Lys Thr Phe Ser Pro Gly Asn Trp Val Met Gly Phe Gly 145 150 155 aga gac aaa gtg aat ggg agg tat aaa gtg gtg agg atg tct ttt gct 531 Arg Asp Lys Val Asn Gly Arg Tyr Lys Val Val Arg Met Ser Phe Ala 160 165 170 ttc tgg aga gtt agg caa gag gag cct gtg gtg gaa tgt ggt gtt ctt 579 Phe Trp Arg Val Arg Gln Glu Glu Pro Val Val Glu Cys Gly Val Leu 175 180 185 gat gtt gat act ggt gaa tgg cgg aag ctg agt cca cct cct tat gtg 627 Asp Val Asp Thr Gly Glu Trp Arg Lys Leu Ser Pro Pro Pro Tyr Val 190 195 200 gtc aat gtg gga agc aaa tcg gta tgc gtg aat gga tct atc tac tgg 675 Val Asn Val Gly Ser Lys Ser Val Cys Val Asn Gly Ser Ile Tyr Trp 205 210 215 220 tta cac att cag acg gtt tac aga ata cta gcc ttg gat ctt cac aaa 723 Leu His Ile Gln Thr Val Tyr Arg Ile Leu Ala Leu Asp Leu His Lys 225 230 235 caa gag ttt cat aaa gtc cca gtg ccg cct acg cag atc act gtg gac 771 Gln Glu Phe His Lys Val Pro Val Pro Pro Thr Gln Ile Thr Val Asp 240 245 250 act cag atg gtg aac ctt gag gac cgt ctc gta ctt gct ata acc aga 819 Thr Gln Met Val Asn Leu Glu Asp Arg Leu Val Leu Ala Ile Thr Arg 255 260 265 gtt agc cct gaa tgg ata cta gag gta tgg ggc atg gat aca tac aaa 867 Val Ser Pro Glu Trp Ile Leu Glu Val Trp Gly Met Asp Thr Tyr Lys 270 275 280 gaa aaa tgg agc aag act tac tcc ata agt ttg gat cat aga gtt gtt 915 Glu Lys Trp Ser Lys Thr Tyr Ser Ile Ser Leu Asp His Arg Val Val 285 290 295 300 tcc tgg cga agg cag aaa agg tgg ttc acg ccc gtg gca gtt tct aag 963 Ser Trp Arg Arg Gln Lys Arg Trp Phe Thr Pro Val Ala Val Ser Lys 305 310 315 caa gcg aat ctt gtc ttc tat gac aat aag aag agg cta ttc aaa tat 1011 Gln Ala Asn Leu Val Phe Tyr Asp Asn Lys Lys Arg Leu Phe Lys Tyr 320 325 330 tat cca gtg aaa gat gag att cgt tgt ctc tcc tta gac att tgt gtt 1059 Tyr Pro Val Lys Asp Glu Ile Arg Cys Leu Ser Leu Asp Ile Cys Val 335 340 345 ctg tct cct tac gtg gaa aac ttg gtc cct ctt ccg tta aag cca agc 1107 Leu Ser Pro Tyr Val Glu Asn Leu Val Pro Leu Pro Leu Lys Pro Ser 350 355 360 cat ccg cat cct act ccg aaa aat tca gat ttt gaa atg agg ata tca 1155 His Pro His Pro Thr Pro Lys Asn Ser Asp Phe Glu Met Arg Ile Ser 365 370 375 380 aga tgc cgc ttg ttt tcg acg cca ggt tct tgg ata tcc aaa att ttg 1203 Arg Cys Arg Leu Phe Ser Thr Pro Gly Ser Trp Ile Ser Lys Ile Leu 385 390 395 aaa tgg aat gtt atg act cta gag att ttg ttt acc tct cta gca ata 1251 Lys Trp Asn Val Met Thr Leu Glu Ile Leu Phe Thr Ser Leu Ala Ile 400 405 410 gtt ggt tat ata tgc tta cct ctc tag gagttattta tcttgtttca 1298 Val Gly Tyr Ile Cys Leu Pro Leu * 415 420 aaatattagt tggttatata tgctttcgag atctttctga taaa 1342 4 420 PRT Arabidopsis thaliana 4 Met Gly Glu Glu Glu Glu Asn Pro Asn Ser Ile Asp Ile Leu Pro Glu 1 5 10 15 Leu Leu Glu Glu Val Leu Leu Arg Leu Pro Thr Lys Ser Ile Leu Lys 20 25 30 Cys Arg Ile Val Ser Lys Gln Trp Arg Ser Leu Leu Glu Ser Ser Arg 35 40 45 Phe Ala Glu Arg His Met Ser Leu Gln Asn Ser Arg Arg Arg Ile Leu 50 55 60 Ala Ala Tyr Asn Cys Asp Cys Gly Gly Arg Arg Lys Leu Leu Pro Glu 65 70 75 80 Ser Arg Phe Glu Gly Asp Glu Glu Ile Val Tyr Leu His Cys Asp Ala 85 90 95 Ser Arg Pro Ser Met Thr Cys Gln Gly Val Ile Cys Phe Pro Glu Gln 100 105 110 Asp Trp Ile Ile Val Leu Asn Pro Ser Thr Ser Gln Leu Arg Arg Phe 115 120 125 Pro Ser Gly Leu Asn His Asn Cys Arg Phe Arg Ile Gly Leu Trp Lys 130 135 140 Thr Phe Ser Pro Gly Asn Trp Val Met Gly Phe Gly Arg Asp Lys Val 145 150 155 160 Asn Gly Arg Tyr Lys Val Val Arg Met Ser Phe Ala Phe Trp Arg Val 165 170 175 Arg Gln Glu Glu Pro Val Val Glu Cys Gly Val Leu Asp Val Asp Thr 180 185 190 Gly Glu Trp Arg Lys Leu Ser Pro Pro Pro Tyr Val Val Asn Val Gly 195 200 205 Ser Lys Ser Val Cys Val Asn Gly Ser Ile Tyr Trp Leu His Ile Gln 210 215 220 Thr Val Tyr Arg Ile Leu Ala Leu Asp Leu His Lys Gln Glu Phe His 225 230 235 240 Lys Val Pro Val Pro Pro Thr Gln Ile Thr Val Asp Thr Gln Met Val 245 250 255 Asn Leu Glu Asp Arg Leu Val Leu Ala Ile Thr Arg Val Ser Pro Glu 260 265 270 Trp Ile Leu Glu Val Trp Gly Met Asp Thr Tyr Lys Glu Lys Trp Ser 275 280 285 Lys Thr Tyr Ser Ile Ser Leu Asp His Arg Val Val Ser Trp Arg Arg 290 295 300 Gln Lys Arg Trp Phe Thr Pro Val Ala Val Ser Lys Gln Ala Asn Leu 305 310 315 320 Val Phe Tyr Asp Asn Lys Lys Arg Leu Phe Lys Tyr Tyr Pro Val Lys 325 330 335 Asp Glu Ile Arg Cys Leu Ser Leu Asp Ile Cys Val Leu Ser Pro Tyr 340 345 350 Val Glu Asn Leu Val Pro Leu Pro Leu Lys Pro Ser His Pro His Pro 355 360 365 Thr Pro Lys Asn Ser Asp Phe Glu Met Arg Ile Ser Arg Cys Arg Leu 370 375 380 Phe Ser Thr Pro Gly Ser Trp Ile Ser Lys Ile Leu Lys Trp Asn Val 385 390 395 400 Met Thr Leu Glu Ile Leu Phe Thr Ser Leu Ala Ile Val Gly Tyr Ile 405 410 415 Cys Leu Pro Leu 420 

What is claimed is:
 1. A transgenic plant comprising a recombinant polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a sequence selected from those of SEQ ID NOs:2, 4, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence encoding a polypeptide comprising a conservatively substituted variant of a polypeptide of (a); (c) one of SEQ ID NOs: 1, 3, or a complementary nucleotide sequence thereof; (d) a nucleotide sequence comprising silent substitutions in a nucleotide sequence of (c); (e) a nucleotide sequence which hybridizes under stringent conditions to a nucleotide sequence of one or more of: (a), (b), (c), or (d); (f) a nucleotide sequence comprising at least 15 consecutive nucleotides outside of a conserved domain of any of (a)-(e); (g) a nucleotide sequence comprising a subsequence or fragment of any of (a)-(f), which subsequence or fragment encodes a polypeptide that modifies a plant's trait; (h) a nucleotide sequence having at least 31% sequence identity to a nucleotide sequence of any of (a)-(g); (i) a nucleotide sequence having at least 60% sequence identity to a nucleotide sequence of any of (a)-(g); (j) a nucleotide sequence having at least 95% sequence identity to a nucleotide sequence of any of (a)-(g); (k) a nucleotide sequence which encodes a polypeptide having at least 31% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (l) a nucleotide sequence which encodes a polypeptide having at least 60% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (m) a nucleotide sequence which encodes a polypeptide having at least 75% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (n) a nucleotide sequence which encodes a polypeptide having at least 95% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (o) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least 86% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (p) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 90% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (q) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 95% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (r) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 98% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (s) a nucleotide sequence which encodes a polypeptide having at least 31% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; (t) a nucleotide sequence which encodes a polypeptide having at least 60% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; (u) a nucleotide sequence which encodes a polypeptide having at least 75% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; and (v) a nucleotide sequence which encodes a polypeptide having at least 95% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; wherein the plant possesses an altered trait as compared to a wild type plant, or the plant exhibits an altered phenotype as compared to a wild type plant, or the plant expresses an altered level of one or more genes associated with a plant trait as compared to a wild type plant.
 2. The transgenic plant of claim 1, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to said nucleotide sequence.
 3. The transgenic plant of claim 1, wherein the plant is selected from the group consisting of: soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, mint and other labiates, rosaceous fruits, and vegetable brassicas.
 4. An isolated or recombinant polynucleotide comprising a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence encoding a polypeptide comprising a sequence selected from those of SEQ ID NOs:2, 4, or a complementary nucleotide sequence thereof; (b) a nucleotide sequence encoding a polypeptide comprising a conservatively substituted variant of a polypeptide of (a); (c) one of SEQ ID NOs: 1, 3, or a complementary nucleotide sequence thereof; (d) a nucleotide sequence comprising silent substitutions in a nucleotide sequence of (c); (e) a nucleotide sequence which hybridizes under stringent conditions to a nucleotide sequence of one or more of: (a), (b), (c), or (d); (f) a nucleotide sequence comprising at least 15 consecutive nucleotides outside of a conserved domain of any of (a)-(e); (g) a nucleotide sequence comprising a subsequence or fragment of any of (a)-(f), which subsequence or fragment encodes a polypeptide that modifies a plant's trait; (h) a nucleotide sequence having at least 31% sequence identity to a nucleotide sequence of any of (a)-(g); (i) a nucleotide sequence having at least 60% sequence identity to a nucleotide sequence of any of (a)-(g); (j) a nucleotide sequence having at least 95% sequence identity to a nucleotide sequence of any of (a)-(g); (k) a nucleotide sequence which encodes a polypeptide having at least 31% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (l) a nucleotide sequence which encodes a polypeptide having at least 60% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (m) a nucleotide sequence which encodes a polypeptide having at least 75% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (n) a nucleotide sequence which encodes a polypeptide having at least 95% sequence identity outside of a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (o) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least 86% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (p) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 90% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (q) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 95% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (r) a nucleotide sequence encoding a polypeptide having an amino acid domain with at least about 98% sequence identity to a conserved domain of a polypeptide of SEQ ID NOs:2 or 4; (s) a nucleotide sequence which encodes a polypeptide having at least 31% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; (t) a nucleotide sequence which encodes a polypeptide having at least 60% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; (u) a nucleotide sequence which encodes a polypeptide having at least 75% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4; and (v) a nucleotide sequence which encodes a polypeptide having at least 95% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or
 4. 5. The isolated or recombinant polynucleotide of claim 4, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to the nucleotide sequence.
 6. An isolated or recombinant polypeptide comprising a subsequence of at least about 15 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim
 4. 7. A method of using the isolated or recombinant polynucleotide of claim 4 for producing a plant having a modified trait, the method comprising selecting a polynucleotide that encodes a polypeptide, inserting the polynucleotide into an expression vector, introducing the vector into a plant or a cell of a plant to overexpress the polypeptide, thereby producing a modified plant, and selecting for a modified trait.
 8. The transgenic plant of claim 1, wherein the trait is selected from the group consisting of: enhanced tolerance to freezing, chilling, heat, drought, water saturation, radiation and ozone; improved tolerance to microbial, fungal or viral diseases; improved tolerance to pest infestations, decreased herbicide sensitivity; improved tolerance of heavy metals or enhanced ability to take up heavy metals; improved growth under poor photoconditions.
 9. The transgenic plant of claim 1, wherein the trait is an alteration in the level of one or more of the compounds selected from the group consisting of: taxol, tocopherol, tocotrienol, sterols, phytosterols, vitamins, wax monomers, anti-oxidants, amino acids, lignins, cellulose, tannins, prenyllipids, glucosinolates, and terpenoids.
 10. The transgenic plant of claim 1, wherein the trait is an alteration in one or more physical characteristics selected from the group consisting of: the number of trichomes, fruit and seed size and number, yield of stems, leaves, or roots, stability of seeds during storage, susceptibility of the seed to shattering, root hair length and quantity, internode distances, or the quality of seed coat.
 11. The transgenic plant of claim 1, wherein the trait is an alteration in a plant growth characteristic selected from the group consisting of: growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, biomass or transpiration characteristics, apical dominance, branching patterns, number of organs, organ identity, and organ shape or size.
 12. The transgenic plant of claim 1, wherein the trait is an alteration in one or more characteristics selected from the group consisting of protein or oil production, seed protein or oil production, insoluble sugar level, soluble sugar level, and starch composition.
 13. The method of claim 7, wherein the trait is selected from the group consisting of: enhanced tolerance to freezing, chilling, heat, drought, water saturation, radiation and ozone; improved tolerance to microbial, fungal or viral diseases; improved tolerance to pest infestations, decreased herbicide sensitivity; improved tolerance of heavy metals or enhanced ability to take up heavy metals, improved growth under poor photoconditions.
 14. The method of claim 7, wherein the trait is an alteration in the level of one or more of the compounds selected from the group consisting of: taxol, tocopherol, tocotrienol, sterols, phytosterols, vitamins, wax monomers, anti-oxidants, amino acids, lignins, cellulose, tannins, prenyllipids, glucosinolates, and terpenoids.
 15. The method of claim 7, wherein the trait is an alteration in one or more physical characteristics selected from the group consisting of: the number of trichomes, fruit and seed size and number, yield of stems, leaves, or roots, stability of seeds during storage, susceptibility of the seed to shattering, root hair length and quantity, internode distances, or the quality of seed coat.
 16. The method of claim 7, wherein the trait is an alteration in a plant growth characteristic selected from the group consisting of: growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, biomass or transpiration characteristics, apical dominance, branching patterns, number of organs, organ identity, and organ shape or size.
 17. The method of claim 7, wherein the trait is an alteration in one or more characteristics selected from the group consisting of protein or oil production, seed protein or oil production, insoluble sugar level, soluble sugar level, and starch composition.
 18. A plant produced by the method of claim
 13. 19. A plant produced by the method of claim
 14. 20. A plant produced by the method of claim
 15. 21. A plant produced by the method of claim
 16. 22. A plant produced by the method of claim
 17. 23. A method of using the isolated or recombinant polynucleotide of claim 4 for producing a plant having a modified trait, the method comprising selecting a polynucleotide that when expressed produces an antisense nucleic acid sequence, inserting the polynucleotide into an expression vector, introducing the vector into a plant or a cell of a plant to express the antisense nucleic acid, thereby producing a modified plant, and selecting for a modified trait.
 24. The method of claim 23, wherein the trait is selected from the group consisting of: enhanced tolerance to freezing, chilling, heat, drought, water saturation, radiation and ozone; improved tolerance to microbial, fungal or viral diseases; improved tolerance to pest infestations, decreased herbicide sensitivity; improved tolerance of heavy metals or enhanced ability to take up heavy metals, improved growth under poor photoconditions.
 25. The method of claim 23, wherein the trait is an alteration in the level of one or more of the compounds selected from the group consisting of: taxol, tocopherol, tocotrienol, sterols, phytosterols, vitamins, wax monomers, anti-oxidants, amino acids, lignins, cellulose, tannins, prenyllipids, glucosinolates, and terpenoids.
 26. The method of claim 23, wherein the trait is an alteration in one or more physical characteristics selected from the group consisting of: the number of trichomes, fruit and seed size and number, yield of stems, leaves, or roots, stability of seeds during storage, susceptibility of the seed to shattering, root hair length and quantity, internode distances, or the quality of seed coat.
 27. The method of claim 23, wherein the trait is an alteration in a plant growth characteristic selected from the group consisting of: growth rate, germination rate of seeds, vigor of plants and seedlings, leaf and flower senescence, male sterility, apomixis, flowering time, flower abscission, rate of nitrogen uptake, biomass or transpiration characteristics, apical dominance, branching patterns, number of organs, organ identity, and organ shape or size.
 28. The method of claim 23, wherein the trait is an alteration in one or more characteristics selected from the group consisting of protein or oil production, seed protein or oil production, insoluble sugar level, soluble sugar level, and starch composition.
 29. A plant produced by the method of claim
 24. 30. A plant produced by the method of claim
 25. 31. A plant produced by the method of claim
 26. 32. A plant produced by the method of claim
 27. 33. A plant produced by the method of claim
 28. 34. An isolated or recombinant polypeptide comprising a subsequence of at least about 10 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are outside of a conserved domain.
 35. An isolated or recombinant polypeptide comprising a subsequence of at least about 20 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are outside of a conserved domain.
 36. An isolated or recombinant polypeptide comprising a subsequence of at least about 30 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are outside of a conserved domain.
 37. An isolated or recombinant polypeptide comprising a subsequence of at least about 10 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are within a conserved domain.
 38. An isolated or recombinant polypeptide comprising a subsequence of at least about 20 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are within a conserved domain.
 39. An isolated or recombinant polypeptide comprising a subsequence of at least about 30 contiguous amino acids encoded by the recombinant or isolated polynucleotide of claim 4, wherein the contiguous amino acids are within a conserved domain.
 40. A polypeptide having at least 31% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4, or the length of the polypeptide itself.
 41. A polypeptide having at least 60% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4, or the length of the polypeptide itself.
 42. A polypeptide having at least 75% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4, or the length of the polypeptide itself.
 43. A polypeptide having at least 95% sequence identity over the entire length of a polypeptide of SEQ ID NOs:2 or 4, or the length of the polypeptide itself. 